EurekaMag PDF full texts Chapter 40,242

Hegyi, E.; Busová, B.; Niks, M. 1990: HLA-A and -B antigens in IPPD-sensitive persons. Contact Dermatitis 22(4): 228-229

Biemond, I.; Burnham, W.R.; D'Amaro, J.; Langman, M.J. 1986: HLA-A and -B antigens in inflammatory bowel disease. Gut 27(8): 934-941

Darke, C.; Wagner, M.M.; McMillan, G.H. 1979: HLA-A and B antigen frequencies in an asbestos exposed population with normal and abnormal chest radiographs. Tissue Antigens 13(3): 228-232

Zervas, J.; Constantopoulos, C.; Toubis, M.; Anagnostopoulos, D.; Cotsovoulou, V. 1987: HLA-A and B antigens and pulmonary tuberculosis in Greeks. British Journal of Diseases of the Chest 81(2): 147-149

Sukumaran, K.D.; Joo, O.K. 1990: HLA-A and HLA-B antibodies of pregnant mothers in Malaysia. Medical Journal of Malaysia 45(2): 144-147

Yoshinari, N.H.; Guaditano, G.; Marchiori, P.E.; Oliveira, D.P.; Rosales, T.; Maeda, L.C.; Muniz, I. 1988: HLA-A and HLA-B antigens in patients with systemic lupus erythematosus with renal involvement. Revista do Hospital das Clinicas 43(5): 228-231

Braf, Z.F.; Gazit, E.; Many, M. 1979: HLA-A and HLA-B antigens in transitional cell carcinoma of the bladder. Journal of Urology 122(4): 465-466

Bućin, D. 1986: HLA-A antigen incompatibility and HLA-B antigen compatibility associated with enhanced kidney allograft survival in blood-transfused patients. Experimental and Clinical Immunogenetics 3(3): 138-144

Bućin, D.; Lindholm, T.; Persson, N.H. 1992: HLA-A region in highly sensitized patients: another immune response gene region. Experimental and Clinical Immunogenetics 9(3): 154-160

Joysey, V.C.; Wolf, E. 1978: HLA-A, -B and -C antigens, their serology and cross-reaction. British Medical Bulletin 34(3): 217-222

Guirguis, F.K.; Sawy, M.E.; Khalil, S.; Mikhail, M.M.; Zaky, A.; Helmy, M.A.; Helmy-Khalil, S. 1985: HLA-A, -B and -C specificities in insulin dependent diabetes mellitus in the Egyptian population. Annales de Biologie Clinique 43(3): 233-237

Walton, S.; Keczkes, K.; Learoyd, P.A.; Rajah, S.M. 1986: HLA-A, -B and DR antigens in nickel sensitive females. Clinical and Experimental Dermatology 11(6): 636-640

Säfwenberg, J.; Hammarström, L.; Lindblom, J.B.; Matell, G.; Möller, E.; Osterman, P.O.; Smith, C.I. 1978: HLA-A, -B, -C and -D antigens in male patients with myasthenia gravis. Tissue Antigens 12(2): 136-142

Rodríguez-Córdoba, S.; Regueiro, J.R.; Arnaiz Villena, A. 1986: HLA-A, -B, -C, -Bw4, Bw6 and -DR antigens are expressed on purified seminal cells other than spermatozoa. Scandinavian Journal of Immunology 24(5): 545-548

Lee, T.D.; Lee, A.; Shi, W.X. 1991: HLA-A, -B, -DR, -DQ antigens in black North Americans. Tissue Antigens 37(2): 79-83

Wadee, A.A.; Dunn, D.S. 1991: HLA-A, B and C polymorphisms in three major populations living in South Africa. Gene Geography: a Computerized Bulletin on Human Gene Frequencies 5(1-2): 23-32

Raffoux, C.; David, V.; Couderc, L.D.; Rabian, C.; Clauvel, J.P.; Seligmann, M.; Colombani, J. 1987: HLA-A, B and DR antigen frequencies in patients with AIDS-related persistent generalized lymphadenopathy (PGL) and thrombocytopenia. Tissue Antigens 29(1): 60-62

Klouda, P.T.; Harrison, R.; Corbin, S.A.; Bradley, B.A.; Easty, D.L. 1986: HLA-A, B and DR antigens in patients with keratoconus. Tissue Antigens 27(2): 114-115

Prazák, J.; Mĕricka, O. 1987: HLA-A, B antigens and bronchogenic pulmonary carcinoma. Casopis Lekaru Ceskych 126(34): 1081-1082

Wang, R.F.; Chu, R.Y.; Guo, B.K. 1986: HLA-A, B antigens and the relation between high myopia and high myopia with glaucoma. Chinese Medical Journal 99(10): 775-778

Bertrams, J.; Baur, M.P. 1979: HLA-A, B, Bf three point association of 1,072 haplotypes in a German population. Tissue Antigens 14(4): 317-324

Orren, A.; Taljaard, D.; de Toit, E. 1985: HLA-A, B, C and DR antigen associations in insulin dependent diabetes mellitus (IDDM) in South African Negro (black) and Cape coloured people. Tissue Antigens 26(5): 332-339

Yang, P.M.; Sung, J.L.; Chen, D.S. 1989: HLA-A, B, C and DR antigens in chronic hepatitis B viral infection. Hepato-Gastroenterology 36(5): 363-366

Kusber, M. 1985: HLA-A, B, C and DR antigens in exogenous allergic alveolitis--association with HLA-DRw6. Praxis und Klinik der Pneumologie 39(10): 356-359

Mozzanica, N.; Rizzolo, L.; Veneroni, G.; Diotti, R.; Hepeisen, S.; Finzi, A.F. 1990: HLA-A, B, C and DR antigens in nickel contact sensitivity. British Journal of Dermatology 122(3): 309-313

Mayr, W.R. 1977: HLA-A, B, C gene and haplotype frequencies in Vienna. An analysis of family data. Human Genetics 37(1): 41-48

Baldauf, C.; Schaller, J.; Herrmann, K.; Haustein, U.F. 1989: HLA-A, B, C phenotype frequencies in progressive systemic scleroderma. Dermatologische Monatschrift 175(1): 16-19

Chen, R. 1988: HLA-A, B, C, DR antigens in north Chinese with nasopharyngeal carcinoma. Zhonghua Er Bi Yan Hou Ke Za Zhi 23(2): 106-107

Gallina, G.; Cumbo, V.; Messina, P.; Caruso, C. 1985: HLA-A, B, C, DR, MT, and MB antigens in recurrent aphthous stomatitis. Oral Surgery Oral Medicine and Oral Pathology 59(4): 364-370

Mercier, P.; Vallo, J.J.; Vialettes, B.; Vague, P. 1985: HLA-A, B, DR antigens and insulin-dependent diabetes in Algerians. Tissue Antigens 26(1): 20-24

Maharaj, B.; Hammond, M.G. 1990: HLA-A, B, DR, and DQ antigens in black patients with idiopathic dilated cardiomyopathy. American Journal of Cardiology 65(20): 1402-1403

Maharaj, B.; Hammond, M.G.; Appadoo, B.; Leary, W.P.; Pudifin, D.J. 1987: HLA-A, B, DR, and DQ antigens in black patients with severe chronic rheumatic heart disease. Circulation 76(2): 259-261

Májský, A.; Gregor, P.; Prazák, J. 1989: HLA-A, B-antigens and hypertrophic cardiomyopathy. Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 44(12): 361-362

Pachoula-Papasteriades, C.; Boki, K.; Varla-Leftherioti, M.; Kappos-Rigatou, I.; Fostiropoulos, G.; Economidou, J. 1986: HLA-A,-B, and -DR antigens in relation to gold and D-penicillamine toxicity in Greek patients with RA. Disease Markers 4(1-2): 35-41

Shah, S.J.; Panthaki, M.H.; Banker, D.D. 1988: HLA-A,-B,-C matching in renal transplantation. Indian Journal of Medical Research 87: 59-61

Dyer, P.A.; Ridway, J.C.; Flanagan, N.G. 1986: HLA-A,B and DR antigens in chronic lymphocytic leukaemia. Disease Markers 4(3): 231-237

Boisjoly, H.M.; Roy, R.; Dubé, I.; Laughrea, P.A.; Michaud, R.; Douville, P.; Heébert, J. 1986: HLA-A,B and DR matching in corneal transplantation. Ophthalmology 93(10): 1290-1297

Solow, H.; Hidalgo, R.; Blajchman, M.; Singal, D.P. 1977: HLA-A,B,C and B-lymphocyte alloantigens in insulin-dependent diabetes. Transplantation Proceedings 9(4): 1859-1861

Huang, H.S.; Huang, M.J.; Huang, C.C.; Huang, B.Y.; Lin, J.D.; Juang, J.H.; Liu, R.T. 1989: HLA-A,B,C and DR antigens in Chinese with non-insulin-dependent diabetes: comparison with goitrous diabetics. Taiwan Yi Xue Hui Za Zhi. Journal of the Formosan Medical Association 88(1): 43-47

Kamel, M.A.; Zakaria, S.; Mabrouk, M.A.; Zakaria, E. 1987: HLA-A,B,C and DR antigens in Egyptian patients with schistosomal colonic polyposis. Journal of the Egyptian Society of Parasitology 17(2): 609-613

Zakaria, S.; Kamel, M.A.; Mabrouk, M.A.; Zakaria, E. 1988: HLA-A,B,C and DR antigens in Egyptian patients with schistosomal hepatosplenomegaly. Journal of the Egyptian Society of Parasitology 18(1): 253-257

Ayed, K.; Bardi, R.; Gebuhrer, L.; Gorgi, Y.; Betuel, H. 1987: HLA-A,B,C and DR antigens in a sample of the Tunisian population. Tissue Antigens 29(5): 225-231

Kao, J.S.; Yu, H.S.; Shey, H.M.; Chen, G.S. 1987: HLA-A,B,C and DR in Chinese with psoriasis: relation to age of onset and clinical expression of the disease. Taiwan Yi Xue Hui Za Zhi. Journal of the Formosan Medical Association 86(3): 259-263

Lampson, L.A.; Whelan, J.P.; Fisher, C.A. 1985: HLA-A,B,C and beta 2-microglobulin are expressed weakly by human cells of neuronal origin, but can be induced in neuroblastoma cell lines by interferon. Progress in Clinical and Biological Research 175: 379-388

Ballardini, G.; Bianchi, F.B.; Mirakian, R.; Fallani, M.; Pisi, E.; Bottazzo, G.F. 1987: HLA-A,B,C, HLA-D/DR and HLA-D/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease. Clinical and Experimental Immunology 70(1): 35-46

Albanidou-Farmaki, E.; Kayavis, I.G.; Polymenidis, Z.; Papanayotou, P. 1988: HLA-A,B,C, and DR antigens in recurrent oral ulcers. Annals of Dentistry 47(1): 5-8; 15

Grosse-Wilde, H.; Valentine-Thon, E.; Vögeler, U.; Passarge, E.; Lorenzen, F.; Sippell, W.G.; Bidlingmaier, F.; Knorr, D. 1988: HLA-A,B,C,DR typing and 17-OHP determination for second trimester prenatal diagnosis of 21-hydroxylase deficient CAH. Prenatal Diagnosis 8(2): 131-143

Stam, N.J.; Vroom, T.M.; Peters, P.J.; Pastoors, E.B.; Ploegh, H.L. 1990: HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. International Immunology 2(2): 113-125

Heise, E.R.; Mentnech, M.S.; Olenchock, S.A.; Kutz, S.A.; Morgan, W.K.; Merchant, J.A.; Major, P.C. 1979: HLA-A1 and coalworkers' pneumoconiosis. American Review of Respiratory Disease 119(6): 903-908

Metzer, W.S.; Newton, J.E.; Paige, S.R. 1988: HLA-A1 and schizophrenia. Biological Psychiatry 24(3): 364-365

Stastny, P.; Gilliam, J.N. 1979: HLA-A1, B8, DRw3 in patients with a distinct form of lupus erythematosus. Transplantation Proceedings 11(4): 1869-1870

Hashimoto, K.; Miki, Y.; Nakata, S.; Matsuyama, M. 1977: HLA-A10 in pemphigus among Japanese. Archives of Dermatology 113(11): 1518-1519

Shin, D.H.; Becker, B. 1977: HLA-A11 and HLA-Bw35 and resistance to glaucoma in white patients with ocular hypertension. Archives of Ophthalmology 95(3): 423-424

McGregor, J.M.; Reddi, G.; MacDonald, D.; Vaughan, R.W.; Welsh, K.I. 1992: HLA-A11 in renal allograft recipients with skin cancer. Journal of Investigative Dermatology 98(2): 261-262

Orgad, S.; Cohen, I.J.; Neumann, Y.; Vogel, R.; Kende, G.; Ramot, B.; Zaizov, R.; Gazit, E. 1988: HLA-A11 is associated with poor prognosis in childhood acute lymphoblastic leukemia (ALL). Leukemia 2(12 Suppl): 79s-87s

Bavinck, J.N.; Kootte, A.M.; van der Woude, F.J.; Vandenbroucke, J.P.; Vermeer, B.J.; Claas, F.H. 1990: HLA-A11-associated resistance to skin cancer in renal-transplant recipients. New England Journal of Medicine 323(19): 1350

Small, G.W.; Matsuyama, S.S. 1986: HLA-A2 as a possible marker for early-onset Alzheimer disease in men. Neurobiology of Aging 7(3): 211-214

Scornik, J.C. 1987: HLA-A2 epitopes recognized by alloantibodies from broadly sensitized patients. Human Immunology 18(4): 277-285

Slovin, S.F.; Lackman, R.D.; Mastrangelo, M.J. 1987: HLA-A2 in sarcomas: an immunobiologic perspective. Transplantation 43(6): 923-925

Payami, H.; Kaye, J.; Becker, W.; Norman, D.; Wetzsteon, P. 1991: HLA-A2, or a closely linked gene, confers susceptibility to early-onset sporadic Alzheimer's disease in men. Neurology 41(10): 1544-1548

Garboczi, D.N.; Hung, D.T.; Wiley, D.C. 1992: HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proceedings of the National Academy of Sciences of the United States of America 89(8): 3429-3433

Henderson, R.A.; Michel, H.; Sakaguchi, K.; Shabanowitz, J.; Appella, E.; Hunt, D.F.; Engelhard, V.H. 1992: HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science 255(5049): 1264-1266

Tsuneto, L.T.; Arce-Gomez, B.; Petzl-Erler, M.L.; Queiroz-Telles, F. 1989: HLA-A29 and genetic susceptibility to chromoblastomycosis. Journal of Medical and Veterinary Mycology: Bi-Monthly Publication of the International Society for Human and Animal Mycology 27(3): 181-185

Tabary, T.; Prochnicka-Chalufour, A.; Cornillet, P.; Lehoang, P.; Betuel, H.; Cohen, J.H. 1991: HLA-A29 sub-types and "Birdshot" choroido-retinopathy susceptibility: a possible "resistance motif" in the HLA-A29.1 molecule. Comptes Rendus de l'Academie des Sciences. Serie Iii Sciences de la Vie 313(13): 599-605

De Waal, L.P.; Lardy, N.M.; van der Horst, A.R.; Baarsma, G.S.; Kijlstra, A.; Noens, L.; Priem, H.A. 1992: HLA-A29 subtypes and birdshot chorioretinopathy. Immunogenetics 35(1): 51-53

LeHoang, P.; Ozdemir, N.; Benhamou, A.; Tabary, T.; Edelson, C.; Betuel, H.; Semiglia, R.; Cohen, J.H. 1992: HLA-A29.2 subtype associated with birdshot retinochoroidopathy. American Journal of Ophthalmology 113(1): 33-35

Caputo, D.; Bisaccia, G.; Sabbadini, M.G.; Zibetti, A. 1977: HLA-A3 linked C3 deficiency in multiple sclerosis. Bollettino Dell'istituto Sieroterapico Milanese 56(3): 260-263

Cohen, E.; Singal, D.P.; Khurana, U.; Gregory, S.G.; Cox, C.; Sinks, L.; Henderson, E.; Fitzpatrick, J.E.; Higby, D. 1977: HLA-A9 and survival in acute lymphocytic leukemia and myelocytic leukemia. Progress in Clinical and Biological Research 16: 65-70

Sandberg, L.; Blohmé, I.; Brynger, H.; Lindholm, A. 1977: HLA-ABC matching and outcome of primary cadaveric kidney transplantations in Gothenburg. Scandinavian Journal of Urology and Nephrology. Supplementum 42: 25-27

Zemmour, J.; Koller, B.H.; Ennis, P.D.; Geraghty, D.E.; Lawlor, D.A.; Orr, H.T.; Parham, P. 1990: HLA-AR, an inactivated antigen-presenting locus related to HLA-A. Implications for the evolution of the MHC. Journal of Immunology 144(9): 3619-3629

Suciu-Foca, N.; Susinno, E.; Godfrey, M.; McKiernan, P.; Rohowsky, C.; Sankel, M.; Suciu, A. 1979: HLA-Antigens in the Romanian population. Transplantation Proceedings 11(4): 1732-1734

Vannas, S.; Tiilikainen, A.; Vannas, A.; Karjalainen, K. 1978: HLA-B 12 and HLA-B 27 antigens and susceptibility to the corneal allograft reaction. Acta Ophthalmologica 56(5): 689-696

Malchus, R.; Marsch, W.C.; Ehlers, G. 1986: HLA-B 16 in Hailey-Hailey's disease. Acta Dermato-Venereologica 66(3): 264-266

Libich, M.; Májský, A.; Bartsch, D. 1975: HLA-B 27 (W 27) antigen and other immunological factors in anklyosing spondylarthritis. Casopis Lekaru Ceskych 114(49): 1521-1523

Hamza, M.; Ayed, K.; Houissa, R.; Ben Ayed, H. 1979: HLA-B 27 and ankylosing spondylarthritis in Tunisia. La Tunisie Medicale 56(5): 431-433

Gömär, B.; Gyódi, K.E. 1977: HLA-B 27 antigen in spondylitis ankylopoietica (Bechterew's disease). Orvosi Hetilap 118(11): 616-619

Reekers, P.; van der Beucken, M.; Andrien, M.; Beelen, J.; Mueller-Eckhardt, G.; Schreuder, G.M. 1986: HLA-B POT: a new HLA-antigen within the B7-cross reactive group. Tissue Antigens 28(3): 182-189

Andrien, M.; Reekers, P.; Stordeur, P.; Vandercruys, M.; Dupont, E. 1989: HLA-B SNA antigen: a BW6 associated B locus antigen belonging to the B5 CREG. Tissue Antigens 33(3): 400-407

Andrien, M.; Reekers, P.; Stordeur, P.; Vandercruys, M.; Dupont, E. 1989: HLA-B SNA antigen: a BW6-associated B locus antigen belonging to the B5 CREG. Transplantation Proceedings 21(1 Pt 1): 646

Hamza, M.; Houissa, R.; Ben Ayed, H. 1976: HLA-B and chronic juvenile polyarthritis. La Tunisie Medicale 54(5): 779-782

Fournié, B.; Granel, J.; Heraud, A.; Cambon-Thomsen, A.; Pages, M.; Dromer, C.; Ohayon, E.; Fournié, A. 1991: HLA-B and psoriatic rheumatism. Study of 193 cases. Revue du Rhumatisme et des Maladies Osteo-Articulaires 58(4): 269-273

Coppin, H.L.; Denny, D.W.; Weissman, S.M.; McDevitt, H.O. 1985: HLA-B locus polymorphism: studies with a specific hybridization probe. Proceedings of the National Academy of Sciences of the United States of America 82(24): 8614-8618

Carpenter, C.B.; Goguen, J.E.; Bradley, J.W.; Turka, L.A.; Cho, S.I.; Milford, E.L. 1989: HLA-B, DR matching and cadaver renal allograft survival in new England. new England Organ Bank. Transplantation Proceedings 21(1 Part 1): 663-664

Netzel, B.; Grosse-Wilde, H.; Suciu-Foca, N.; Rittner, C.; Scholz, S.; Albert, E.D. 1976: HLA-B/D recombination frequency and MLC studies in recombinant families. Zeitschrift für Immunitatsforschung. Immunobiology 152(4): 289-292

Bailey, M.; Wallace, M. 1978: HLA-B12 as a genetic marker for vesicoureteric reflux?. British Medical Journal 1(6104): 48-49

Kianto, U.; Reunala, T.; Karvonen, J.; Lassus, A.; Tiilikainen, A. 1977: HLA-B12 in alopecia areata. Archives of Dermatology 113(12): 1716

Levine, L.S. 1985: HLA-B14 and nonclassical 21-hydroxylase deficiency in a heterogeneous new York population. Annals of the new York Academy of Sciences 458: 65-70

Alonso, A.; Doyle, P.; Williams, E.; Gill, D.; Ollier, W.; Jaraquemada, D.; Awad, J.; Festenstein, H. 1985: HLA-B15 heterogeneity in different populations. Tissue Antigens 25(1): 33-37

Heise, E.; Parrish, E.; Cooper, R. 1979: HLA-B17 and the HLA-A1, B17 haplotype in acute myelogenous leukemia. Tissue Antigens 14(2): 98-104

Huuskonen, M.S.; Tiilikainen, A.; Alanko, K. 1979: HLA-B18 antigens and protection from pulmonary fibrosis in asbestos workers. British Journal of Diseases of the Chest 73(3): 253-259

Erickson, R.P.; Pairitz, G.L.; Karolyi, J.M.; Kapur, J.J.; Odenheimer, D.J.; Schultz, J.S.; Sing, C.F. 1985: HLA-B18 is associated with decreased levels of isoproterenol-stimulated cAMP in lymphocytes. American Journal of Human Genetics 37(1): 124-132

Khan, M.A. 1989: HLA-B27 and B12(B44) in Crohn's disease with ankylosing spondylitis. Journal of Rheumatology 16(6): 851-852

Haberhauer, G.; Bröll, H. 1988: HLA-B27 and B27 cross-reactive group associated sacroiliac joint involvement in Paget's disease of bone. Beitrage Zur Orthopadie und Traumatologie 35(4): 173-176

López de Castro, J.A. 1989: HLA-B27 and HLA-A2 subtypes: structure, evolution and function. Immunology Today 10(7): 239-246

Feltkamp, T.E. 1990: HLA-B27 and acute anterior uveitis. Current Eye Research 9 Suppl: 213-218

Diez, R.A. 1990: HLA-B27 and agranulocytosis by levamisole. Immunology Today 11(8): 270

McLean, I.L.; Adams, D.D.; Highton, J. 1985: HLA-B27 and ankylosing spondylitis: an anti-idiotypic model. Journal of Clinical and Laboratory Immunology 18(3): 123-127

Khan, M.A. 1991: HLA-B27 and arthritis: back to the future. Journal of Rheumatology 18(10): 1638

Wagener, P.; Mau, W.; Zeidler, H.; Eckert, G.; Robin-Winn, M.; Deicher, H. 1985: HLA-B27 and clinical aspects of ankylosing spondylitis: results of prospective studies. Immunological Reviews 86: 93-100

Benjamin, R.; Parham, P. 1992: HLA-B27 and disease: a consequence of inadvertent antigen presentation?. Rheumatic Diseases Clinics of North America 18(1): 11-21

Petty, R.E. 1990: HLA-B27 and rheumatic diseases of childhood. Journal of Rheumatology. Suppl 26: 7-10

Anonymous 1978: HLA-B27 and risk of ankylosing spondylitis. British Medical Journal 2(6138): 650-651

Archer, J.R.; Winrow, V.R. 1987: HLA-B27 and the causes of arthritis: does molecular biology help?. Annals of the Rheumatic Diseases 46(9): 713-715

Reynolds, T.L.; Khan, M.A. 1988: HLA-B27 and the putative susceptibility gene for ankylosing spondylitis. Journal of Rheumatology 15(6): 1037-1038

Gaucher, A.; Netter, P.; Fuare, G.; Raffoux, C.; Chanson, B.; Baumgartner, J.; Psurel, J.; Streiff, F. 1977: HLA-B27 antigen and alkaptonuria. Revue du Rhumatisme et des Maladies Osteo-Articulaires 44(4): 273-277

Khan, M.A. 1977: HLA-B27 antigen and rheumatic diseases. Ohio State Medical Journal 73(9): 619-621

Jajić, Z.; Jajić, I.; Jajić, I. 1991: HLA-B27 antigen and rheumatoid arthritis. Acta Medica Iugoslavica 45(3): 195-202

Nasrallah, N.S.; Masi, A.T.; Chandler, R.W.; Feigenbaum, S.L.; Kaplan, S.B. 1977: HLA-B27 antigen and rheumatoid factor negative (seronegative) peripheral arthritis. Studies in younger patients with early-diagnosed arthritis. American Journal of Medicine 63(3): 379-386

Amor, B. 1979: HLA-B27 antigen and seronegative arthritis. Acta Rhumatologica Belgica 3(2): 164-175

Mladenović, V.; Parunović, A. 1979: HLA-B27 antigen in acute anterior uveitis and ankylosing spondylitis or Reiter's disease. Reumatizam 26(6): 219-223

Jajić, I.; Kastelan, A. 1977: HLA-B27 antigen in ankylosing spondylitis and its role in the etiopathogenesis of the disease. Reumatizam 24(6): 195-200

Macera, C.; Losada, M.; Melendez, M.; Fuentes, C.; Mauritz, A.M. 1977: HLA-B27 antigen in ankylosing spondylitis and other forms of rheumatism. Revista Medica de Chile 105(2): 90-92

Joliat, G.; Ferro, A.; Jeannet, M.; Ott, H. 1976: HLA-B27 antigen in diagnosis of atypical seronegative inflammatory arthropathy. Annals of the Rheumatic Diseases 35(6): 531-533

Le Goff, P.; Le Menn, G.; Youinou, P.; Clavier, J.; Baret, M.; Saleun, J.P. 1978: HLA-B27 antigen in subjects with osseous proliferation. La Nouvelle Presse Medicale 7(2): 120-121

Dostál, C.; Nohejl, J.; Ivasková, E.; Fáberová, R.; Zvárová, J.; Roth, Z.; Trnavský, K. 1988: HLA-B27 antigen in the nonspecific back pain type of spondylopathy. Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca 55(2): 128-135

Levitin, P.M.; Gough, W.W.; Davis, J.S. 1976: HLA-B27 antigen in women with ankylosing spondylitis. JAMA 235(24): 2621-2622

Rojo, S.; López de Castro, J.A.; Aparicio, P.; Van Seventer, G.; Bragado, R. 1986: HLA-B27 antigenicity: antibodies against the chemically synthesized 63-84 peptide from HLA-B27.1 display alloantigenic specificity and discriminate among HLA-B27 subtypes. Journal of Immunology 137(3): 904-910

Haberhauer, G.; Bröll, H. 1989: HLA-B27 as a diagnostic aid in rheumatology. Zeitschrift für Arztliche Fortbildung 83(1): 21-23

Haberhauer, G.; Bröll, H. 1988: HLA-B27 as a genetic marker of extra-articular manifestations of ankylosing spondylitis. Beitrage Zur Orthopadie und Traumatologie 35(8): 398-401

Beersma, M.F.; Bijlmakers, M.J.; Geelen, J.L.; Feltkamp, T.E. 1992: HLA-B27 as a receptor for cytomegalovirus. Current Eye Research 11 Suppl: 141-146

Schumacher, T.M.; Genant, H.K.; Kellet, M.J.; Mall, J.C.; Fye, K.H. 1978: HLA-B27 associated arthropathies. Radiology 126(2): 289-297

McGuigan, L.E.; Geczy, A.F.; Prendergast, J.K.; Edmonds, J.P.; Hart, H.H.; Bashir, H.V. 1986: HLA-B27 associated cross-reactive marker on the cells of New Zealand patients with ankylosing spondylitis. Annals of the Rheumatic Diseases 45(2): 144-148

Siegel, D.M.; Baum, J. 1988: HLA-B27 associated dactylitis in children. Journal of Rheumatology 15(6): 976-977

Lionarons, R.J.; van Zoeren, M.; Verhagen, J.N.; Lammers, H.A. 1986: HLA-B27 associated reactive spondyloarthropathies in a Dutch military hospital. Annals of the Rheumatic Diseases 45(2): 141-143

Hussein, A. 1987: HLA-B27 associated spondyloarthritis in childhood. Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 135(4): 185-194

Kapasi, K.; Inman, R.D. 1992: HLA-B27 expression modulates gram-negative bacterial invasion into transfected L cells. Journal of Immunology 148(11): 3554-3559

Zervas, J.; Tsokos, G.; Papadakis, G.; Kabouklis, E.; Papadopoulos, D. 1977: HLA-B27 frequency in Greek patients with acute anterior uveitis. British Journal of Ophthalmology 61(11): 699-701

Yazici, H.; Schreuder, I.; Yurdakul, S.; Ozbakir, F. 1987: HLA-B27 in Turkish patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 46(9): 718

Friis, J.; Morling, N.; Pedersen, F.K.; Heilmann, C.; Jørgensen, B.; Svejgaard, A.; Thomsen, K. 1985: HLA-B27 in juvenile chronic arthritis. Journal of Rheumatology 12(1): 119-122

Hrncírová, L.; Klabusay, L.; Vitulová, V. 1991: HLA-B27 in the families of probands with arthritis after acute respiratory tract disease. Vnitrni Lekarstvi 37(9-10): 776-780

Saveuse, H.; Rouveix, E.; de Bandt, M.; Struz, P.; Haettich, B.; Dorra, M. 1988: HLA-B27 inflammatory spondylarthropathy, psoriasis and HIV infection. Presse Medicale 17(14): 698-699

Møller, P. 1990: HLA-B27 is necessary but not sufficient. Scandinavian Journal of Rheumatology. Suppl 87: 131-133

Grassi, W.; Offidani, A.M.; Blasetti, P.; Simonetti, O.; Cervini, C. 1988: HLA-B27 negative ankylosing spondylitis and hidradenitis suppurativa: report of a case. Clinical Rheumatology 7(2): 278-283

Mielants, H.; Veys, E.M.; Verbraeken, H.; De Vos, M.; Cuvelier, C. 1990: HLA-B27 positive idiopathic acute anterior uveitis: a unique manifestation of subclinical gut inflammation. Journal of Rheumatology 17(6): 841-842

Choksi, A.P.; Joshi, V.R. 1988: HLA-B27 positive spondyloarthritis in a case of tuberculous rectal stricture. Journal of the Association of Physicians of India 36(5): 337-339

Mielants, H.; Veys, E.M. 1985: HLA-B27 related arthritis and bowel inflammation. Part 1. Sulfasalazine (salazopyrin) in HLA-B27 related reactive arthritis. Journal of Rheumatology 12(2): 287-293

Mielants, H.; Veys, E.M.; Cuvelier, C.; De Vos, M.; Botelberghe, L. 1985: HLA-B27 related arthritis and bowel inflammation. Part 2. Ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis. Journal of Rheumatology 12(2): 294-298

Sheldon, P. 1987: HLA-B27 related arthritis, sulphasalazine and rheumatoid arthritis. British Journal of Rheumatology 26(5): 321-324

MacLean, I.L.; Archer, J.R.; Whelan, M.A. 1991: HLA-B27 subtypes. Lancet 337(8746): 927

Sanmarti, R.; Cañete, J.D.; Collado, A.; Brancos, M.A.; Rotés-Querol; Ercilla, M.G. 1989: HLA-B27 subtypes and seronegative spondyloarthropathies. Clinical and Experimental Rheumatology 7(1): 102-103

MacLean, L. 1992: HLA-B27 subtypes: implications for the spondyloarthropathies. Annals of the Rheumatic Diseases 51(8): 929-931

Baron, M.; Zendel, I. 1989: HLA-B27 testing in ankylosing spondylitis: an analysis of the pretesting assumptions. Journal of Rheumatology 16(5): 631

Albrecht, J.; Müller, H.A. 1987: HLA-B27 typing by use of flow cytofluorometry. Clinical Chemistry 33(9): 1619-1623

Derhaag, P.J.; van der Horst, A.R.; de Waal, L.P.; Feltkamp, T.E. 1989: HLA-B27+ acute anterior uveitis and other antigens of the major histocompatibility complex. Investigative Ophthalmology and Visual Science 30(10): 2160-2164

Toubert, A.; Philippon, A.; Amor, B. 1987: HLA-B27, ankylosing spondylitis and Klebsiella pneumoniae: toward a molecular approach. Journal of Rheumatology 14(2): 391-393

Schmidt, K.L.; Mueller-Eckhardt, C.; Breithaupt, H. 1978: HLA-B27, antinuclear antibodies and drug-induced agranulocytosis. Klinische Wochenschrift 56(23): 1189-1191

Clunie, G.P.; Koki, G.; Prasad, M.L.; Richens, J.E.; Bhatia, K.; Keat, A. 1990: HLA-B27, arthritis and spondylitis in an isolated community in Papua new Guinea. British Journal of Rheumatology 29(2): 97-100

Geczy, A.F.; Prendergast, J.K.; Sullivan, J.S.; Upfold, L.I.; McGuigan, L.E.; Bashir, H.V.; Prendergast, M.; Edmonds, J.P. 1987: HLA-B27, molecular mimicry, and ankylosing spondylitis: popular misconceptions. Annals of the Rheumatic Diseases 46(2): 171-172

Sheerin, K.A.; Giannini, E.H.; Brewer, E.J.; Barron, K.S. 1988: HLA-B27-associated arthropathy in childhood: long-term clinical and diagnostic outcome. Arthritis and Rheumatism 31(9): 1165-1170

O'Donoghue, D.J. 1985: HLA-B27-associated heart disease. American Journal of Medicine 79(1): A53 A107

Mody, G.M.; Deenadayalu, V.K.; Kelbe, D.M. 1990: HLA-B27-associated seronegative enthesopathy and arthropathy in a black child. South African Medical Journal 77(1): 41-42

Saal, J.G.; Wojatschek, C.; Rautenstrauch, H. 1988: HLA-B27-negative sacroiliitis as a complication of inflammatory forms of acne: case reports and review of the literature. Zeitschrift für Rheumatologie 47(6): 405-412

Lehman, T.J.; Hanson, V.; Kornreich, H.; Peters, R.S.; Schwabe, A.D. 1978: HLA-B27-negative sacroiliitis: a manifestation of familial Mediterranean fever in childhood. Pediatrics 61(3): 423-426

Genth, E.; Peuckert, H.; Brude, E.; Hehl, M.; Hartl, W. 1978: HLA-B27-positive oligarthritis. Zeitschrift für Rheumatologie 37(9-10): 313-328

Linssen, A.; Feltkamp, T.E. 1987: HLA-B27-related diseases and their pathogenesis. Nederlands Tijdschrift Voor Geneeskunde 131(44): 1955-1959

Bergfeldt, L.; Insulander, P.; Lindblom, D.; Möller, E.; Edhag, O. 1988: HLA-B27: an important genetic risk factor for lone aortic regurgitation and severe conduction system abnormalities. American Journal of Medicine 85(1): 12-18

Upfold, L.I.; Sullivan, J.S.; Prendergast, J.K.; Geczy, A.F. 1985: HLA-B27: speculations on the nature of its involvement in ankylosing spondylitis. Progress in Allergy 36: 177-189

Van Bohemen, C.G.; Nabbe, A.J.; Landheer, J.E.; Grumet, F.C.; Mazurkiewicz, E.S.; Dinant, H.J.; Lionarons, R.J.; van Bodegom, P.C.; Zanen, H.C. 1986: HLA-B27M1M2 and high immune responsiveness to Shigella flexneri in post-dysenteric arthritis. Immunology Letters 13(1-2): 71-74

Yuki, N.; Sato, S.; Itoh, T.; Miyatake, T. 1991: HLA-B35 and acute axonal polyneuropathy following Campylobacter infection. Neurology 41(10): 1561-1563

Eisera, N.; Fabio, G.; Marchini, M.; Zarantonello, M.; Lazzarin, A.; Scorza, R. 1991: HLA-B35 and thrombocytopenia in drug users with AIDS. Journal of Infectious Diseases 163(4): 926-927

Itescu, S.; Mathur-Wagh, U.; Skovron, M.L.; Brancato, L.J.; Marmor, M.; Zeleniuch-Jacquotte, A.; Winchester, R. 1992: HLA-B35 is associated with accelerated progression to AIDS. Journal of Acquired Immune Deficiency Syndromes 5(1): 37-45

Alarif, L.; Castro, O.; Ofosu, M.; Dunston, G.; Scott, R.B. 1986: HLA-B35 is associated with red cell alloimmunization in sickle cell disease. Clinical Immunology and Immunopathology 38(2): 178-183

Carreno, B.M.; Anderson, R.W.; Coligan, J.E.; Biddison, W.E. 1990: HLA-B37 and HLA-A2.1 molecules bind largely nonoverlapping sets of peptides. Proceedings of the National Academy of Sciences of the United States of America 87(9): 3420-3424

Joseph, G.; Nguyen, V.; Smith, J.D. 1992: HLA-B38 and clozapine-induced agranulocytosis. Annals of Internal Medicine 116(7): 605

Lieberman, J.A.; Yunis, J.; Egea, E.; Canoso, R.T.; Kane, J.M.; Yunis, E.J. 1990: HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia. Archives of General Psychiatry 47(10): 945-948

Crivellato, E.; Zacchi, T. 1987: HLA-B39 and the axial type of psoriatic arthritis. Acta Dermato-Venereologica 67(3): 249-250

Charles, P.J.; Sweatman, M.C.; Markwick, J.R.; Maini, R.N. 1991: HLA-B40: a marker for susceptibility to lung disease in rheumatoid arthritis. Disease Markers 9(2): 97-101

Rose, S.; Mehra, N.K.; Kumar, R.; Vaidya, M.C. 1991: HLA-B5 and B21 antigens in aortoarteritis. Indian Journal of Pediatrics 58(1): 85-89

Rotter, J.I.; Rimoin, D.L.; Gursky, J.M.; Terasaki, P.; Sturdevant, R.A. 1977: HLA-B5 associated with duodenal ulcer. Gastroenterology 73(3): 438-440

Hayashi, H.; Ennis, P.D.; Ariga, H.; Salter, R.D.; Parham, P.; Kano, K.; Takiguchi, M. 1989: HLA-B51 and HLA-Bw52 differ by only two amino acids which are in the helical region of the alpha 1 domain. Journal of Immunology 142(1): 306-311

Wolf, M.D.; Folk, J.C.; Panknen, C.A.; Goeken, N.E. 1990: HLA-B7 and HLA-DR2 antigens and acute posterior multifocal placoid pigment epitheliopathy. Archives of Ophthalmology 108(5): 698-700

Khan, M.A.; Kushner, I.; Braun, W.E.; Schacter, B.Z.; Steinberg, A.G. 1977: HLA-B7 and ankylosing spondylitis in American blacks. New England Journal of Medicine 297(9): 513

Buckley, C.E.; White, D.H.; Seigler, H.F. 1977: HLA-B7 associated tuberculin hyporesponsiveness in BCG treated melanoma patients. Monographs in Allergy 11: 97-105

Schacter, B.; Braun, W.E.; Bukowski, R.; Deodhar, S. 1977: HLA-B7 association with low spontaneous cell-mediated cytotoxicity (Sp-CMC) to renal cell carcinoma cell lines. Transplantation Proceedings 9(4): 1849-1851

Goodfriend, L.; Santilli, J.; Schacter, B.; Bias, W.B.; Marsh, D.G. 1977: HLA-B7 cross-reacting group and human IgE-mediated sensitivity to ragweed allergen Ra5. Monographs in Allergy 11: 80-82

Toubert, A.; Sire, J.; Sodoyer, R.; Amor, B.; Jordan, B.R. 1988: HLA-B7/B27 constructs: a tool to understand the molecular mimicry hypothesis between HLA-B27 and gram-negative bacterial antigens in ankylosing spondylitis. British Journal of Rheumatology 27(Suppl 2): 19-22

Clough, J.D.; Aponte, C.J.; Braun, W.E. 1977: HLA-B8 and clinical features of Sjogren's syndrome. Clinical Immunology and Immunopathology 7(3): 324-329

Katz, S.I.; Hertz, K.C.; Rogentine, N.; Strober, W. 1977: HLA-B8 and dermatitis herpetiformis in patients with IgA deposits in skin. Archives of Dermatology 113(2): 155-156

Drannik, G.N.; Montag, T.S.; Zolotkovskaia, O.Z. 1988: HLA-B8 antigen as a possible risk factor for developing illnesses accompanied by an autoimmune component. Urologiia i Nefrologiia 6: 20-24

Scherak, O.; Kolarz, G.; Mayr, W.R. 1978: HLA-B8 in caucasian patients with systemic lupus erythematosus. Scandinavian Journal of Rheumatology 7(1): 3-6

Behan, W.M.; Behan, P.O.; Dick, H.A. 1978: HLA-B8 in polymyositis. New England Journal of Medicine 298(22): 1260-1261

Iványi, D.; Dostál, C.; Mrklas, L. 1976: HLA-B8 in systemic lupus erythematosus. Tissue Antigens 8(1): 91-93

O'Regan, S. 1979: HLA-B8, autoimmune polyendocrinopathy and systemic lupus erythematosus. Canadian Medical Association Journal 121(9): 1168-1169

Candore, G.; Colucci, A.T.; Modica, M.A.; Caruso, C. 1991: HLA-B8,DR3 T cell impairment is completely restored by in vitro treatment with interleukin-2. Immunopharmacology and Immunotoxicology 13(4): 551-561

Modica, M.A.; Cammarata, G.; Caruso, C. 1990: HLA-B8,DR3 phenotype and lymphocyte responses to phytohaemagglutinin. Journal of Immunogenetics 17(1-2): 101-107

Kallenberg, C.G.; Klaassen, R.J.; Beelen, J.M.; The, T.H. 1985: HLA-B8/DR3 phenotype and the primary immune response. Clinical Immunology and Immunopathology 34(1): 135-140

Kawa, A.; Nakamura, S.; Nakazawa, M.; Sakaguchi, S.; Kawabata, T.; Maeda, Y.; Kanehisa, T. 1977: HLA-BW35 and B5 in Japanese patients with Graves' disease. Acta Endocrinologica 86(4): 754-757

Buc, M.; Nyulassy, S.; Hnilica, P.; Stefanovic, J. 1976: HLA-BW35 and subacute de Quervain's thyroiditis. Diabete and Metabolisme 2(3): 163

Al-Arif, L.I.; Goldstein, R.A.; Affronti, L.F.; Janicki, B.W. 1979: HLA-Bw15 and tuberculosis in a North American black population. American Review of Respiratory Disease 120(6): 1275-1278

Hildebrand, W.H.; Madrigal, J.A.; Little, A.M.; Parham, P. 1992: HLA-Bw22: a family of molecules with identity to HLA-B7 in the alpha 1-helix. Journal of Immunology 148(4): 1155-1162

Alarcón, G.S.; Koopman, W.J.; Acton, R.T.; Barger, B.O. 1985: HLA-Bw35 and gold toxicity in rheumatoid arthritis. Arthritis and Rheumatism 28(2): 236-237

Berthoux, F.C.; Gagne, A.; Sabatier, J.C.; Ducret, F.; Le Petit, J.C.; Marcellin, M.; Mercier, B.; Brizard, C.P. 1978: HLA-Bw35 and mesangial IgA glomerulonephritis. New England Journal of Medicine 298(18): 1034-1035

Gran, J.T.; Husby, G. 1986: HLA-Bw35 and mucocutaneous toxicity in rheumatoid arthritis patients treated with gold. Arthritis and Rheumatism 29(2): 303

Ohno, S.; Asanuma, T.; Sugiura, S.; Wakisaka, A.; Aizawa, M.; Itakura, K. 1978: HLA-Bw51 and Behçet's disease. JAMA 240(6): 529

Hirose, S.; Ohno, S.; Matsuda, H. 1985: HLA-Bw54 and glaucomatocyclitic crisis. Archives of Ophthalmology 103(12): 1837-1839

Watanabe, H.; Okumura, M.; Hirayama, K.; Sasazuki, T. 1990: HLA-Bw54-DR4-DRw53-DQw4 haplotype controls nonresponsiveness to hepatitis-B surface antigen via CD8-positive suppressor T cells. Tissue Antigens 36(2): 69-74

Robinson, W.P.; van der Linden, S.M.; Khan, M.A.; Rentsch, H.U.; Cats, A.; Russell, A.; Thomson, G. 1989: HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. Arthritis and Rheumatism 32(9): 1135-1141

Tibensky, D.; Decary, F.; Delovitch, T.L. 1988: HLA-C genes are transcribed in HLA-C blank individuals. Immunogenetics 27(3): 220-224

Arnett, F.C.; Hochberg, M.C.; Bias, W.B. 1978: HLA-C locus antigens in HLA-B27 associated arthritis. Arthritis and Rheumatism 21(8): 885-888

Hajek-Rosenmayr, A.; Jungl, L.; Stammler, M.; Kirnbauer, M. 1989: HLA-C locus antigens seen by one-dimensional isoelectric focusing: definition of the so far known HLA-C specificities and of two subtypes. Human Immunology 26(4): 227-236

Hajek-Rosenmayr, A.; Jungl, L.; Stammler, M.; Kirnbauer, M. 1989: HLA-C "blank" alleles express class i gene products. Biochemical analysis of four different HLA-C "blank" polypeptides. Immunogenetics 30(6): 399-404

Nössner, E.; Schendel, D.J. 1991: HLA-Cw7-associated restriction fragment length polymorphism detected with an HLA-C locus-specific DNA probe. Tissue Antigens 37(4): 168-170

Kaldany, A.; Carpenter, C.B.; Suthanthiran, M.; Garovoy, M.R.; Strom, T.B.; George, K. 1978: HLA-D activity in lymphocyte subcellular fractions. Transplantation Proceedings 10(4): 785-788

Stastny, P. 1978: HLA-D and Ia antigens in rheumatoid arthritis and systemic lupus erythematosus. Arthritis and Rheumatism 21(5): S139-S143

Cochrum, K.; Hanes, D.; Van Speybroeck, J.; Perkins, H.; Ferrone, S.; Indeveri, F.; Amend, W.; Vincenti, F.; Feduska, N.; Salvatierra, O. 1979: HLA-D antigen disparity and HLA-DRw antibodies in intrafamilial renal allograft survival. Transplantation Proceedings 11(1): 404-410

Foldes, J.; Shamir, S.; Brautbar, C.; Schermann, L.; Menczel, J. 1991: HLA-D antigens and Paget's disease of bone. Clinical Orthopaedics and Related Research 266: 301-303

Nuotio, P.; Nissilä, M.; Ilonen, J. 1986: HLA-D antigens in rheumatoid arthritis and toxicity to gold and penicillamine. Scandinavian Journal of Rheumatology 15(3): 255-258

Giphart, M.J.; Kaufman, J.F.; Fuks, A.; Albrechtsen, D.; Solheim, B.G.; Bruning, J.W.; Strominger, J.L. 1977: HLA-D associated alloantisera react with molecules similar to Ia antigens. Proceedings of the National Academy of Sciences of the United States of America 74(8): 3533-3536

Rodriguez-Cordoba, S.; Regueiro, J.R.; Arnaiz-Villena, A. 1990: HLA-D determinants are expressed on human seminal cells other than spermatozoa but not on purified spermatozoa. Journal of Reproductive Immunology 18(3): 237-245

Ansari, A.A.; Shinomiya, N.; Zwollo, P.; Marsh, D.G. 1991: HLA-D gene studies in relation to immune responsiveness to a grass allergen Lol p IIi. Immunogenetics 33(1): 24-32

Yoshida, T.O. 1978: HLA-D locus and human cell alloantigens. Nihon Rinsho. Japanese Journal of Clinical Medicine 36(9): 3102-3106

Duvic, M.; Hordinsky, M.K.; Fiedler, V.C.; O'Brien, W.R.; Young, R.; Reveille, J.D. 1991: HLA-D locus associations in alopecia areata. DRw52a may confer disease resistance. Archives of Dermatology 127(1): 64-68

Kemple, K.; Gatti, R.A.; Leibold, W.; Klinenberg, J.; Bluestone, R. 1979: HLA-D locus typing in ankylosing spondylitis and Reiter's syndrome. Arthritis and Rheumatism 22(4): 371-375

Fletcher, J.; Mijovic, C.; Jenkins, D.; Bradwell, A.R.; Barnett, A.H. 1988: HLA-D region RFLP and type 1 diabetes. Diabetic Medicine: a Journal of the British Diabetic Association 5(6): 596-597

Hitman, G.A.; Karir, P.K.; Sachs, J.A.; Ramachandran, A.; Snehalatha, C.; Viswanathan, M.; Mohan, V. 1988: HLA-D region RFLPs indicate that susceptibility to insulin-dependent diabetes in South India is located in the HLA-DQ region. Diabetic Medicine: a Journal of the British Diabetic Association 5(1): 57-60

Thomas, A.; Lindsay, J.; Wilkinson, M.; Bodmer, J. 1988: HLA-D region alpha-chain monoclonal antibodies: cross-reaction between an anti-DP alpha-chain antibody and smooth muscle. Journal of Pathology 154(4): 353-363

Reid, B.; Green, D.; Buchanan, W.W.; Singal, D.P. 1991: HLA-D region and Hsp70 genes in rheumatoid arthritis. Transplantation Proceedings 23(1 Part 1): 457-458

Sontheimer, R.D.; Stastny, P.; Nũnez, G. 1986: HLA-D region antigen expression by human epidermal Langerhans cells. Journal of Investigative Dermatology 87(6): 707-710

Spencer, J.; Pugh, S.; Isaacson, P.G. 1986: HLA-D region antigen expression on stomach epithelium in absence of autoantibodies. Lancet 2(8513): 983

McCusker, C.T.; Reid, B.; Green, D.; Gladman, D.D.; Buchanan, W.W.; Singal, D.P. 1991: HLA-D region antigens in patients with rheumatoid arthritis. Arthritis and Rheumatism 34(2): 192-197

Pallone, F.; Fais, S.; Capobianchi, M.R. 1988: HLA-D region antigens on isolated human colonic epithelial cells: enhanced expression in inflammatory bowel disease and in vitro induction by different stimuli. Clinical and Experimental Immunology 74(1): 75-79

Myers, L.K.; Ball, E.J.; Nunez, G.; Fink, C.W.; Stastny, P. 1987: HLA-D region epitopes associated with juvenile arthritis. Recognition by alloreactive T cell clones and alloantisera. Arthritis and Rheumatism 30(7): 744-751

Deighton, C.M.; Walker, D.J. 1992: HLA-D region genes and rheumatoid arthritis. Annals of the Rheumatic Diseases 51(8): 1023-1024

Singal, D.P.; Green, D.; Reid, B.; Gladman, D.D.; Buchanan, W.W. 1992: HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA. Annals of the Rheumatic Diseases 51(1): 23-28

Taneja, V.; Mehra, N.; Singh, Y.N.; Kumar, A.; Malaviya, A.; Singh, R.R. 1990: HLA-D region genes and susceptibility to D-penicillamine-induced myositis. Arthritis and Rheumatism 33(9): 1445-1447

Goldstein, R.; Duvic, M.; Targoff, I.N.; Reichlin, M.; McMenemy, A.M.; Reveille, J.D.; Warner, N.B.; Pollack, M.S.; Arnett, F.C. 1990: HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis. Arthritis and Rheumatism 33(8): 1240-1248

Takeuchi, Y.; Matsuki, K.; Saito, Y.; Sugimoto, T.; Juji, T. 1990: HLA-D region genomic polymorphism associated with Takayasu's arteritis. Angiology 41(6): 421-426

Okoye, R.C.; Ollier, W.; Jaraquemada, D.; Awad, J.; Navarrete, C.; Cutbush, S.; Carthy, D.; Dos-Santos, A.; Festenstein, H. 1989: HLA-D region heterogeneity in a Nigerian population. Tissue Antigens 33(4): 445-456

Hashemi, S.; Hsu, S.H.; Bias, W.B. 1986: HLA-D restriction of "naturally occurring" MLR suppressor cells in acquired common variable hypogammaglobulinemia. Human Immunology 17(4): 480-489

Todd, I.; Pujol-Borrell, R.; Abdul-Karim, B.A.; Hammond, L.J.; Feldmann, M.; Bottazzo, G.F. 1987: HLA-D subregion expression by thyroid epithelium in autoimmune thyroid diseases and induced in vitro. Clinical and Experimental Immunology 69(3): 532-542

Hajek-Rosenmayr, A.; Obergruber, G.; Mayr, W.R. 1987: HLA-D typing in Austria. a panel study using 26 newly defined homozygous typing cells. Tissue Antigens 29(2): 93-100

Maeda, M.; Inoko, H.; Ando, A.; Uryu, N.; Tsuji, K. 1989: HLA-D typing of heterozygotes using restriction fragment length polymorphism in the HLA-DQ gene region on the basis of standard band patterns derived from HLA homozygotes. Human Immunology 25(3): 195-205

Halim, K.; Festenstein, H.; Farrant, J. 1979: HLA-D typing of human lymphocytes using frozen and thawed spermatozoa. Journal of Immunological Methods 25(1): 31-36

Paty, D.W.; Cousin, H.K.; Stiller, C.R.; Boucher, D.W.; Furesz, J.; Warren, K.G.; Marchuk, L.; Dossetor, J.B. 1977: HLA-D typing with an association of Dw2 and absent immune responses towards herpes simplex (type i) antigen in multiple sclerosis. Transplantation Proceedings 9(4): 1845-1848

Netzel, B.; Bornkamm, G.; Lenhard, V.; Scholz, S.; Grosse-Wilde, H. 1977: HLA-D typing with homozygous lymphoblastoid cell lines. Zeitschrift für Immunitatsforschung. Immunobiology 153(1): 85-89

Gatti, R.A.; Schwartzmann, J.; Kemple, K.; Leibold, W. 1979: HLA-D typing with lymphoblastoid cell lines. VII. A computer program for data analysis. Tissue Antigens 14(3): 194-204

Farid, N.R.; Sampson, L.; Noel, P.; Barnard, J.M.; Davis, A.J.; Hillman, D.A. 1979: HLA-D--related (DRw) antigens in juvenile diabetes mellitus. Diabetes 28(6): 552-557

Albrechtsen, D. 1977: HLA-D-associated 'Ia-like' antigens on human macrophages. Scandinavian Journal of Immunology 6(9): 907-912

Thomsen, M.; Platz, P.; Christy, M.; Nerup, J.; Ryder, L.P.; Svejgaard, A. 1979: HLA-D-associated resistance and susceptibility to insulin-dependent diabetes mellitus. Transplantation Proceedings 11(2): 1307-1308

Ditta, S.D.; George, C.F.; Singh, S.M. 1992: HLA-D-region genomic DNA restriction fragments in DRw15 (DR2) familial narcolepsy. Sleep 15(1): 48-57

Todd, I.; Londei, M.; Pujol-Borrell, R.; Mirakian, R.; Feldmann, M.; Bottazzo, G.F. 1986: HLA-D/DR expression on epithelial cells: the finger on the trigger?. Annals of the new York Academy of Sciences 475: 241-250

Buc, M.; Porubská, S.; Bencová, M.; Nyulassy, S.; Stefanovic, J. 1989: HLA-D/DR identity results in a positive CML reaction. Folia Biologica 35(2): 78-89

Coppin, H.L.; Villedieu, P.; Thomsen, M.; Giraud, P.; Cambon-Thomsen, A.; Charron, D. 1987: HLA-D/DR-BON: a new biochemically and cellularly defined polymorphism indistinguishable by RFLP from DR1. Immunogenetics 25(2): 130-132

Sarles, J.; Gorvel, J.P. 1988: HLA-DA expression in children with celiac disease. Gastroenterology 94(2): 557-558

Inoko, H. 1990: HLA-DNA typing. Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 778-785

Amar, A.; Nepom, G.T.; Mickelson, E.; Erlich, H.; Hansen, J.A. 1987: HLA-DP and HLA-DO genes in presumptive HLA-identical siblings: structural and functional identification of allelic variation. Journal of Immunology 138(6): 1947-1953

Sasagawa, M.; Sasaki, T.; Yasuda, M.; Mochizuki, M.; Yamazaki, T.; Kurose, T.; Tanaka, K.; Hando, T. 1988: HLA-DP and HLA-DQ antigen expression on trophoblasts of normal human pregnancy and trophoblastic diseases. Nihon Sanka Fujinka Gakkai Zasshi 40(10): 1525-1530

Odum, N.; Platz, P.; Jakobsen, B.K.; Petersen, C.M.; Jacobsen, N.; Møller, J.; Ryder, L.P.; Lamm, L.; Svejgaard, A. 1987: HLA-DP and bone marrow transplantation: DP-incompatibility and severe acute graft versus host disease. Tissue Antigens 30(5): 213-216

Caffrey, C.; Hitman, G.A.; Niven, M.J.; Cassell, P.G.; Kumar, P.; Fry, L.; Mackintosh, P.; Gallagher, R.; Feighery, C.; Weir, D. 1990: HLA-DP and coeliac disease: family and population studies. Gut 31(6): 663-667

Yamagata, K.; Hanafusa, T.; Nakajima, H.; Sada, M.; Amemiya, H.; Tomita, K.; Miyagawa, J.; Noguchi, T.; Tanaka, T.; Kono, N. 1991: HLA-DP and susceptibility to insulin-dependent diabetes mellitus in Japanese. Tissue Antigens 38(3): 107-110

Dong, R.P.; Kimura, A.; Numano, F.; Yajima, M.; Hashimoto, Y.; Kishi, Y.; Nishimura, Y.; Sasazuki, T. 1992: HLA-DP antigen and Takayasu arteritis. Tissue Antigens 39(3): 106-110

Odum, N.; Saida, T.; Ohta, M.; Svejgaard, A. 1989: HLA-DP antigens and HTLV-1 antibody status among Japanese with multiple sclerosis: evidence for an increased frequency of HLA-DPw4. Journal of Immunogenetics 16(6): 467-473

Odum, N.; Hyldig-Nielsen, J.J.; Morling, N.; Sandberg-Wollheim, M.; Platz, P.; Svejgaard, A. 1988: HLA-DP antigens are involved in the susceptibility to multiple sclerosis. Tissue Antigens 31(5): 235-237

Odum, N.; Georgsen, J.; Fugger, L.; Møller, J.; Jakobsen, B.K.; Hofmann, B.; Skinhøj, P.; Klokker, M.; Dickmeiss, E.; Svejgaard, A. 1990: HLA-DP antigens in HIV-infected individuals. Disease Markers 8(3): 113-116

Odum, N.; Morling, N.; Georgsen, J.; Jakobsen, B.K.; Frentz, G.; Jensen, G.F.; Fugger, L.; Svejgaard, A. 1990: HLA-DP antigens in patients with alopecia areata. Tissue Antigens 35(3): 114-117

Mueller-Eckhardt, G.; Pawelec, G.; Haas, R.; Otto, C.; Kiefel, V.; Odum, N.; Mueller-Eckhardt, C. 1989: HLA-DP antigens in patients with chronic autoimmune thrombocytopenia (AITP). Tissue Antigens 34(2): 121-126

Hoffman, R.W.; Shaw, S.; Francis, L.C.; Larson, M.G.; Petersen, R.A.; Chylack, L.T.; Glass, D.N. 1986: HLA-DP antigens in patients with pauciarticular juvenile rheumatoid arthritis. Arthritis and Rheumatism 29(9): 1057-1062

Buc, M.; Porubská, S.; Bencova, M.; Nyulassy, S.; Stefanovic, J. 1988: HLA-DP antigens provide the proliferative impetus for the generation of cytotoxic T lymphocytes. Tissue Antigens 32(5): 291-294

Bodmer, J.G.; Tonks, S.; Oza, A.M.; Lister, T.A.; Bodmer, W.F. 1989: HLA-DP based resistance to Hodgkin's disease. Lancet 1(8652): 1455-1456

Begovich, A.B.; Helmuth, R.C.; Oksenberg, J.R.; Sakai, K.; Tabira, T.; Sasazuki, T.; Steinman, L.; Erlich, H.A. 1990: HLA-DP beta and susceptibility to multiple sclerosis: an analysis of caucasoid and Japanese patient populations. Human Immunology 28(4): 365-372

Pesando, J.M.; Graf, L.; Hoffman, P. 1986: HLA-DP can be expressed with or without -DR molecules on a malignant B cell line. Journal of Immunology 137(6): 1932-1936

Wang, F.Q.; al-Daccak, R.; Ju, L.Y.; Lethielleux, P.; Charron, D.; Loiseau, P.; Colombani, J. 1992: HLA-DP distribution in Shanghai Chinese--a study by polymerase chain reaction--restriction fragment length polymorphism. Human Immunology 33(2): 129-132

Al-Daccak, R.; Loiseau, P.; Soulie, A.; Varrin, F.; Rabian, C.; Raffoux, C.; Cohen, D.; Degos, L.; Gluckman, E.; Colombani, J. 1990: HLA-DP genotyping in HLA-A,B, and DR identical intrafamilial bone marrow transplantation. Leukemia 4(3): 222-226

Galeazzi, M.; Sebastiani, G.D.; Passiu, G.; Angelini, G.; Delfino, L.; Asherson, R.A.; Khamashta, M.A.; Hughes, G.R. 1992: HLA-DP genotyping in patients with systemic lupus erythematosus: correlations with autoantibody subsets. Journal of Rheumatology 19(1): 42-46

Pawelec, G.; Reekers, P.; Brackertz, D.; Sansom, D.; Schneider, E.M.; Blaurock, M.; Müller, C.; Rehbein, A.; Balko, I.; Wernet, P. 1988: HLA-DP in rheumatoid arthritis. Tissue Antigens 31(2): 83-89

Kato, Y.; Mitsuishi, Y.; Cecka, M.; Hopfield, J.; Hunt, L.; Champlin, R.; Terasaki, P.I.; Gajewski, J.L. 1991: HLA-DP incompatibilities and severe graft-versus-host disease in unrelated bone marrow transplants. Transplantation 52(2): 374-376

Olerup, O.; Möller, E.; Persson, U. 1990: HLA-DP incompatibilities induce proliferation in primary mixed lymphocyte culture in HLA-A, -B, -C, -DR, and -DQ-identical individuals. Transplantation Proceedings 22(1): 141-142

Olerup, O.; Möller, E.; Persson, U. 1990: HLA-DP incompatibilities induce significant proliferation in primary mixed lymphocyte cultures in HLA-A, -B, -DR and -DQ compatible individuals: implications for allogeneic bone marrow transplantation. Tissue Antigens 36(5): 194-202

Pawelec, G.; Ehninger, G.; Schmidt, H.; Wernet, P. 1986: HLA-DP matching and graft-versus-host disease in allogeneic bone marrow transplantation. Transplantation 42(5): 558-560

Pawelec, G.; Ehninger, G.; Schmidt, H.; Rehbein, A.; Balko, I.; Wernet, P. 1987: HLA-DP matching in allogeneic bone marrow transplantation. Transplantation Proceedings 19(1 Part 3): 2741-2743

Magzoub, M.M.; Stephens, H.A.; Sachs, J.A.; Biro, P.A.; Cutbush, S.; Wu, Z.; Bottazzo, G.F. 1992: HLA-DP polymorphism in Sudanese controls and patients with insulin-dependent diabetes mellitus. Tissue Antigens 40(2): 64-68

Arendse, B.; Martell, R.W.; Jacobs, M.; Oosthuizen, O.; du Toit, E.D. 1992: HLA-DP polymorphism in the present-day San (Bushmen) and Khoi (Hottentots) using polymerase chain reaction and sequence-specific oligonucleotide typing. Tissue Antigens 40(1): 38-40

Odum, N.; Hofmann, B.; Jakobsen, B.K.; Langhoff, E.; Morling, N.; Platz, P.; Ryder, L.P.; Svejgaard, A. 1986: HLA-DP related suppression of mixed lymphocyte reaction with alloactivated lymphocytes. Tissue Antigens 27(1): 32-43

Hermann, E.; Mayet, W.J.; Thomssen, H.; Sieper, J.; Poralla, T.; Meyer zum Büschenfelde, K.H.; Fleischer, B. 1992: HLA-DP restricted Chlamydia trachomatis specific synovial fluid T cell clones in Chlamydia induced Reiter's disease. Journal of Rheumatology 19(8): 1243-1246

Wank, R.; Grosse-Wilde, H. 1989: HLA-DP types of homozygous typing cells: DPw3 found in three Dw19 HTC. Immunogenetics 29(2): 138-141

Angelini, G.; Bugawan, T.L.; Delfino, L.; Erlich, H.A.; Ferrara, G.B. 1989: HLA-DP typing by DNA amplification and hybridization with specific oligonucleotides. Human Immunology 26(3): 169-177

Dekker, J.W.; Easteal, S. 1990: HLA-DP typing by amplified fragment length polymorphisms (AFLPs). Immunogenetics 32(1): 56-59

Maeda, M.; Inoko, H.; Ando, A.; Uryu, N.; Nagata, Y.; Tsuji, K. 1988: HLA-DP typing by analysis of DNA restriction fragment length polymorphisms in the HLA-DP beta subregion. Human Immunology 21(4): 239-248

Easteal, S.; Kohonen-Corish, M.R.; Zimmet, P.; Serjeantson, S.W. 1990: HLA-DP variation as additional risk factor in IDDM. Diabetes 39(7): 855-857

Hishikawa, T.; Tokano, Y.; Sekigawa, I.; Ando, S.; Takasaki, Y.; Hashimoto, H.; Hirose, S.; Okumura, K.; Abe, M.; Shirai, T. 1990: HLA-DP+ T cells and deficient interleukin-2 production in patients with systemic lupus erythematosus. Clinical Immunology and Immunopathology 55(2): 285-296

Easteal, S.; Viswanathan, M.; Serjeantson, S.W. 1990: HLA-DP, -DQ and -DR RFLP types in south Indian insulin-dependent diabetes mellitus patients. Tissue Antigens 35(2): 71-74

Piccinini, L.A.; Goldsmith, N.K.; Roman, S.H.; Davies, T.F. 1987: HLA-DP, DQ and DR gene expression in Graves' disease and normal thyroid epithelium. Tissue Antigens 30(4): 145-154

Tokano, Y.; Hishikawa, T.; Hirose, T.; Sekigawa, I.; Hashimoto, H.; Okumura, K.; Hirose, S. 1990: HLA-DP-positive T cells in patients with systemic lupus erythematosus. Autoimmunity 5(3): 179-183

Salazar, M.; Yunis, I.; Alosco, S.M.; Chopek, M.; Yunis, E.J. 1992: HLA-DPB1 allele mismatches between unrelated HLA-A,B,C,DR (generic) DQA1-identical unrelated individuals with unreactive MLC. Tissue Antigens 39(4): 203-208

Reveille, J.D.; Brady, J.; MacLeod-St Clair, M.; Durban, E. 1992: HLA-DPB1 alleles and autoantibody subsets in systemic lupus erythematosus, Sjögren's syndrome and progressive systemic sclerosis: a question of disease relevance. Tissue Antigens 40(1): 45-48

Roth, M.P.; Coppin, H.; Descoins, P.; Ruidavets, J.B.; Cambon-Thomsen, A.; Clanet, M. 1991: HLA-DPB1 gene polymorphism and multiple sclerosis: a large case-control study in the southwest of France. Journal of Neuroimmunology 34(2-3): 215-222

Eiermann, T.H.; Fakler, J.; Müller, C.R.; Ballas, M.; Goldmann, S.F. 1991: HLA-DPB1 oligonucleotide typing of a southwest German Caucasian population. Tissue Antigens 38(5): 193-198

Gao, X.; Fernandez-Viña, M.; Olsen, N.J.; Pincus, T.; Stastny, P. 1991: HLA-DPB1*0301 is a major risk factor for rheumatoid factor-negative adult rheumatoid arthritis. Arthritis and Rheumatism 34(10): 1310-1312

Hsu, K.C.; Hill, D.L.; Hoffman, R.W. 1992: HLA-DPB1*0401 is associated with the presence of autoantibodies reactive with the U1-70 kD polypeptide antigen of U1-small nuclear ribonucleoprotein among connective tissue disease patients. Tissue Antigens 39(5): 272-275

Yunis, J.J.; Wescott, M.; Lechin, S.J.; Alosco, S.M.; Awdeh, Z.; Alper, C.A.; Yunis, E.J. 1990: HLA-DQ RFLP variants of five HLA-DQw2-bearing major histocompatibility complex extended haplotypes. Immunogenetics 32(2): 88-95

Helmuth, R.; Fildes, N.; Blake, E.; Luce, M.C.; Chimera, J.; Madej, R.; Gorodezky, C.; Stoneking, M.; Schmill, N.; Klitz, W. 1990: HLA-DQ alpha allele and genotype frequencies in various human populations, determined by using enzymatic amplification and oligonucleotide probes. American Journal of Human Genetics 47(3): 515-523

Nepom, B.S.; Schwarz, D.A.; Johnston, J.V.; Radka, S.F. 1989: HLA-DQ alpha polymorphisms: oligonucleotide probes characterize the contribution of first and second domains to electrophoretic variants. Human Immunology 25(4): 257-267

Michelsen, B.; Dyrberg, T.; Vissing, H.; Serup, P.; Lernmark, A. 1990: HLA-DQ and -DX genes in insulin-dependent diabetes mellitus. Current Topics in Microbiology and Immunology 164: 57-68

Lundin, K.E.; Rønningen, K.S.; Aono, S.; Spurkland, A.; Gaudernack, G.; Isshiki, G.; Thorsby, E. 1989: HLA-DQ antigens and DQ beta amino acid 57 of Japanese patients with insulin-dependent diabetes mellitus: detection of a DRw8DQw8 haplotype. Tissue Antigens 34(4): 233-241

Altmann, D.M. 1992: HLA-DQ associations with autoimmune disease. Autoimmunity 14(1): 79-83

Lanchbury, J.S.; Sakkas, L.I.; Marsh, S.G.; Bodmer, J.G.; Welsh, K.I.; Panayi, G.S. 1989: HLA-DQ beta 3.1 allele is a determinant of susceptibility to DR4-associated rheumatoid arthritis. Human Immunology 26(1): 59-71

Lee, G.; Shamma, F.N.; Diamond, M.P.; Lee, J.T. 1992: HLA-DQ beta 57 in Hispanic patients with insulin-dependent diabetes mellitus. American Journal of Obstetrics and Gynecology 167(6): 1565-1570

Inoko, H.; Ando, A.; Tsuji, K.; Matsuki, K.; Juji, T.; Honda, Y. 1986: HLA-DQ beta chain DNA restriction fragments can differentiate between healthy and narcoleptic individuals with HLA-DR2. Immunogenetics 23(2): 126-128

Zhou, P.; Smart, M.K.; Cheng, S.; Savarirayan, S.; Inoko, H.; David, C.S. 1992: HLA-DQ beta chain can present mouse endogenous provirus MTV-9 product and clonally delete Tcr V beta 5+ and V beta 11+ T cells in transgenic mice. Immunogenetics 35(4): 219-223

Bao, M.Z.; Wang, J.X.; Dorman, J.S.; Trucco, M. 1989: HLA-DQ beta non-ASP-57 allele and incidence of diabetes in China and the USA. Lancet 2(8661): 497-498

Erlich, H.A.; Bugawan, T.L.; Scharf, S.; Nepom, G.T.; Tait, B.; Griffith, R.L. 1990: HLA-DQ beta sequence polymorphism and genetic susceptibility to IDDM. Diabetes 39(1): 96-103

Singal, D.P.; D'Souza, M.; Reid, B.; Bensen, W.G.; Kassam, Y.B.; Adachi, J.D. 1987: HLA-DQ beta-chain polymorphism in HLA-DR4 haplotypes associated with rheumatoid arthritis. Lancet 2(8568): 1118-1120

Bell, J.; Rassenti, L.; Smoot, S.; Smith, K.; Newby, C.; Hohlfeld, R.; Toyka, K.; McDevitt, H.; Steinman, L. 1986: HLA-DQ beta-chain polymorphism linked to myasthenia gravis. Lancet 1(8489): 1058-1060

Reijonen, H.; Ilonen, J.; Knip, M.; Michelsen, B.; Akerblom, H.K. 1990: HLA-DQ beta-chain restriction fragment length polymorphism as a risk marker in type 1 (insulin-dependent) diabetes mellitus: a Finnish family study. Diabetologia 33(6): 357-362

Fujisaku, A.; Frank, M.B.; Neas, B.; Reichlin, M.; Harley, J.B. 1990: HLA-DQ gene complementation and other histocompatibility relationships in man with the anti-Ro/SSA autoantibody response of systemic lupus erythematosus. Journal of Clinical Investigation 86(2): 606-611

Amar, A.; Mickelson, E.; Hansen, J.A.; Nepom, G.T. 1986: HLA-DQ heterogeneity among HLA-DRw11(5) haplotypes. Tissue Antigens 28(5): 278-287

Bushell, A.; Higgins, R.M.; Wood, K.J.; Morris, P.J. 1989: HLA-DQ mismatches between donor and recipient in the presence of HLA-DR compatibility do not influence the function or outcome of renal transplants. Human Immunology 26(3): 179-189

Fernandez, N.; Labeta, M.; Kurpisz, M.; Solana, R.; Festenstein, H. 1986: HLA-DQ molecular heterogeneity in HLA-DR4-Dw4 consanguineous cell lines. Disease Markers 4(1-2): 191-198

Ottenhoff, T.H.; Walford, C.; Nishimura, Y.; Reddy, N.B.; Sasazuki, T. 1990: HLA-DQ molecules and the control of Mycobacterium leprae-specific T cell nonresponsiveness in lepromatous leprosy patients. European Journal of Immunology 20(10): 2347-2350

Kwok, W.W.; Schwarz, D.; Nepom, B.S.; Hock, R.A.; Thurtle, P.S.; Nepom, G.T. 1988: HLA-DQ molecules form alpha-beta heterodimers of mixed allotype. Journal of Immunology 141(9): 3123-3127

Li, S.G.; de Vries, R.R. 1989: HLA-DQ molecules may be products of an immune suppression gene responsible for Mycobacterium leprae-specific nonresponsiveness. International Journal of Leprosy and other Mycobacterial Diseases: Official Organ of the International Leprosy Association 57(2): 554-556

Trucco, M.; Rosenshine, S.; Cascino, I.; Duquesnoy, R.J. 1986: HLA-DQ polymorphism analyzed by sequential restriction endonuclease DNA digestion. Immunogenetics 24(3): 184-190

Singal, D.P.; Bensen, W.G.; Kassam, Y.B. 1988: HLA-DQ polymorphism in rheumatoid arthritis. Lancet 1(8584): 529

Sterkers, G.; Zeliszewski, D.; Chaussée, A.M.; Deschamps, I.; Font, M.P.; Freidel, C.; Hors, J.; Betuel, H.; Dausset, J.; Levy, J.P. 1988: HLA-DQ rather than HLA-DR region might be involved in dominant nonsusceptibility to diabetes. Proceedings of the National Academy of Sciences of the United States of America 85(17): 6473-6477

Bell, J.I.; Steinman, L.; Toyka, K.; McDevitt, H.O. 1987: HLA-DQ restriction fragment length polymorphisms in myasthenia gravis. Annals of the new York Academy of Sciences 505: 382-387

Nakatsuji, T.; Moriya, K.; Ando, A.; Inoko, H.; Tsuji, K. 1986: HLA-DQ structural polymorphism in HLA-DR2 associated HLA-D clusters. Human Immunology 16(2): 157-162

Aparicio, J.M.; Wakisaka, A.; Takada, A.; Matsuura, N.; Aizawa, M. 1988: HLA-DQ system and insulin-dependent diabetes mellitus in Japanese: does it contribute to the development of IDDM as it does in Caucasians?. Immunogenetics 28(4): 240-246

Ohta, N.; Edahiro, T.; Ishii, A.; Yasukawa, M.; Hosaka, Y. 1990: HLA-DQ-controlled T cell response to soluble egg antigen of Schistosoma japonicum in humans. Clinical and Experimental Immunology 79(3): 403-408

Sugita, M.; Kumagai, S.; Umehara, H.; Iwai, K.; Sorachi, K.; Imura, H. 1990: HLA-DQ-specific autoreactive T cell clone with helper and cytotoxic functions. Immunology Letters 26(3): 265-269

Otová, B.; Stefanová, I.; Horejsí, V.; Nĕmec, M.; Kren, V.; Viklický, V. 1987: HLA-DQ1 + DQ3-specific monoclonal antibody cross-reacts with a rat MHC-encoded polymorphic determinant. Folia Biologica 33(6): 424-429

Teramae, N.; Azuma, T.; Kodama, T.; Kashima, K.; Kawai, K. 1992: HLA-DQA1 DNA typing in patients with duodenal ulcer by the PCR-RFLP method. Gastroenterologia Japonica 27(3): 425

De Stefano, F.; Casarino, L.; Mannucci, A.; Delfino, L.; Canale, M.; Ferrara, G.B. 1992: HLA-DQA1 allele and genotype frequencies in a northern Italian population. Forensic Science International 55(1): 59-66

Mijovic, C.H.; Jenkins, D.; Jacobs, K.H.; Penny, M.A.; Fletcher, J.A.; Barnett, A.H. 1991: HLA-DQA1 and -DQB1 alleles associated with genetic susceptibility to IDDM in a black population. Diabetes 40(6): 748-753

Gu, X.F.; Larger, E.; Clauser, E.; Bessaoud, K.; Krishnamoorthy, R.; Elion, J.; Assan, R. 1991: HLA-DQA1 and DQB1 alleles in French and Algerian type 1 diabetic subjects. Diabetes Research 17(4): 189-197

Conrad, S.; Trucco, M.; Böhm, B.O. 1990: HLA-DQA1 and HLA-DQB1 DNA typing in multiplex IDDM families by use of sequence-specific oligonucleotide probes and genomic sequencing. Biomedica Biochimica Acta 49(12): 1219-1222

Spurkland, A.; Rønningen, K.S.; Vandvik, B.; Thorsby, E.; Vartdal, F. 1991: HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis. Human Immunology 30(1): 69-75

Yunis, I.; Salazar, M.; Alosco, S.M.; Gomez, N.; Yunis, E.J. 1992: HLA-DQA1 and MLC among HLA (generic)-identical unrelated individuals. Tissue Antigens 39(4): 182-186

Van Kerckhove, C.; Luyrink, L.; Taylor, J.; Melin-Aldana, H.; Balakrishnan, K.; Maksymowych, W.; Elma, M.; Lovell, D.; Choi, E.; Glass, D.N. 1991: HLA-DQA1*0101 haplotypes and disease outcome in early onset pauciarticular juvenile rheumatoid arthritis. Journal of Rheumatology 18(6): 874-879

Yamagata, K.; Hanafusa, T.; Nakajima, H.; Sada, M.; Amemiya, H.; Noguchi, T.; Tanaka, T.; Kono, N.; Tarui, S. 1991: HLA-DQA1*1 contributes to resistance and A1*3 confers susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 34(2): 133-136

Rowe, J.R.; Neme de Gimenez, M.H.; Emler, C.A.; Sheehy, M.J. 1990: HLA-DQA2 (DX alpha) polymorphism and insulin dependent diabetes. Human Immunology 29(4): 256-262

Vallet-Colom, I.; Lévy-Marchal, C.; Zarrouk, D.; Tichet, J.; Krishnamoorthy, R.; Czernichow, P.; Elion, J. 1990: HLA-DQB 1 codon 57 and genetic susceptibility to type 1 (insulin-dependent) diabetes mellitus in French children. Diabetologia 33(3): 174-176

Reijonen, H.; Ilonen, J.; Knip, M.; Akerblom, H.K. 1991: HLA-DQB1 alleles and absence of Asp 57 as susceptibility factors of IDDM in Finland. Diabetes 40(12): 1640-1644

Marrosu, M.G.; Muntoni, F.; Murru, M.R.; Costa, G.; Pischedda, M.P.; Pirastu, M.; Sotgiu, S.; Rosati, G.; Cianchetti, C. 1992: HLA-DQB1 genotype in Sardinian multiple sclerosis: evidence for a key role of DQB1 *0201 and *0302 alleles. Neurology 42(4): 883-886

Nomura, N.; Ota, M.; Tsuji, K.; Inoko, H. 1991: HLA-DQB1 genotyping by a modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 38(2): 53-59

David, A.L.; Taylor, G.M.; Gokhale, D.; Aplin, J.D.; Seif, M.W.; Tindall, V.R. 1992: HLA-DQB1*03 and cervical intraepithelial neoplasia type IIi. Lancet 340(8810): 52

Kurth, J.H.; Bowcock, A.M.; Erlich, H.A.; Cavallisforza, L.L. 1992: HLA-DQa allelic frequencies detected with PCR in a variety of human populations. Gene Geography: a Computerized Bulletin on Human Gene Frequencies 6(3): 175-183

Wise, R.A.; Wigley, F.M.; Scott, T.E.; Hochberg, M.C. 1988: HLA-DQw alloantigens and pulmonary dysfunction in rheumatoid arthritis. Chest 94(3): 609-614

Sengar, D.P.; Couture, R.A.; Raman, S.; Jindal, S.L. 1990: HLA-DQw1 compatibility and cadaveric renal allograft survival. Transplantation 50(1): 156-158

Pawelec, G.; Wernet, P. 1987: HLA-DQw3 dissected by cloned alloreactive T cells. Immunogenetics 25(5): 356-358

Ando, M.; Hirayama, K.; Soda, K.; Okubo, R.; Araki, S.; Sasazuki, T. 1989: HLA-DQw3 in Japanese summer-type hypersensitivity pneumonitis induced by Trichosporon cutaneum. American Review of Respiratory Disease 140(4): 948-950

Radka, S.F.; Nelson, K.A.; Johnston, J.V. 1989: HLA-DQw3-related determinants: analysis of subunit and spatial relationships. Human Immunology 25(4): 225-236

Markussen, G.; Rønningen, K.S.; Paulsen, G.; Gaudernack, G.; Sollid, L.M.; Thorsby, E. 1988: HLA-DQw3.1 and DQw3.2 associated exon polymorphisms detected by oligonucleotide probes. Tissue Antigens 31(4): 204-210

Monos, D.S.; Spielman, R.S.; Gogolin, K.J.; Radka, S.F.; Baker, L.; Zmijewski, C.M.; Kamoun, M. 1987: HLA-DQw3.2 allele of the DR4 haplotype is associated with insulin-dependent diabetes; correlation between DQ beta restriction fragments and DQ beta chain variation. Immunogenetics 26(4-5): 299-303

Stephens, H.A.; Sakkas, L.I.; Vaughan, R.W.; Teitsson, I.; Welsh, K.I.; Panayi, G.S. 1989: HLA-DQw7 is a disease severity marker in patients with rheumatoid arthritis. Immunogenetics 30(2): 119-122

Gyódi, K.E.; Onodi, K.; Petrányi, G. 1979: HLA-DR (IA) atigens in the Hungarian population. Orvosi Hetilap 120(21): 1253-1255

Miller, T.P.; Lippman, S.M.; Spier, C.M.; Slymen, D.J.; Grogan, T.M. 1988: HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma. Journal of Clinical Investigation 82(1): 370-372

Swanson, P.E.; Wick, M.R. 1990: HLA-DR (Ia-like) reactivity in tumors of bone and soft tissue: an immunohistochemical comparison of monoclonal antibodies LN3 and LK8D3 in routinely processed specimens. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 3(2): 113-119

Ludvigsson, J.; Samuelsson, U.; Beauforts, C.; Deschamps, I.; Dorchy, H.; Drash, A.; Francois, R.; Herz, G.; New, M.; Schober, E. 1986: HLA-DR 3 is associated with a more slowly progressive form of type 1 (insulin-dependent) diabetes. Diabetologia 29(4): 207-210

Davies, R.; Pace, R.; Jazwinska, E.C.; Serjeantson, S.W. 1990: HLA-DR RFLP distributions in two groups of aboriginal Australians. Australian and New Zealand Journal of Medicine 20(6): 790-793

Mancardi, G.L.; Cadoni, A.; Zicca, A.; Schenone, A.; Tabaton, M.; De Martini, I.; Zaccheo, D. 1988: HLA-DR Schwann cell reactivity in peripheral neuropathies of different origins. Neurology 38(6): 848-851

Geggel, H.S.; Nettles, J.W.; Nepom, B.S. 1992: HLA-DR alleles and sterile ulcerative keratitis. Cornea 11(6): 505-509

Gao, X.J.; Olsen, N.J.; Pincus, T.; Stastny, P. 1990: HLA-DR alleles with naturally occurring amino acid substitutions and risk for development of rheumatoid arthritis. Arthritis and Rheumatism 33(7): 939-946

Bidwell, J.L.; Jarrold, E.A. 1986: HLA-DR allogenotyping using exon-specific cDNA probes and application of rapid minigel methods. Molecular Immunology 23(10): 1111-1116

Piccinini, L.A.; Schachter, B.S.; Davies, T.F. 1986: HLA-DR alpha chain expression in human thyroid cells. Endocrinology 118(6): 2611-2613

Gorski, J.; Niven, M.J.; Sachs, J.A.; Mach, B.; Cassell, P.G.; Festenstein, H.; Awad, J.; Hitman, G.A. 1987: HLA-DR alpha, -DX alpha, and DR beta III gene association studies in DR3 individuals. Human Immunology 20(4): 273-278

Serjeantson, S.W.; Ranford, P.R.; Kirk, R.L.; Kohonen-Corish, M.R.; Mohan, V.; Ramachandran, A.; Snehalatha, C.; Viswanathan, M. 1987: HLA-DR and -DQ DNA genotyping in insulin-dependent diabetes patients in South India. Disease Markers 5(2): 101-108

Kohonen-Corish, M.R.; Dunckley, H.; Serjeantson, S.W. 1988: HLA-DR and -DQ DNA genotyping in seven populations of Asia-Oceania and Australia. Tissue Antigens 32(1): 32-40

Serjeantson, S.W.; White, B.S.; Jazwinska, E.C.; Yenchitsomanus, P.T.; Mickleson, K.N.; Trent, R.J. 1987: HLA-DR and -DQ DNA polymorphisms: new linkage relationships established by RFLP genomic typing in Polynesians and Melanesians. Human Immunology 20(2): 145-153

Cowan, E.P.; Pierce, M.L.; McFarland, H.F.; McFarlin, D.E. 1991: HLA-DR and -DQ allelic sequences in multiple sclerosis patients are identical to those found in the general population. Human Immunology 32(3): 203-210

Abdulkadir, J.; Worku, Y.; Schreuder, G.M.; D'Amaro, J.; de Vries, R.R.; Ottenhoff, T.H. 1989: HLA-DR and -DQ antigens in malnutrition-related diabetes mellitus in Ethiopians: a clue to its etiology?. Tissue Antigens 34(5): 284-289

Marsh, S.G.; Bodmer, J.G. 1989: HLA-DR and -DQ epitopes and monoclonal antibody specificity. Immunology Today 10(9): 305-312

Brogelli, L.; Moretti, S.; Borgognoni, L.; Giannotti, B. 1990: HLA-DR and 96-K antigens and intratumoral lymphocytic infiltrate in primary cutaneous melanoma as markers of tumor progression. Dermatologica 180(2): 69-72

Cullen, C.G.; Middleton, D.; Savage, D.A.; Hawkins, S. 1991: HLA-DR and DQ DNA genotyping in multiple sclerosis patients in Northern Ireland. Human Immunology 30(1): 1-6

Fletcher, J.; Mijovic, C.; Odugbesan, O.; Mackay, E.; Bradwell, A.R.; Barnett, A.H. 1988: HLA-DR and DQ DNA polymorphisms in subjects of Asian Indian and white Caucasian origin. Molecular Immunology 25(4): 411-417

Trabace, S.; Nicotra, M.; Cappellacci, S.; Morellini, M.; Muttinelli, C.; Sbracia, M.; Di Prima, M.A.; Masala, C. 1991: HLA-DR and DQ antigens and anticardiolipin antibodies in women with recurrent spontaneous abortions. American Journal of Reproductive Immunology 26(4): 147-149

Lin, S.C.; Sun, A. 1990: HLA-DR and DQ antigens in Chinese patients with oral lichen planus. Journal of Oral Pathology and Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 19(7): 298-300

Kraïba, R.; Loiseau, P.; Faille, A.; Poirier, O.; Piatier-Tonneau, D.; Degos, L.; Abita, J.P.; Charron, D. 1989: HLA-DR and DQ antigens in chronic lymphocytic leukemia: dissociation of expression revealed by cell surface, protein, and mRNA studies. Leukemia 3(5): 386-393

Ottenhoff, T.H.; Mengistu, M.; Tadesse, G.; De Vries, R.R.; Converse, P.J. 1987: HLA-DR and DQ antigens in insulin-dependent diabetics in Ethiopia. Tissue Antigens 30(5): 193-197

Valsecchi, R.; Bontempelli, M.; Rossi, A.; Bellavita, P.; Barcella, A.; Di Landro, A.; Cainelli, T. 1988: HLA-DR and DQ antigens in lichen planus. Acta Dermato-Venereologica 68(1): 77-80

Hamm, H.; Klemmer, S.; Kreuzer, I.; Steijlen, P.M.; Happle, R.; Bröcker, E.B. 1988: HLA-DR and HLA-DQ antigen expression of anagen and telogen hair bulbs in long-standing alopecia areata. Archives of Dermatological Research 280(3): 179-181

Sher, M.R.; Schultz, J.S.; Ragsdale, C.G.; Kapur, J.J.; Sullivan, D.B.; Cassidy, J.T. 1985: HLA-DR and MT associations with the clinical and serologic manifestations of pauciarticular onset juvenile rheumatoid arthritis. Journal of Rheumatology 12(1): 114-118

Weissel, M.; Kainz, H.; Hoefer, R.; Mayr, W.R. 1988: HLA-DR and differentiated thyroid cancer. Lack of association with the nonmedullary types and possible association with the medullary type. Cancer 62(12): 2486-2488

Kameyama, K.; Takezaki, S.; Kanzaki, T.; Nishiyama, S. 1986: HLA-DR and melanoma-associated antigen (p97) expression during the cell cycle in human melanoma cell lines, and the effects of recombinant gamma-interferon: two-color flow cytometric analysis. Journal of Investigative Dermatology 87(3): 313-318

Hayward, C.; Gilfillan, A.; Livingstone, J.; Adam, M.; McIntosh, I.; Brock, D.J.; Liston, W.A. 1990: HLA-DR and pre-eclampsia in Edinburgh. Lancet 335(8703): 1458-1459

Raffel, L.J.; Vadheim, C.M.; Klein, R.; Moss, S.E.; Riley, W.J.; Maclaren, N.K.; Rotter, J.I. 1991: HLA-DR and the 5' insulin gene polymorphism in insulin-dependent diabetes. Metabolism, Clinical and Experimental 40(12): 1244-1248

Bahr, G.M.; Sattar, M.A.; Stanford, J.L.; Shaaban, M.A.; Al Shimali, B.; Siddiqui, Z.; Gabriel, M.; Al Saffar, M.; Shahin, A.; Chugh, T.D. 1989: HLA-DR and tuberculin tests in rheumatoid arthritis and tuberculosis. Annals of the Rheumatic Diseases 48(1): 63-68

Weiss, S.H.; Mann, D.L.; Murray, C.; Popovic, M. 1985: HLA-DR antibodies and HTLV-IIi antibody ELISA testing. Lancet 2(8447): 157

Middleton, D.; Johnston, P.B.; Gillespie, E.L. 1985: HLA-DR antigen association with proliferative diabetic retinopathy. International Ophthalmology 8(1): 33-35

Regezi, J.A.; Zarbo, R.J.; Lloyd, R.V. 1986: HLA-DR antigen detection in giant cell lesions. Journal of Oral Pathology 15(8): 434-438

Teh, M.; Lee, Y.S. 1992: HLA-DR antigen expression in intestinal-type and diffuse-type gastric carcinoma. Cancer 69(5): 1104-1107

Chiba, M.; Iizuka, M.; Horie, Y.; Igarashi, K.; Masamune, O. 1989: HLA-DR antigen expression in macroscopically uninvolved areas of intestinal epithelia in Crohn's disease. Gastroenterologia Japonica 24(4): 365-372

Kimura, T.; Fujiwara, K.; Kuki, K.; Hayashi, Y.; Tabata, T. 1990: HLA-DR antigen expression in tonsillar epithelium. With special reference to focal infection. Acta Oto-Laryngologica 110(5-6): 459-465

Fredrikson, S.; Karlsson-Parra, A.; Olsson, T.; Link, H. 1987: HLA-DR antigen expression on T cells from cerebrospinal fluid in multiple sclerosis and aseptic meningo-encephalitis. Clinical and Experimental Immunology 68(2): 298-304

Katakura, S. 1991: HLA-DR antigen expression on colonic epithelium of ulcerative colitis in comparison with infectious colitis and ischemic colitis. Nihon Shokakibyo Gakkai Zasshi 88(5): 1191-1199

Misaki, T.; Konishi, J.; Arai, K.; Iida, Y.; Kasagi, K.; Kuma, K.; Torizuka, K. 1987: HLA-DR antigen expression on intrathyroidal lymphocytes and thyrocytes in Hashimoto's thyroiditis and Graves' disease: an immunohistological study. Endocrinologia Japonica 34(2): 257-262

Terui, T.; Aiba, S.; Kato, T.; Tanaka, T.; Tagami, H. 1987: HLA-DR antigen expression on keratinocytes in highly inflamed parts of psoriatic lesions. British Journal of Dermatology 116(1): 87-93

Munzarová, M.; Zemanová, D.; Rejthar, A.; Mechl, Z.; Kolcová, V. 1989: HLA-DR antigen expression on melanoma metastases and the course of the disease. Cancer Immunology Immunotherapy: Cii 30(3): 185-189

Aikawa, Y.; Yoshiike, T.; Ogawa, H. 1989: HLA-DR antigen expression on peripheral T cell subsets in pityriasis rosea Gibert, herpes zoster, and psoriasis. Nihon Hifuka Gakkai Zasshi. Japanese Journal of Dermatology 99(4): 443-447

Yoshiike, T.; Aikawa, Y.; Wongwaisayawan, H.; Ogawa, H. 1991: HLA-DR antigen expression on peripheral T cell subsets in pityriasis rosea and herpes zoster. Dermatologica 182(3): 160-163

Cheadle, W.G.; Hershman, M.J.; Wellhausen, S.R.; Polk, H.C. 1991: HLA-DR antigen expression on peripheral blood monocytes correlates with surgical infection. American Journal of Surgery 161(6): 639-645

Lee, M.S.; Shong, Y.K.; Cho, B.Y.; Lee, H.K.; Koh, C.S.; Min, H.K.; Lee, M.; Oh, S.K.; Whang, E.S.; Cha, C.Y. 1988: HLA-DR antigen expression on the thyrocytes of Graves' disease patients. Korean Journal of Internal Medicine 3(1): 15-23

Carrera, M.; Combalia, N.; Griñó, J.M.; Castelao, A.M. 1988: HLA-DR antigen expression on tubular and endothelial cells from fine-needle aspiration cytology. Transplantation Proceedings 20(4): 610-611

Bhatia, E.; Mehra, N.K.; Taneja, V.; Vaidya, M.C.; Ahuja, M.M. 1985: HLA-DR antigen frequencies in a North Indian type i diabetic population. Diabetes 34(6): 565-567

Limas, C.J.; Limas, C. 1992: HLA-DR antigen linkage of anti-beta receptor antibodies in idiopathic dilated and ischaemic cardiomyopathy. British Heart Journal 67(5): 402-405

Májský, A. 1991: HLA-DR antigen typing using the 2-color fluorescence test; the specificity and sensitivity of the method in comparison with the monocytotoxicity and B-lymphocytotoxicity tests. Vnitrni Lekarstvi 37(3): 279-284

Furihata, M.; Ohtsuki, Y.; Ido, E.; Iwata, J.; Sonobe, H.; Araki, K.; Ogoshi, S.; Ohmori, K. 1992: HLA-DR antigen- and S-100 protein-positive dendritic cells in esophageal squamous cell carcinoma--their distribution in relation to prognosis. Virchows Archiv. B Cell Pathology Including Molecular Pathology 61(6): 409-414

Ilonen, J.; Reijonen, H.; Arvilommi, H.; Jokinen, I.; Möttönen, T.; Hannonen, P. 1990: HLA-DR antigens and HLA-DQ beta chain polymorphism in susceptibility to rheumatoid arthritis. Annals of the Rheumatic Diseases 49(7): 494-496

Offidani, A.M.; Simonetti, O.; Politi, A.; Salvi, A.; Gabrielli, A.; Bossi, G. 1988: HLA-DR antigens and alopecia areata. Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 123(9): 409-412

Dejelo, C.L.; Braun, W.E.; Khan, M.A.; Clough, J.D. 1978: HLA-DR antigens and ankylosing spondylitis. Transplantation Proceedings 10(4): 971-972

McNeil, H.P.; Gavaghan, T.P.; Krilis, S.A.; Geczy, A.F.; Chesterman, C.N. 1990: HLA-DR antigens and anticardiolipin antibodies. Clinical and Experimental Rheumatology 8(4): 425-426

Savi, M.; Ferraccioli, G.F.; Neri, T.M.; Zanelli, P.; Dall'Aglio, P.P.; Tincani, A.; Balestrieri, G.; Carella, G.; Cattaneo, R. 1988: HLA-DR antigens and anticardiolipin antibodies in northern Italian systemic lupus erythematosus patients. Arthritis and Rheumatism 31(12): 1568-1570

McHugh, N.J.; Maddison, P.J. 1989: HLA-DR antigens and anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis and Rheumatism 32(12): 1623-1624

Pile, K.D.; Tikly, M.; Bell, J.I.; Wordsworth, B.P. 1992: HLA-DR antigens and rheumatoid arthritis in black South Africans: a study of ethnic groups. Tissue Antigens 39(3): 138-140

Lee, B.W.; Tan, S.H.; Wong, H.B.; Chan, S.H.; Wee, G.B.; Tan, C.L.; Tan, K.W. 1985: HLA-DR antigens in Chinese children with insulin-dependent diabetes mellitus. Annals of the Academy of Medicine Singapore 14(2): 219-222

Visscher, F.; van der Horst, A.R.; Smit, L.M. 1990: HLA-DR antigens in Kleine-Levin syndrome. Annals of Neurology 28(2): 195

Mikesell, J.F.; Bergfeld, W.F.; Braun, W.E. 1986: HLA-DR antigens in alopecia areata. Preliminary report. Cleveland Clinic Quarterly 53(2): 189-191

v Maarsseveen, T.; Mullink, R.; Rensen, R.; Stam, J. 1985: HLA-DR antigens in epithelioid cell granulomas of sarcoidosis, using semithin frozen sections. A concept about granuloma formation. Sarcoidosis 2(2): 148-153

Jayanthi, M.; Habibullah, C.M.; Ishaq, M. 1990: HLA-DR antigens in gastric carcinoma. Immunology Letters 24(4): 265-266

Aaron, S.; Davis, P.; Bertouch, J. 1986: HLA-DR antigens in gold-induced neutropenia. Arthritis and Rheumatism 29(12): 1515-1517

Sriram, S.; Stewart, G.J.; Buhler, M.; Grumet, C.; Engleman, E. 1985: HLA-DR antigens in multiple sclerosis: two-dimensional gel electrophoresis. Neurology 35(2): 248-251

Zarbo, R.J.; Regezi, J.A.; Lloyd, R.V.; Crissman, J.D.; Batsakis, J.G. 1987: HLA-DR antigens in normal, inflammatory, and neoplastic salivary glands. Oral Surgery Oral Medicine and Oral Pathology 64(5): 577-584

Gouet, D.; Alcalay, D.; Azais, I.; Alcalay, M.; Becq-Giraudon, B.; Sudre, Y.; Bontoux, D. 1985: HLA-DR antigens in polymyalgia rheumatica and giant cell arteritis. Journal of Rheumatology 12(3): 627-628

Bassendine, M.F.; Dewar, P.J.; James, O.F. 1985: HLA-DR antigens in primary biliary cirrhosis: lack of association. Gut 26(6): 625-628

Scherak, O.; Mayr, W.R.; Smolen, J.S. 1987: HLA-DR antigens in rheumatoid arthritis. A Swiss collaborative study; final report. Rheumatology International 7(3): 139-140

Catalan, F.; Milovanovic, A. 1986: In vitro activity of the combination of mercurobutal and sodium lauryl sulfate on Trichomonas. Revue Francaise de Gynecologie et d'Obstetrique 81(6-7): 389-391

Smolen, J.S.; Klippel, J.H.; Penner, E.; Reichlin, M.; Steinberg, A.D.; Chused, T.M.; Scherak, O.; Graninger, W.; Hartter, E.; Zielinski, C.C. 1987: HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens. Annals of the Rheumatic Diseases 46(6): 457-462

Costabel, U.; Bross, K.J.; Andreesen, R.; Matthys, H. 1986: HLA-DR antigens on human macrophages from bronchoalveolar lavage fluid. Thorax 41(4): 261-265

Chan, C.C.; Detrick, B.; Nussenblatt, R.B.; Palestine, A.G.; Fujikawa, L.S.; Hooks, J.J. 1986: HLA-DR antigens on retinal pigment epithelial cells from patients with uveitis. Archives of Ophthalmology 104(5): 725-729

Speiser, P.; Pausch, V. 1986: HLA-DR as a criterion in the selection of organ recipients. Wiener Medizinische Wochenschrift 136(4): 89-95

Cook, D.J. 1986: HLA-DR associated immune responsiveness. Clinical Transplants 1986: 247-256

Galeazzi, M.; Sebastiani, G.D.; Cappellacci, S.; Lulli, P.; Mazzilli, M.C.; Tosi, R.; Tanigaki, N. 1989: HLA-DR association in rheumatoid arthritis and the shared susceptibility epitope hypothesis. Arthritis and Rheumatism 32(5): 663-664

MacDonald, M.J.; Famuyiwa, O.O.; Nwabuebo, I.A.; Bella, A.F.; Junaid, T.A.; Marrari, M.; Duquesnoy, R.J. 1986: HLA-DR associations in black type I diabetics in Nigeria. Further support for models of inheritance. Diabetes 35(5): 583-589

Kohonen-Corish, M.R.; Serjeantson, S.W. 1986: HLA-DR beta gene DNA polymorphisms revealed by Taq I correlate with HLA-DR specificities. Human Immunology 15(3): 263-271

Böhme, J.; Andersson, M.; Andersson, G.; Möller, E.; Peterson, P.A.; Rask, L. 1985: HLA-DR beta genes vary in number between different DR specificities, whereas the number of DQ beta genes is constant. Journal of Immunology 135(3): 2149-2155

Haegert, D.G.; Michaud, M.; Schwab, C.; Tansey, C.; Décary, F.; Francis, G. 1989: HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis. Journal of Neuroscience Research 23(1): 46-54

Gorski, J. 1989: HLA-DR beta-chain polymorphism. Second domain polymorphism reflects evolutionary relatedness of alleles and may explain public serologic epitopes. Journal of Immunology 143(1): 329-333

Cheng, H.F.; Nolasco, F.; Cameron, J.S.; Hildreth, G.; Neild, G.H.; Hartley, B.; Neild, G. 1989: HLA-DR display by renal tubular epithelium and phenotype of infiltrate in interstitial nephritis. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 4(3): 205-215

Field, L.L.; Fothergill-Payne, C.; Bertrams, J.; Baur, M.P. 1986: HLA-DR effects in a large German IDDM dataset. Genetic Epidemiology. Suppl 1: 323-328

Poulsen, L.O.; Elling, P.; Sørensen, F.B.; Høedt-Rasmussen, K. 1986: HLA-DR expression and disease activity in ulcerative colitis. Scandinavian Journal of Gastroenterology 21(3): 364-368

Link, H.; Fredrikson, S. 1987: HLA-DR expression and neopterin levels as activity markers in multiple sclerosis. Rivista di Neurologia 57(3): 154-158

Khoury, E.L.; Berline, J.W. 1988: HLA-DR expression by adrenocortical cells of the zona reticularis: structural and allotypic characterization. Tissue Antigens 31(4): 191-203

Khoury, E.L.; Price, V.H.; Greenspan, J.S. 1988: HLA-DR expression by hair follicle keratinocytes in alopecia areata: evidence that it is secondary to the lymphoid infiltration. Journal of Investigative Dermatology 90(2): 193-200

Prescott, S.; James, K.; Busuttil, A.; Hargreave, T.B.; Chisholm, G.D.; Smyth, J.F. 1989: HLA-DR expression by high grade superficial bladder cancer treated with BCG. British Journal of Urology 63(3): 264-269

Moutsopoulos, H.M.; Hooks, J.J.; Chan, C.C.; Dalavanga, Y.A.; Skopouli, F.N.; Detrick, B. 1986: HLA-DR expression by labial minor salivary gland tissues in Sjögren's syndrome. Annals of the Rheumatic Diseases 45(8): 677-683

Boshkov, L.K.; Kelton, J.G.; Halloran, P.F. 1992: HLA-DR expression by platelets in acute idiopathic thrombocytopenic purpura. British Journal of Haematology 81(4): 552-557

Ratech, H. 1990: HLA-DR expression in B-cell non-Hodgkin's malignant lymphomas: a multiparameter flow cytometry study. Human Pathology 21(12): 1275-1282

Lampert, I.A.; Kirkland, S.; Farrell, S.; Borysiewicz, L.K. 1985: HLA-DR expression in a human colonic carcinoma cell line. Journal of Pathology 146(4): 337-344

Sloane, J.P.; Elliott, C.J.; Powles, R. 1988: HLA-DR expression in epidermal keratinocytes after allogeneic bone marrow transplantation. Relationship to histology, rash, marrow purging, and systemic graft-versus-host disease. Transplantation 46(6): 840-844

Goldberg, J.; Rial, M.; Casadei, D.; Vila, N.; Zarazaga, C.N.; Mainetti, L. 1988: HLA-DR expression in fine-needle aspiration biopsy cell samples as a marker of rejection in kidney grafts. Transplantation Proceedings 20(4): 612-613

MacDonald, T.T.; Weinel, A.; Spencer, J. 1988: HLA-DR expression in human fetal intestinal epithelium. Gut 29(10): 1342-1348

Park, S.H.; Bae, Y.M.; Kim, T.J.; Ha, I.S.; Kim, S.; Chi, J.G.; Lee, S.K. 1992: HLA-DR expression in human fetal thymocytes. Human Immunology 33(4): 294-298

Beilke, M.A.; Riding In, D.; Hamilton, R.; Stone, G.A.; Jordan, E.K.; Brashears, G.; Nusbaum, W.; Huddleston, D.; Gibbs, C.J.; Gravell, M. 1991: HLA-DR expression in macaque neuroendothelial cells in vitro and during SIV encephalitis. Journal of Neuroimmunology 33(2): 129-143

Andersson, R.; Hansson, G.K.; Söderström, T.; Jonsson, R.; Bengtsson, B.A.; Nordborg, E. 1988: HLA-DR expression in the vascular lesion and circulating T lymphocytes of patients with giant cell arteritis. Clinical and Experimental Immunology 73(1): 82-87

Esteban, F.; Ruiz-Cabello, F.; Concha, A.; Pérez-Ayala, M.; Sánchez-Rozas, J.A.; Garrido, F. 1990: HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx. Clinical and Experimental Metastasis 8(4): 319-328

Nagura, H.; Ohtani, H.; Masuda, T.; Kimura, M.; Nakamura, S. 1991: HLA-DR expression on M cells overlying Peyer's patches is a common feature of human small intestine. Acta Pathologica Japonica 41(11): 818-823

Ress, S.R.; Strassmann, G.; Bach, F.H. 1985: HLA-DR expression on cytotoxic T lymphocytes. Scandinavian Journal of Immunology 22(5): 455-461

Liang, Y.R. 1992: HLA-DR expression on hepatic cells in hepatitis B. Zhonghua Bing Li Xue Za Zhi 21(4): 212-214

Bos, H.J.; Keizer, G.D.; vd Muijsenberg, A.J.; Beelen, R.H. 1990: HLA-DR expression on human peritoneal macrophages in vivo and in vitro. Cell Biology International Reports 14(6): 499-508

Auböck, J.; Romani, N.; Grubauer, G.; Fritsch, P. 1986: HLA-DR expression on keratinocytes is a common feature of diseased skin. British Journal of Dermatology 114(4): 465-472

Gillis, D.; Silvestrini, R.A.; Kamath, S. 1986: HLA-DR expression on renal tubular cells in various renal disorders. Pathology 18(4): 480-481

Terada, T.; Nakanuma, Y.; Obata, H. 1991: HLA-DR expression on the microvasculature of portal tracts in idiopathic portal hypertension. Immunohistochemical characteristics and relation to portal phlebosclerosis. Archives of Pathology and Laboratory Medicine 115(10): 993-997

Almirall, J.; Sole, M.; Campistol, J.M.; Bru, C.; Oppenheimer, F.; Andreu, J.; Revert, L. 1992: HLA-DR expression on tubular cells in kidney transplants. Transplantation Proceedings 24(1): 69-70

Pryds, O.; Lervang, H.H.; Kristensen, H.P.; Jakobsen, B.K.; Svejgaard, A. 1987: HLA-DR factors associated with postpartum hypothyroidism: an early manifestation of Hashimoto's thyroiditis?. Tissue Antigens 30(1): 34-37

Savi, M.; Ferraccioli, G. 1986: HLA-DR frequencies in northern Italy. Journal of Rheumatology 13(2): 479

Cone, R.D.; Platzer, M.; Piccinini, L.A.; Jaramillo, M.; Davies, T.F. 1988: HLA-DR gene expression in a proliferating human thyroid cell clone (12S). Endocrinology 123(4): 2067-2074

Chen, X. 1992: HLA-DR gene frequencies in IgA nephropathy patients obtained by oligonucleotide genotyping. Zhonghua Yi Xue Za Zhi 72(4): 206-209; 254

Obata, F.; Ito, K.; Kaneko, T.; Yang, Y.G.; Onda, K.; Ito, I.; Yabe, N.; Watanabe, K.; Kashiwagi, N. 1991: HLA-DR gene frequencies in the Japanese population obtained by oligonucleotide genotyping. Tissue Antigens 38(3): 124-132

Yunis, I.; Salazar, M.; Yunis, E.J. 1991: HLA-DR generic typing by AFLP. Tissue Antigens 38(2): 78-88

Peyman, J.A.; Nelson, P.J.; Hammond, G.L. 1992: HLA-DR genes are silenced in human trophoblasts and stimulation of signal transduction pathways does not circumvent interferon-gamma unresponsiveness. Transplantation Proceedings 24(2): 470-471

Hui, K.; Festenstein, H.; de Klein, A.; Grosveld, G.; Grosveld, F. 1985: HLA-DR genotyping by restriction fragment length polymorphism analyses. Immunogenetics 22(3): 231-239

Kristoferistsch, W.; Mayr, W.R.; Partsch, H.; Neumann, R.; Stanek, G. 1986: HLA-DR in Lyme borreliosis. Lancet 2(8501): 278

Balthazar, P.A.; Gabriel Júnior, A.; de Oliveira, D.P.; de Oliveira, M.A.; Rosales, T.; Iglesias, S.S.; Assad, R.L.; Cossermelli, W. 1985: HLA-DR in patients with systemic lupus erythematosus with anti-ribonucleoprotein antibodies and in mixed connective tissue disease. Revista do Hospital das Clinicas 40(6): 249-253

Iakovleva, D.B.; Benevolenskaia, L.I.; Orlov-Morozov, A.V.; Kalinina, N.M. 1985: HLA-DR in rheumatoid arthritis. Terapevticheskii Arkhiv 57(8): 80-82

Chelladurai, M.; Honn, K.V.; Walz, D.A. 1991: HLA-DR is a procoagulant. Biochemical and Biophysical Research Communications 178(2): 467-473

Mann, D.L.; Read-Connole, E.; Arthur, L.O.; Robey, W.G.; Wernet, P.; Schneider, E.M.; Blattner, W.A.; Popovic, M. 1988: HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class Ii antigens. Journal of Immunology 141(4): 1131-1136

Valeri, M.; Adorno, D.; Piazza, A.; Torlone, N.; Provenzani, L.; Monaco, P.I.; Casciani, C.U. 1990: HLA-DR matching and graft survival in heart transplant. Transplantation Proceedings 22(4): 1906-1907

Adorno, D.; Valeri, M.; Piazza, A.; Torlone, N.; Monaco, P.I.; Provenzani, L.; Casciani, C.U. 1988: HLA-DR matching in heart transplants: may it be a selective criterion?. Transplantation Proceedings 20(5): 1038-1039

Pfeffer, P.F.; Foerster, A.; Frøysaker, T.; Simonsen, S.; Thorsby, E. 1988: HLA-DR mismatch and histologically evaluated rejection episodes in cardiac transplants can be correlated. Transplantation Proceedings 20(3): 367-368

Odum, N.; Martin, P.J.; Schieven, G.L.; Masewicz, S.; Hansen, J.A.; Ledbetter, J.A. 1991: HLA-DR molecules enhance signal transduction through the CD3/Ti complex in activated T cells. Tissue Antigens 38(2): 72-77

Pesando, J.M.; Hoffman, P.; Stucki, M.A. 1989: HLA-DR molecules on all cells are electrophoretically unique. Leukemia Research 13(9): 851-862

Tiercy, J.M.; Goumaz, C.; Mach, B.; Jeannet, M. 1991: HLA-DR oligotyping of 100 kidney transplant patients with difficult serological typing: correlation between serology and DNA typing. Transplantation Proceedings 23(1 Part 1): 383-384

Lewis, D.E.; Ulrich, R.G.; Atassi, H.; Atassi, M.Z. 1990: HLA-DR peptide inhibits HIV-induced syncytia. Immunology Letters 24(2): 127-131

De Koster, H.S.; van Rood, J.J.; Termijtelen, A. 1992: HLA-DR peptide-induced alloreactive T cell lines reveal an HLA-DR sequence that can be both "dominant" and "cryptic": evidence for allele-specific processing. European Journal of Immunology 22(6): 1531-1539

Watanabe, I.; Sagawa, A.; Nakabayashi, T.; Mukai, M.; Fujisaku, A.; Nakagawa, S. 1990: HLA-DR positive T cells and CD45R positive CD4 cells in primary Sjögren's syndrome. Ryumachi 30(3): 181-189

Miori, L.; Bellosta, M.; Rabbiosi, G. 1989: HLA-DR positivity in discoid lupus erythematosus. Journal of the American Academy of Dermatology 21(6): 1316-1317

Vinci, G.; Vernant, J.P.; Cordonnier, C.; Bracq, C.; Rochant, H.; Breton-Gorius, J.; Vainchenker, W. 1986: HLA-DR restriction in suppression of hematopoiesis by T cells from allogeneic bone marrow transplants. Journal of Immunology 136(9): 3225-3230

Holloman, J.D.; Bell, J.I.; Kilduff, T.S.; Dement, W.C.; Guilleminault, C.; McDevitt, H.O. 1987: HLA-DR restriction-fragment-length polymorphisms in narcolepsy. Journal of Neuroscience Research 18(1): 239-244

Rodey, G.E.; White, N.; Frazer, T.E.; Duquesnoy, R.J.; Santiago, J.V. 1979: HLA-DR specificities among black Americans with juvenile-onset diabetes. New England Journal of Medicine 301(15): 810-812

Shaw, A.R.; Chan, J.K.; Reid, S.; Seehafer, J. 1985: HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta. Journal of the National Cancer Institute 74(6): 1261-1268

Migliori, R.J.; Simmons, R.L.; Fryd, D.; Noreen, H.; Ascher, N.L.; Sutherland, D.E.; Payne, W.; Najarian, J.S. 1987: HLA-DR tissue typing may be ignored for first but not subsequent cadaver renal transplants. Transplantation Proceedings 19(1 Pt 1): 689-690

Anastasiou-Nana, M.I.; Anderson, J.L.; Carlquist, J.F.; Nanas, J.N. 1986: HLA-DR typing and lymphocyte subset evaluation in rheumatic heart disease: a search for immune response factors. American Heart Journal 112(5): 992-997

Madsen, M.; Johnsen, H.E.; Kissmeyer-Nielsen, F. 1979: HLA-DR typing of frozen B lymphocytes. Transplantation Proceedings 11(2): 1321

Wood, N.; Joysey, V.; Bidwell, J.; Klouda, P. 1990: HLA-DR typing of renal allograft patients and donors by DNA-RFLP: correlation with pretransplant serotyping. Transplantation Proceedings 22(5): 2287

Wordsworth, B.P.; Allsopp, C.E.; Young, R.P.; Bell, J.I. 1990: HLA-DR typing using DNA amplification by the polymerase chain reaction and sequential hybridization to sequence-specific oligonucleotide probes. Immunogenetics 32(6): 413-418

Riisom, K.; Søorensen, I.J.; Møoller, B.; Kruse, T.A.; Graugaard, B.; Lamm, L.U. 1988: HLA-DR typing using restriction fragment length polymorphism (RFLP) with one enzyme and two probes. Tissue Antigens 31(3): 141-150

Cox, N.J.; Mela, A.P.; Zmijewski, C.M.; Spielman, R.S. 1988: HLA-DR typing "at the DNA level": RFLPs and subtypes detected with a DR beta cDNA probe. American Journal of Human Genetics 43(6): 954-963

Bröll, H.; Haberhauer, G. 1987: HLA-DR versus HLA-B5-CREG antigens in rheumatoid arthritis (RA). Scandinavian Journal of Rheumatology 16(4): 285-289

Lucey, D.R.; Nunley, M.; Boswell, R.N.; Koopman, T.L.; Hensley, R.E.; Ward, W.W. 1991: HLA-DR+ CD8+ T cells in the cerebrospinal fluid of a patient with AIDS dementia complex and 355-494/mm3 CD4+ peripheral blood T cells. Journal of Acquired Immune Deficiency Syndromes 4(6): 638-639

Seto, S.K.; Gillette, T.E.; Chandler, J.W. 1987: HLA-DR+/T6- Langerhans cells of the human cornea. Investigative Ophthalmology and Visual Science 28(10): 1719-1722

Jazwinska, E.C.; Serjeantson, S.W. 1988: HLA-DR, -DQ DNA genotyping and T-cell receptor RFLPs in leprosy. Disease Markers 6(3): 173-183

Marley, N.J.; Macartney, J.C.; Ciclitira, P.J. 1987: HLA-DR, DP and DQ expression in the small intestine of patients with coeliac disease. Clinical and Experimental Immunology 70(2): 386-393

Hirose, T.; Goto, M.; Okumura, K. 1990: HLA-DR, DQ and DP antigen expression in synovial fluid T lymphocytes in rheumatoid arthritis: cell cycle analysis of HLA-DP positive T cells. Journal of Rheumatology 17(1): 18-23

Erlich, H.; Bugawan, T.; Begovich, A.B.; Scharf, S.; Griffith, R.; Saiki, R.; Higuchi, R.; Walsh, P.S. 1991: HLA-DR, DQ and DP typing using PCR amplification and immobilized probes. European Journal of Immunogenetics: Official Journal of the British Society for Histocompatibility and Immunogenetics 18(1-2): 33-55

Kobayashi, K.; Atoh, M.; Konoeda, Y.; Yagita, A.; Inoko, H.; Sekiguchi, S. 1990: HLA-DR, DQ and T cell antigen receptor constant beta genes in Japanese patients with ulcerative colitis. Clinical and Experimental Immunology 80(3): 400-403

Lee, T.D.; Lee, G.; Zhao, T.M. 1990: HLA-DR, DQ antigens in North American Caucasians. Tissue Antigens 35(2): 64-70

Awad, J.; Navarrete, C.; Sachs, J.A.; Festenstein, H.; Cassell, P.G.; Niven, M.J.; Hitman, G. 1988: HLA-DR, DQ, and DX alpha RFLPs and their associations with serologically defined HLA-DR and -DQ antigens. Immunogenetics 27(1): 73-76

Al-Daccak, R.; Loiseau, P.; Rabian, C.; Devergie, A.; Bourdeau, H.; Raffoux, C.; Gluckman, E.; Colombani, J. 1990: HLA-DR, DQ, and/or DP genotypic mismatches between recipient-donor pairs in unrelated bone marrow transplantation and transplant clinical outcome. Transplantation 50(6): 960-964

Wong, A.C.; Aoki, K.; Yagami, Y.; Akaza, T.; Takeuchi, S.; Matsunaga, T. 1987: HLA-DR, DRw52.53, and DQ homozygosity in patients with neural tube defects. Jinrui Idengaku Zasshi. Japanese Journal of Human Genetics 32(4): 319-327

Gao, X.; Bhatia, K.; Trent, R.J.; Serjeantson, S.W. 1992: HLA-DR,DQ nucleotide sequence polymorphisms in five Melanesian populations. Tissue Antigens 40(1): 31-37

Pawelec, G.; Schneider, E.M.; Müller, C.; Wernet, P. 1985: HLA-DR-, MB- and novel DC-related determinants restrict purified protein derivative of tuberculin (PPD)-stimulated human T cell proliferation. European Journal of Immunology 15(1): 12-17

Umetsu, D.T.; Yunis, E.J.; Matsui, Y.; Jabara, H.H.; Geha, R.S. 1985: HLA-DR-4-associated alloreactivity of an HLA-DR-3-restricted human tetanus toxoid-specific T cell clone: inhibition of both reactivities by an alloantiserum. European Journal of Immunology 15(4): 356-361

Spurkland, A.; Rønningen, K.S.; Leivestad, T.; Vartdal, F.; Thorsby, E. 1992: HLA-DR-DQ haplotype frequencies in a Norwegian population. Transplantation Proceedings 24(1): 298-299

Carlsson, B.; Wallin, J.; Böhme, J.; Möller, E. 1987: HLA-DR-DQ haplotypes defined by restriction fragment analysis. Correlation to serology. Human Immunology 20(2): 95-113

Smolle, J. 1985: HLA-DR-antigen bearing keratinocytes in various dermatologic disorders. Acta Dermato-Venereologica 65(1): 9-13

Narni, F.; Kudo, J.; Mars, W.; Calabretta, B.; Florine, D.L.; Barlogie, B.; Saunders, G.F. 1986: HLA-DR-associated invariant chain is highly expressed in chronic lymphocytic leukemia. Blood 68(2): 372-377

Bahr, G.M.; Rook, G.A.; Shahin, A.; Stanford, J.L.; Sattar, M.I.; Behbehani, K. 1988: HLA-DR-associated isotype-specific regulation of antibody levels to mycobacteria in rheumatoid arthritis. Clinical and Experimental Immunology 72(1): 26-31

Salier, J.P.; Martin-Mondiere, C.; Sesboüé, R.; Daveau, M.; Goust, J.M.; Govaerts, A.; Schuller, E.; Degos, J.D. 1985: HLA-DR-dependent variation of intrathecal IgG1 (Gm) allotype synthesis in multiple sclerosis. Journal of Immunology 134(3): 1551-1554

Schrøder, H.D.; Olsson, T.; Solders, G.; Kristensson, K.; Link, H. 1988: HLA-DR-expressing cells and T-lymphocytes in sural nerve biopsies. Muscle and Nerve 11(8): 864-870

Caruso, C.; Modica, M.A.; Lio, D.; Cillari, E. 1987: HLA-DR-linked genes are involved in the control of T lymphocyte blood levels. Clinical Immunology and Immunopathology 44(2): 160-166

Chang, D.M.; Chou, C.T.; Lee, C.F.; Chang, M.L. 1987: HLA-DR-positive T lymphocytes in peripheral blood and synovial fluid in patients with rheumatoid arthritis. Taiwan Yi Xue Hui Za Zhi. Journal of the Formosan Medical Association 86(1): 39-42

Smolle, J.; Soyer, H.P.; Juettner, F.M.; Torne, R.; Stettner, H.; Kerl, H. 1988: HLA-DR-positive keratinocytes are associated with suppressor lymphocyte epidermotropism. a biomathematical study. American Journal of Dermatopathology 10(2): 128-132

Mustafa, A.S.; Qvigstad, E. 1989: HLA-DR-restricted antigen-induced proliferation and cytotoxicity mediated by CD4+ T-cell clones from subjects vaccinated with killed M. leprae. International Journal of Leprosy and other Mycobacterial Diseases: Official Organ of the International Leprosy Association 57(1): 1-11

Lindsley, M.D.; Torpey, D.J.; Rinaldo, C.R. 1986: HLA-DR-restricted cytotoxicity of cytomegalovirus-infected monocytes mediated by Leu-3-positive T cells. Journal of Immunology 136(8): 3045-3051

Sasportes, M.; Fradelizi, D.; Dausset, J. 1979: HLA-DR-specific human suppressor cells generated by repeated in vitro sensitization against allogeneic cells. Transplantation Proceedings 11(2): 1451

Guilbert, B.; Fellous, M.; Avrameas, S. 1986: HLA-DR-specific monoclonal antibodies cross-react with several self and nonself non-MHC molecules. Immunogenetics 24(2): 118-121

Taneja, V.; Mehra, N.K.; Reddy, K.S.; Narula, J.; Tandon, R.; Vaidya, M.C.; Bhatia, M.L. 1989: HLA-DR/DQ antigens and reactivity to B cell alloantigen D8/17 in Indian patients with rheumatic heart disease. Circulation 80(2): 335-340

Bogner, U.; Badenhoop, K.; Peters, H.; Schmieg, D.; Mayr, W.R.; Usadel, K.H.; Schleusener, H. 1992: HLA-DR/DQ gene variation in nongoitrous autoimmune thyroiditis at the serological and molecular level. Autoimmunity 14(2): 155-158

Wood, N.A.; Clay, T.M.; Bidwell, J.L. 1991: HLA-DR/Dw matching by PCR fingerprinting: the origin of PCR fingerprints and further applications. European Journal of Immunogenetics: Official Journal of the British Society for Histocompatibility and Immunogenetics 18(1-2): 147-153

Baggesen, K.; Ehlers, N.; Lamm, L.U. 1991: HLA-DR/RFLP compatible corneal grafts. Acta Ophthalmologica 69(2): 229-233

Lang, B.; Melchers, I.; Urlacher, A.; Tanzi-Fetta, R.F.; Kohlbrenner, S.; Tongio, M.M.; Peter, H.H. 1990: HLA-DR1 and DRw6 association in DR4-negative rheumatoid arthritis patients. Rheumatology International 10(4): 171-175

Caruso, C.; Giordano, C.; Galluzzo, A.; Pantò, F.; Modica, M.A. 1988: HLA-DR1 and HLA-DR3 phenotypes and insulin antibody production in diabetic Sicilian patients. Experimental and Clinical Immunogenetics 5(1): 48-51

Valsecchi, R.; Bontempelli, M.; Bellavita, P.M.; Rossi, A.; Barcella, A.; Di Landro, A.; Cainelli, T. 1987: HLA-DR1 and lichen ruber planus. Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 122(6): 277-280

Cicciarelli, J. 1987: HLA-DR1 is a low responsiveness antigen in human kidney transplant recipients. Clinical Transplants 1987: 381-391

Poloy, A.; Tibor, L.; Kramer, J.; Anh-Tuan, N.; Kraszits, E.; Medgyessy, I.; Füst, G.; Stenszky, V.; Farid, N.R. 1991: HLA-DR1 is associated with vitiligo. Immunology Letters 27(1): 59-62

Czarnecki, D.; Lewis, A.; Nicholson, I.; Tait, B.; Nash, C. 1992: HLA-DR1 is not a sign of poor prognosis for the development of multiple basal cell carcinomas. Journal of the American Academy of Dermatology 26(5 Part 1): 717-719

Cook, D.J.; Cecka, J.M.; Terasaki, P.I. 1987: HLA-DR1 recipients have the highest kidney transplant survival. Transplantation Proceedings 19(1 Part 1): 675-677

Salmela, K.; von Willebrand, E.; Kyllönen, L.; Koskimies, S.; Isoniemi, H.; Eklund, B.; Höckerstedt, K.; Ahonen, J. 1991: HLA-DR1, -DR5, and -DR8 antigen disparities are associated with acute steroid-resistant rejection and poor kidney graft survival. Transplantation Proceedings 23(1 Part 2): 1272-1273

Honda, Y.; Juji, T.; Matsuki, K.; Naohara, T.; Satake, M.; Inoko, H.; Someya, T.; Harada, S.; Doi, Y. 1986: HLA-DR2 and Dw2 in narcolepsy and in other disorders of excessive somnolence without cataplexy. Sleep 9(1 Part 2): 133-142

Billiard, M.; Seignalet, J.; Besset, A.; Cadilhac, J. 1986: HLA-DR2 and narcolepsy. Sleep 9(1 Part 2): 149-152

Guilleminault, C.; Grumet, C. 1986: HLA-DR2 and narcolepsy: not all narcoleptic-cataplectic patients are DR2. Human Immunology 17(1): 1-2

Schulz, H.; Geisler, P.; Pollmaecher, T.; Andreas-Zietz, A.; Keller, E.; Scholz, S.; Albert, E.D. 1987: HLA-DR2 and rapid-eye-movement sleep latency: failure to replicate. Lancet 1(8533): 627

Schreiber, W.; Schulz, H.; Lauer, C.J.; Geisler, P.; Pollmächer, T.; Scholz, S.; Krieg, J.C.; Wiegand, M.; Riemann, D.; Emrich, H.E. 1990: HLA-DR2 and sleep onset REM periods in depression. Biological Psychiatry 28(11): 1012-1013

Riemann, D.; Berger, M.; Teuber, J.; Usadel, K.H. 1988: HLA-DR2 and sleep onset REM periods in endogenous depression. British Journal of Psychiatry: the Journal of Mental Science 152: 296

Rubin, R.L.; Hajdukovich, R.M.; Mitler, M.M. 1988: HLA-DR2 association with excessive somnolence in narcolepsy does not generalize to sleep apnea and is not accompanied by systemic autoimmune abnormalities. Clinical Immunology and Immunopathology 49(1): 149-158

Schulz, H.; Geisler, P.; Pollmaecher, T.; Andreas-Zietz, A.; Keller, E.; Scholz, S.; Albert, E.D. 1986: HLA-DR2 correlates with rapid-eye-movement sleep latency in normal human subjects. Lancet 2(8510): 803

Pollack, S.; Gideoni, O.; Peled, R.; Lavie, P. 1988: HLA-DR2 in Israeli Jews with narcolepsy-cataplexy. Israel Journal of Medical Sciences 24(2): 123-125

Lenn, N.J. 1986: HLA-DR2 in childhood narcolepsy. Pediatric Neurology 2(5): 314-315

Confavreux, C.; Gebuhrer, L.; Betuel, H.; Freidel, C.; Bastuji, H.; Aimard, G.; Devic, M.; Jouvet, M. 1987: HLA-DR2 negative narcolepsy. Journal of Neurology Neurosurgery and Psychiatry 50(5): 635-636

Nakao, S.; Yamaguchi, M.; Saito, M.; Yasue, S.; Shiobara, S.; Matsuda, T.; Nitta, M.; Sasaki, M. 1992: HLA-DR2 predicts a favorable response to cyclosporine therapy in patients with bone marrow failure. American Journal of Hematology 40(3): 239-240

Lee, B.S.; Rust, N.A.; McMichael, A.J.; McDevitt, H.O. 1987: HLA-DR2 subtypes form an additional supertypic family of DR beta alleles. Proceedings of the National Academy of Sciences of the United States of America 84(13): 4591-4595

Font, M.P.; Gebuhrer, L.; Betuel, H.; Freidel, C.; Dausset, J.; Cohen, D. 1986: HLA-DR2, -DR5, and DRw6 associated Dw subtypes correlate with HLA-DR beta and -DQ beta restriction fragment length polymorphisms. Proceedings of the National Academy of Sciences of the United States of America 83(10): 3361-3365

Blumenthal, M.; Marcus-Bagley, D.; Awdeh, Z.; Johnson, B.; Yunis, E.J.; Alper, C.A. 1992: HLA-DR2, [HLA-B7, SC31, DR2], and [HLA-B8, SC01, DR3] haplotypes distinguish subjects with asthma from those with rhinitis only in ragweed pollen allergy. Journal of Immunology 148(2): 411-416

Kreisler, J.M.; Rementeria, M.C.; de Pablo, R.; Moreno, M.E. 1988: HLA-DR2, a marker for class i antigen sensitization. Transplantation 45(6): 1071-1074

Reveille, J.D.; Barger, B.O.; Hodge, T.W. 1991: HLA-DR2-DRB1 allele frequencies in DR2-positive black Americans with and without systemic lupus erythematosus. Tissue Antigens 38(4): 178-180

Cohen, N.; Brautbar, C.; Font, M.P.; Dausset, J.; Cohen, D. 1986: HLA-DR2-associated Dw subtypes correlate with RFLP clusters: most DR2 IDDM patients belong to one of these clusters. Immunogenetics 23(2): 84-89

Körner, J.; Propping, P.; Fritze, J. 1990: HLA-DR2-frequencies in affective disorders. British Journal of Psychiatry: the Journal of Mental Science 156: 907-908

Bruserud, O.; Jervell, J.; Thorsby, E. 1985: HLA-DR3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with type 1 (insulin-dependent) diabetes and healthy subjects. Diabetologia 28(7): 420-426

Althaus, B.; Straub, J.J.; Neri, T.M.; Hauenstein, M.; Müller-Brand, J.; Berger, W.; Farid, N.R. 1986: HLA-DR3 and DRw6: prognostic factors for the incidence of hypothyroidism in Graves' disease after radioiodine treatment. Acta Endocrinologica 113(3): 323-328

Pozzilli, P.; Tarn, A.C.; Gale, E.A. 1985: HLA-DR3 and activated lymphocytes: significance in autoimmunity. Lancet 2(8461): 954-955

Caruso, C.; Candore, G.; Modica, M.A. 1990: HLA-DR3 and immunoresponsiveness. Lancet 336(8713): 506-507

Schifferdecker, E.; Manfras, B.; Kühnl, P.; Holzberger, G.; Boehm, B.O. 1991: HLA-DR3 and variations of the T cell receptor beta gene in Graves' disease. Acta Endocrinologica 124(6): 658-660

Fiorito, S.; Autore, C.; Fragola, P.V.; Purpura, M.; Cannata, D.; Sangiorgi, M. 1986: HLA-DR3 antigen linkage in patients with hypertrophic obstructive cardiomyopathy. American Heart Journal 111(1): 91-94

Jontell, M.; Ståhlblad, P.A.; Rosdahl, I.; Lindblom, B. 1987: HLA-DR3 antigens in erosive oral lichen planus, cutaneous lichen planus, and lichenoid reactions. Acta Odontologica Scandinavica 45(5): 309-312

Cohen, M.G.; Li, E.K.; Ng, P.Y. 1992: HLA-DR3, C4A*QO and toxicity from gold in rheumatoid arthritis. British Journal of Rheumatology 31(9): 645

Dunston, G.M.; Henry, L.W.; Christian, J.; Ofosu, M.D.; Callender, C.O. 1989: HLA-DR3, DQ heterogeneity in American blacks is associated with susceptibility and resistance to insulin dependent diabetes mellitus. Transplantation Proceedings 21(1 Pt 1): 653-655

Genth, E.; Zarnowski, H.; Mierau, R.; Wohltmann, D.; Hartl, P.W. 1987: HLA-DR4 and Gm(1,3;5,21) are associated with U1-nRNP antibody positive connective tissue disease. Annals of the Rheumatic Diseases 46(3): 189-196

Stastny, P.; Ball, E.J.; Khan, M.A.; Olsen, N.J.; Pincus, T.; Gao, X. 1988: HLA-DR4 and other genetic markers in rheumatoid arthritis. British Journal of Rheumatology 27(Suppl 2): 132-138

Scott, T.E.; Wise, R.A.; Hochberg, M.C.; Wigley, F.M. 1987: HLA-DR4 and pulmonary dysfunction in rheumatoid arthritis. American Journal of Medicine 82(4): 765-771

Silman, A.J.; Reeback, J.; Jaraquemada, D. 1986: HLA-DR4 as a predictor of outcome three years after onset of rheumatoid arthritis. Rheumatology International 6(5): 233-235

Ollier, W.; Carthy, D.; Cutbush, S.; Okoye, R.; Awad, J.; Fielder, A.; Silman, A.; Festenstein, H. 1989: HLA-DR4 associated Dw types in rheumatoid arthritis. Tissue Antigens 33(1): 30-37

Van der Gaag, R.; Wiersinga, W.M.; Koornneef, L.; Mourits, M.P.; Prummel, M.F.; Berghout, A.; de Vries, R.R.; Schreuder, G.M.; D'Amaro, J. 1990: HLA-DR4 associated response to corticosteroids in Graves' ophthalmopathy patients. Journal of Endocrinological Investigation 13(6): 489-492

Khan, M.A.; Yamashita, T.S.; Reynolds, T.L.; Wolfe, F.; Khan, M.K. 1988: HLA-DR4 genotype frequency and gender effect in familial rheumatoid arthritis. Tissue Antigens 31(5): 254-258

Friman, C.; Schlaut, J.; Davis, P. 1985: HLA-DR4 in Felty's syndrome. Journal of Rheumatology 12(3): 628-629

Frentz, G.; Thomsen, K.; Jakobsen, B.K.; Svejgaard, A. 1986: HLA-DR4 in alopecia areata. Journal of the American Academy of Dermatology 14(1): 129-130

Miehle, W.; Schattenkirchner, M.; Albert, D.; Bunge, M. 1985: HLA-DR4 in ankylosing spondylitis with different patterns of joint involvement. Annals of the Rheumatic Diseases 44(1): 39-44

Richardson, J.E.; Gladman, D.D.; Fam, A.; Keystone, E.C. 1987: HLA-DR4 in giant cell arteritis: association with polymyalgia rheumatica syndrome. Arthritis and Rheumatism 30(11): 1293-1297

MacDonald, M.J.; Gottschall, J.; Hunter, J.B.; Winter, K.L. 1986: HLA-DR4 in insulin-dependent diabetic parents and their diabetic offspring: a clue to dominant inheritance. Proceedings of the National Academy of Sciences of the United States of America 83(18): 7049-7053

Palacios-Boix, A.A.; Estrada-G, I.; Colston, M.J.; Panayi, G.S. 1988: HLA-DR4 restricted lymphocyte proliferation to a Mycobacterium tuberculosis extract in rheumatoid arthritis and healthy subjects. Journal of Immunology 140(6): 1844-1850

Wordsworth, B.P.; Lanchbury, J.S.; Sakkas, L.I.; Welsh, K.I.; Panayi, G.S.; Bell, J.I. 1989: HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class Ii region. Proceedings of the National Academy of Sciences of the United States of America 86(24): 10049-10053

Taneja, V.; Mehra, N.K.; Chandershekaran, A.N.; Ahuja, R.K.; Singh, Y.N.; Malaviya, A.N. 1992: HLA-DR4-DQw8, but not DR4-DQw7 haplotypes occur in Indian patients with rheumatoid arthritis. Rheumatology International 11(6): 251-255

Holbeck, S.L.; Kim, S.J.; Silver, J.; Hansen, J.A.; Nepom, G.T. 1985: HLA-DR4-associated haplotypes are genotypically diverse within HLA. Journal of Immunology 135(1): 637-641

Reid, M.J.; Nish, W.A.; Whisman, B.A.; Goetz, D.W.; Hylander, R.D.; Parker, W.A.; Freeman, T.M. 1992: HLA-DR4-associated nonresponsiveness to mountain-cedar allergen. Journal of Allergy and Clinical Immunology 89(2): 593-598

Devereux, D.; O'Hehir, R.E.; McGuire, J.; van Schooten, W.C.; Lamb, J.R. 1991: HLA-DR4Dw4-restricted T cell recognition of self antigen(s) in the rheumatoid synovial compartment. International Immunology 3(7): 635-640

Jones, E.H.; Biggar, R.J.; Nkrumah, F.K.; Lawler, S.D. 1985: HLA-DR7 association with African Burkitt's lymphoma. Human Immunology 13(3): 211-217

Matsuo, T.; Matsuo, N. 1991: HLA-DR9 associated with the severity of acute retinal necrosis syndrome. Ophthalmologica. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 203(3): 133-137

Nagy, M.; Mayr, W.R.; Menzel, G.R. 1991: HLA-DR: serology versus restriction fragment length polymorphism. Vox Sanguinis 61(1): 59-61

Doherty, D.G.; Donaldson, P.T. 1991: HLA-DRB and DQB typing by a combination of serology, restriction fragment length polymorphism analysis and oligonucleotide probing. European Journal of Immunogenetics: Official Journal of the British Society for Histocompatibility and Immunogenetics 18(1-2): 111-124

Ansari, A.A. 1991: HLA-DRB nucleotide sequences arranged in polymorphic groups. Indian Journal of Medical Research 94: 255-265

Marsh, S.G.; Bodmer, J.G. 1990: HLA-DRB nucleotide sequences, 1990. Immunogenetics 31(3): 141-144

Wilton, A.N.; Barendse, W.J.; Donald, J.A.; Marshall, P.; Trudinger, B.; Gallery, E.D.; Brennecke, S.P.; Cooper, D.W. 1991: HLA-DRB types in pre-eclampsia and eclampsia. Tissue Antigens 38(3): 137-141

Ota, M.; Seki, T.; Fukushima, H.; Tsuji, K.; Inoko, H. 1992: HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 39(4): 187-202

Olerup, O.; Zetterquist, H. 1991: HLA-DRB1*01 subtyping by allele-specific PCR amplification: a sensitive, specific and rapid technique. Tissue Antigens 37(5): 197-204

Spurkland, A.; Tabira, T.; Rønningen, K.S.; Vandvik, B.; Thorsby, E.; Vartdal, F. 1991: HLA-DRB1, -DQA1, -DQB1, -DPA1 and -DPB1 genes in Japanese multiple sclerosis patients. Tissue Antigens 37(4): 171-173

Smrzka, O.W.; Faé, I.; Pickl, W.F.; Fischer, G.F. 1991: HLA-DRB3 typing by restriction digestion of locus-specific amplified DNA. Tissue Antigens 37(5): 205-210

Sanchez, B.; Moreno, I.; Magariño, R.; Garzon, M.; Gonzalez, M.F.; Garcia, A.; Nuñez-Roldan, A. 1990: HLA-DRw10 confers the highest susceptibility to rheumatoid arthritis in a Spanish population. Tissue Antigens 36(4): 174-176

Freidel, A.C.; Gebuhrer, L.; Betuel, H.; Farre, A.; Labonne, M.P.; Lambert, J. 1991: HLA-DRw11, DQw7 has four cellular subtypes revealed by homozygous typing cells and undetected by restriction fragment length polymorphism. Human Immunology 30(3): 183-189

Jazwinska, E.C.; Olive, C.; Dunckley, H.; Naito, S.; Kuseba, T.; Serjeantson, S.W. 1990: HLA-DRw15 is increased in frequency in Japanese scleroderma patients. Disease Markers 8(6): 323-326

Shaffer, A.L.; Falk-Wade, J.A.; Tortorelli, V.; Cigan, A.; Carter, C.; Hassan, K.; Hurley, C.K. 1992: HLA-DRw52-associated DRB1 alleles: identification using polymerase chain reaction-amplified DNA, sequence-specific oligonucleotide probes, and a chemiluminescent detection system. Tissue Antigens 39(2): 84-90

Valentin, N.; Vergracht, A.; Bignon, J.D.; Cheneau, M.L.; Blanchard, D.; Kaplan, C.; Reznikoff-Etievant, M.F.; Muller, J.Y. 1990: HLA-DRw52a is involved in alloimmunization against PL-A1 antigen. Human Immunology 27(2): 73-79

Limas, C.J.; Limas, C. 1988: HLA-DRw6 antigen linkage in chronic congestive heart failure secondary to coronary artery disease (ischemic cardiomyopathy). American Journal of Cardiology 62(10 Part 1): 816-818

Roenhorst, H.W.; Tegzess, A.M.; Beelen, J.M.; Middeldorp, J.M.; The, T.H. 1985: HLA-DRw6 as a risk factor for active cytomegalovirus but not for herpes simplex virus infection after renal allograft transplantation. British Medical Journal 291(6496): 619-622

Mueller-Eckhardt, C.; Kiefel, V.; Kroll, H.; Mueller-Eckhardt, G. 1989: HLA-DRw6, a new immune response marker for immunization against the platelet alloantigen Bra. Vox Sanguinis 57(1): 90-91

Stewart, G.J.; Basten, A.; Guinan, J.; Bashir, H.V.; Cameron, J.; McLeod, J.G. 1977: HLA-DW2, viral immunity and family studies in multiple sclerosis. Journal of the Neurological Sciences 32(2): 153-167

Rossi, M.L.; Jones, N.R.; Karr, G.F.; Esiri, M.M.; Havas, L.; Coakham, H.B. 1991: HLA-Dr expression by tumor cells compared with survival in high grade astrocytomas. Tumori 77(2): 122-125

Caligaris-Cappio, F.; Bergui, L.; Tesio, L.; Ziano, R.; Camussi, G. 1985: HLA-Dr+ T cells of the Leu 3 (helper) type infiltrate the kidneys of patients with systemic lupus erythematosus. Clinical and Experimental Immunology 59(1): 185-189

Lukacs, K.; Cohen, D.A.; Kaplan, A.M. 1986: HLA-Dr-unrestricted accessory cell function in human neutrophils. Clinical Immunology and Immunopathology 38(3): 344-349

Oudshoorn, M.; du Toit, E.D.; Taljaard, D.G. 1989: HLA-Dw 'RSH': a new HLA-Dw specificity associated with HLA-DRw18(3). Tissue Antigens 33(3): 367-374

Cohen, N.; Mickelson, E.; Amar, A.; Battat, S.; Hansen, J.A.; Brautbar, C. 1987: HLA-Dw clusters associated with DR4 in Israeli Jews and the definition of a new DR4 associated Dw subtype: Dw"SHA". Human Immunology 19(3): 179-188

Jaraquemada, D.; Navarrete, C.; Ollier, W.; Awad, J.; Okoye, R.; Festenstein, H. 1986: HLA-Dw specificity assignments are independent of HLA-DQ, HLA-DR, and other class Ii specificities and define a biologically important segregant series which strongly activates a functionally distinct T cell subset. Human Immunology 16(3): 259-270

Lang, B.; LoGalbo, P.R.; Sanchez, B.; Winchester, R. 1988: HLA-Dw14 and HLA-DR3 haplotypes share a functional determinant recognized by a human alloreactive T-cell clone. Human Immunology 23(1): 59-70

Paty, D.W.; Cousin, H.K.; Stiller, C.R.; Boucher, D.W.; Warren, K.G.; Dossetor, J.B. 1977: HLA-Dw2-related hyporesponsiveness to herpes simplex antigen in multiple sclerosis. Transactions of the American Neurological Association 102: 49-51

Stastny, P.; Fink, C.W. 1977: HLA-Dw4 in adult and juvenile rheumatoid arthritis. Transplantation Proceedings 9(4): 1863-1866

Koller, B.H.; Geraghty, D.E.; Shimizu, Y.; DeMars, R.; Orr, H.T. 1988: HLA-E. a novel HLA class i gene expressed in resting T lymphocytes. Journal of Immunology 141(3): 897-904

Hansen, H.E.; Eriksen, B. 1979: HLA-GLO linkage analysis in 57 informative families. Human Heredity 29(6): 355-360

Messer, G.; Zemmour, J.; Orr, H.T.; Parham, P.; Weiss, E.H.; Girdlestone, J. 1992: HLA-J, a second inactivated class i HLA gene related to HLA-G and HLA-A. Implications for the evolution of the HLA-A-related genes. Journal of Immunology 148(12): 4043-4053

Duceman, B.W.; Ness, D.; Rende, R.; Chorney, M.J.; Srivastava, R.; Greenspan, D.S.; Pan, J.; Weissman, S.M.; Grumet, F.C. 1986: HLA-JY328: mapping studies and expression of a polymorphic HLA class i gene. Immunogenetics 23(2): 90-99

Smeraldi, E.; Bellodi, L.; Scorza-Smeraldi, R.; Fabio, G.; Sacchetti, E. 1976: HLA-SD antigens and schizophrenia: statistical and genetical considerations. Tissue Antigens 8(3): 191-196

Giordano, M.; Magrí, D.; Valentini, G.; Tirri, G.; De Biasi, R. 1979: HLA-SD antigens in progressive systemic sclerosis. Archives of Dermatological Research 266(2): 213

Dostal, V.; Mayr, W.R. 1977: HLA-SD-antigens in cervix cancer and recurrent herpes genitalis patients. Osterreichische Zeitschrift für Onkologie. Austrian Journal of Oncology 3(5-6): 119-121

Papasteriades, C.A.; Skopouli, F.N.; Drosos, A.A.; Andonopoulos, A.P.; Moutsopoulos, H.M. 1988: HLA-alloantigen associations in Greek patients with Sjögren's syndrome. Journal of Autoimmunity 1(1): 85-90

Bellati, U.; Liverani, A.; Noia, G.; Purpura, M. 1989: HLA-alloimmunization in pregnancy. Fetal Therapy 4(Suppl 1): 77-81

Håkansson, U.; Eitrem, R.; Löw, B.; Winblad, S. 1976: HLA-antigen b27 in cases with joint affections in an outbreak of salmonellosis. Scandinavian Journal of Infectious Diseases 8(4): 245-248

Kühnl, P.; Sibrowski, W.; Kalmar, G.; Holzmann, H.; Sollberg, S.; Böhm, B.O. 1990: HLA-antigen frequencies in patients with progressive systemic sclerosis and morphea. Beitrage Zur Infusionstherapie 26: 287-289

Jabbar, A.A.; Dick, H.M. 1977: HLA-antigen frequency in an Iraqi population. Tissue Antigens 10(4): 303-305

Schernthaner, G.; Mayr, W.R.; Ludwig, H. 1976: HLA-antigens and autoimmunity in idiopathic Addison's disease. Diabete and Metabolisme 2(3): 164

Roupe, G.; Rydberg, L.; Swanbeck, G. 1979: HLA-antigens and contact hypersensitivity. Journal of Investigative Dermatology 72(3): 131-132

Kuntz, B.M.; Schmidt, G.D.; Scholz, S.; Albert, E.D. 1978: HLA-antigens and hypernephroma. Tissue Antigens 12(5): 407-408

Scheinin, T.; Matikainen, E.; Groop, L.; Lepäntalo, M.; Koskimies, S.; Kontiainen, S. 1988: HLA-antigens and immunity to insulin in insulin-dependent diabetics with or without diabetic neuropathy. Scandinavian Journal of Clinical and Laboratory Investigation 48(4): 327-332

Spinas, G.A.; Keller, U.; Neri, T.M.; Matter, L.; Staffelbach, O.; Berger, W. 1985: HLA-antigens and islet cell antibodies in type-1 diabetics of various age groups and their first-degree relatives. Schweizerische Medizinische Wochenschrift 115(2): 48-54

Skoven, I.G.; Hjortshøj, A. 1978: HLA-antigens and psoriasiform napkin dermatitis. Dermatologica 157(4): 225-228

Kentala, E.; Repo, U.K.; Lehtipuu, A.L.; Vuornos, T. 1978: HLA-antigens and pulmonary upper lobe fibrocystic changes with and without ankylosing spondylitis. A report of seven cases. Scandinavian Journal of Respiratory Diseases 59(1): 8-12

Karmazsin, L.; Ambró, I.; Stenszky, V.; Kozma, L.; Balázs, C.; Svetlana, K. 1979: HLA-antigens and some autoimmune features of juvenile diabetes mellitus. Acta Paediatrica Academiae Scientiarum Hungaricae 20(1): 11-19

Hafez, M.; el-Salab, S.; el-Shennawy, F.; Bassiony, M.R. 1985: HLA-antigens and tuberculosis in the Egyptian population. Tubercle 66(1): 35-40

Bognetti, E.; Meschi, F.; Malavasi, C.; Pastore, M.R.; Sergi, A.; Illeni, M.T.; Maffeis, C.; Pinelli, L.; Chiumello, G. 1992: HLA-antigens in Italian type 1 diabetic patients: role of DR3/DR4 antigens and breast feeding in the onset of the disease. Acta Diabetologica 28(3-4): 229-232

Hamza, M.; Ayed, K.; Bardi, R.; Gebuhrer, L.; Betuel, H.; Bardin, T.; Plaetke, R.; Lathrop, M. 1990: HLA-antigens in a Tunisian familial chondrocalcinosis. Disease Markers 8(3): 109-112

Dieckhues, B.; Jünemann, G.; Küchle, H.J.; Püttmann, T. 1979: HLA-antigens in eye diseases. Klinische Monatsblatter für Augenheilkunde 175(5): 681-685

Henke, J.; Ungar, W. 1978: HLA-antigens in idiopathic haemochromatosis (i.h.). preliminary report. Zeitschrift für Immunitatsforschung. Immunobiology 154(1): 41-43

Jervell, J.; Solheim, B. 1979: HLA-antigens in long standing insulin dependent diabetics with terminal nephropathy and retinopathy with and without loss of vision. Diabetologia 17(6): 391

Uslontsev, B.M.; Petrova, M.A. 1988: HLA-antigens in patients with bronchial asthma. Vestnik Akademii Meditsinskikh Nauk SSSR 7: 31-34

Wegener, S.; Bruhn, P.; Keysser, M. 1991: HLA-antigens in patients with rheumatoid arthritis. Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 46(1-2): 23-26

Forsberg, B.; Johnson, U. 1989: HLA-antigens in renal transplanted patients with varicella-zoster infection. Tissue Antigens 33(3): 415-417

Kampf, D.; Malchus, R.; Alexander, M.; Hoppe, I. 1979: HLA-antigens in systemic lupus erythematosus (SLE). Archives of Dermatological Research 264(3): 345-350

Hafez, M.; el-Shennawy, F.A. 1986: HLA-antigens in the Egyptian population. Forensic Science International 31(4): 241-246

Bakker, M.; Grumet, F.C.; Feltkamp, T.E.; Kijlstra, A. 1986: HLA-antigens in the human uvea. Documenta Ophthalmologica. Advances in Ophthalmology 61(3-4): 271-279

Hosojima, H.; Miyauchi, E.; Okada, H.; Azukizawa, S.; Morimoto, S. 1991: HLA-antigens in thyrotoxic patients with overt diabetes mellitus. Nihon Naibunpi Gakkai Zasshi 67(8): 811-818

Ziegler, A.G.; Standl, E.; Albert, E.; Mehnert, H. 1991: HLA-associated insulin autoantibody formation in newly diagnosed type i diabetic patients. Diabetes 40(9): 1146-1149

Narni, F.; Selvanayagam, P.; Barlogie, B.; Saunders, G.F. 1987: HLA-associated invariant chain gene expression in human B cell neoplasia. Leukemia 1(6): 504-507

Varla-Leftherioti, M.; Papanicolaou, M.; Spyropoulou, M.; Vallindra, H.; Tsiroyianni, P.; Tassopoulos, N.; Kapasouri, H.; Stavropoulos-Giokas, C. 1990: HLA-associated non-responsiveness to hepatitis B vaccine. Tissue Antigens 35(2): 60-63

Polianskaia, I.S.; Alekseev, L.P.; Chumburidze, V.B.; Iurenev, A.P.; Guniia, M.G.; Dubov, P.B.; Dolbin, A.G. 1990: HLA-associated predisposition to dilated cardiomyopathy. Klinicheskaia Meditsina 68(6): 30-33

Alekseev, L.P.; Khaitova, N.M.; Iazdovskiĭ, V.V. 1988: HLA-associated predisposition to disease and mechanisms of its realization. Vestnik Akademii Meditsinskikh Nauk SSSR 5: 30-38

Scorza Smeraldi, R.; Fabio, G.; Lazzarin, A.; Eisera, N.; Uberti Foppa, C.; Moroni, M.; Zanussi, C. 1988: HLA-associated susceptibility to AIDS: HLA B35 is a major risk factor for Italian HIV-infected intravenous drug addicts. Human Immunology 22(2): 73-79

Fabio, G.; Scorza, R.; Lazzarin, A.; Marchini, M.; Zarantonello, M.; D'Arminio, A.; Marchisio, P.; Plebani, A.; Luzzati, R.; Costigliola, P. 1992: HLA-associated susceptibility to HIV-1 infection. Clinical and Experimental Immunology 87(1): 20-23

Kaplan, C.; Muller, J.Y.; Doinel, C.; Lefrère, J.J.; Paquez, F.; Rouger, P.; Salmon, D.; Salmon, C. 1990: HLA-associated susceptibility to acquired immune deficiency syndrome in HIV-1-seropositive subjects. Human Heredity 40(5): 290-298

Scorza Smeraldi, R.; Fabio, G.; Lazzarin, A.; Eisera, N.B.; Moroni, M.; Zanussi, C. 1986: HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection. Lancet 2(8517): 1187-1189

Polianskaia, I.S.; Alekseev, L.P.; Mushkudiani, E.L.; Iurenev, A.P.; Dubov, P.D.; Khubutiia, A.S.; Zhukova, I.M. 1990: HLA-associated susceptibility to ischemic heart disease. Klinicheskaia Meditsina 68(7): 51-53

Abt, K.; Gülich, A.; Krupp, P.; Reinberg, W. 1992: HLA-associations in Leponex/Clozaril (clozapine)-induced granulocytopenia and agranulocytosis. Statistical viewpoints. Drug Safety 7 Suppl. 1: 10-16

Offermann, G. 1988: HLA-based local donor/recipient matching in renal transplantation: a microcomputer program. International Journal of Bio-Medical Computing 22(3-4): 251-257

Choppin, J.; Martinon, F.; Connan, F.; Gomard, E.; Levy, J.P. 1991: HLA-binding regions of HIV-1 proteins. I. Detection of seven HLA binding regions in the HIV-1 Nef protein. Journal of Immunology 147(2): 569-574

Choppin, J.; Martinon, F.; Connan, F.; Pauchard, M.; Gomard, E.; Levy, J.P. 1991: HLA-binding regions of HIV-1 proteins. II. a systematic study of viral proteins. Journal of Immunology 147(2): 575-583

Yousem, S.A.; Curley, J.M.; Dauber, J.; Paradis, I.; Rabinowich, H.; Zeevi, A.; Duquesnoy, R.; Dowling, R.; Zenati, M.; Hardesty, R. 1990: HLA-class Ii antigen expression in human heart-lung allografts. Transplantation 49(5): 991-995

Fuggle, S.V.; McWhinnie, D.L.; Morris, P.J. 1989: HLA-class Ii antigen induction does not exclude a diagnosis of cyclosporine nephrotoxicity. Transplantation Proceedings 21(1 Part 2): 1525-1526

Brühl, P.; Mergenthaler, H.G.; Ellwart, J.; Dörmer, P. 1990: HLA-class Ii antigens on hemopoietic and stromal cells in human micro long-term bone marrow cultures. Experimental Hematology 18(2): 103-108

Busch, F.W.; Langer, M.; Pawelec, G.; Ziegler, A.; Wernet, P.; Bühring, H.J.; Meyer, P.; Müller, C. 1987: HLA-class Ii antigens on human hematopoietic progenitors. Blut 54(3): 179-188

Al-Tawil, N.G.; Marcusson, J.A.; Möller, E. 1985: HLA-class Ii restriction of the proliferative T lymphocyte responses to nickel, cobalt and chromium compounds. Tissue Antigens 25(3): 163-172

Beniers, A.J.; Peelen, W.P.; Debruyne, F.M.; Schalken, J.A. 1991: HLA-class-i and -class-Ii expression on renal tumor xenografts and the relation to sensitivity for alpha-IFN, gamma-IFN and TNF. International Journal of Cancer 48(5): 709-716

Vannas, S.; Karjalainen, K.; Ruusuvaara, P.; Tiilikainen, A. 1976: HLA-compatible donor cornea for prevention of allograft reaction. Albrecht Von Graefes Archiv für Klinische und Experimentelle Ophthalmologie. Albrecht Von Graefe's Archive for Clinical and Experimental Ophthalmology 198(3): 217-222

Amoroso, A.; Curtoni, E.; Triolo, G.; Segoloni, G. 1987: HLA-compatible transfusions and renal grafts. Nephrologie 8(4): 225-226

Field, L.L.; Dizier, M.H.; Anderson, C.E.; Spence, M.A.; Rotter, J.I. 1986: HLA-dependent GM effects in insulin-dependent diabetes: evidence from pairs of affected siblings. American Journal of Human Genetics 39(5): 640-647

Fischer, A.; Durandy, A.; de Villartay, J.P.; Vilmer, E.; Le Deist, F.; Gérota, I.; Griscelli, C. 1986: HLA-haploidentical bone marrow transplantation for severe combined immunodeficiency using e rosette fractionation and cyclosporine. Blood 67(2): 444-449

Bluetters-Sawatzki, R.; Friedrich, W.; Ebell, W.; Vetter, U.; Stoess, H.; Goldmann, S.F.; Kleihauer, E. 1989: HLA-haploidentical bone marrow transplantation in three infants with adenosine deaminase deficiency: stable immunological reconstitution and reversal of skeletal abnormalities. European Journal of Pediatrics 149(2): 104-109

Rose, M.; Nagai, T. 1988: HLA-haplotype-independent inheritance of monocyte-specific antigen. Kitasato Archives of Experimental Medicine 61(2-3): 165-169

Anonymous 1990: HLA-homozygous donors and transfusion-associated graft-versus-host disease. New England Journal of Medicine 322(14): 1004-1007

Martin, P.J.; Clift, R.A.; Fisher, L.D.; Buckner, C.D.; Hansen, J.A.; Appelbaum, F.R.; Doney, K.C.; Sullivan, K.M.; Witherspoon, R.P.; Storb, R. 1988: HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration. Blood 72(6): 1978-1984

Storb, R.; Appelbaum, F.; Buckner, C.D.; Clift, R.; Anasetti, C.; Beatty, P.; Bianco, J.; Doney, K.; Hansen, J.; Martin, P. 1990: HLA-identical marrow transplantation in the leukemias without T-cell depletion. The Seattle Marrow Transplant Team. Bone Marrow Transplantation 6(Suppl 1): 80-84

Sumrani, N.; Delaney, V.; Ding, Z.K.; Butt, K.; Hong, J. 1990: HLA-identical renal transplants: impact of cyclosporine on intermediate-term survival and renal function. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 16(5): 417-422

Marks, D.I.; Hughes, T.P.; Szydlo, R.; Kelly, S.; Cullis, J.O.; Schwarer, A.P.; Mackinnon, S.; Apperley, J.; Barrett, A.J.; Hows, J.M. 1992: HLA-identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome. British Journal of Haematology 81(3): 383-390

Gluckman, J.C.; Sasportes, M. 1978: HLA-independent cell-mediated alloimmunity detected by a microcytotoxicity assay. Transplantation 26(1): 70-72

Berrens, L.; de la Faille, H.B.; Borst-Eilers, E. 1979: HLA-linked C2 deficiency in a Dutch patient with systemic lupus erythematosus. Journal of Clinical Pathology 32(6): 528-533

Xu, K.Y.; de Vries, R.R.; Fei, H.M.; van Leeuwen, A.; Chen, R.B.; Ye, G.Y. 1985: HLA-linked control of predisposition to lepromatous leprosy. International Journal of Leprosy and other Mycobacterial Diseases: Official Organ of the International Leprosy Association 53(1): 56-63

Lendrum, R.; Walker, G.; Cudworth, A.G.; Woodrow, J.C.; Gamble, D.R. 1976: HLA-linked genes and islet-cell antibodies in diabetes mellitus. British Medical Journal 1(6025): 1565-1567

Fine, P.E.; Wolf, E.; Pritchard, J.; Watson, B.; Bradley, D.J.; Festenstein, H.; Chacko, C.J. 1979: HLA-linked genes and leprosy: a family study in Karigiri, South India. Journal of Infectious Diseases 140(2): 152-161

Shaw, S.; Biddison, W.E. 1979: HLA-linked genetic control of the specicity of human cytotoxic T-cell responses to influenza virus. Journal of Experimental Medicine 149(3): 565-575

Edwards, C.Q.; Griffen, L.M.; Goldgar, D.E.; Skolnick, M.H.; Kushner, J.P. 1989: HLA-linked hemochromatosis alleles in sporadic porphyria cutanea tarda. Gastroenterology 97(4): 972-981

Harvey, R.F. 1986: Gallbladder emptying in celiac disease. Gastroenterology 90(3): 801-802

Suez, D.; Katz, D.; Brautbar, C.; Cohen, T.; Weisman, Z.; Bentwich, Z.; Mozes, E. 1985: HLA-linked immune responsiveness to (T,G)-A-L: a family study. Human Immunology 13(4): 219-234

Sasazuki, T. 1990: HLA-linked immune suppression genes. Jinrui Idengaku Zasshi. Japanese Journal of Human Genetics 35(1): 1-13

Sasazuki, T.; Kikuchi, I.; Hirayama, K.; Matsushita, S.; Ohta, N.; Nishimura, Y. 1989: HLA-linked immune suppression in humans. IMMUNOLOGY. Suppl 2: 21-24; Discussion 25

Matsushita, S.; Muto, M.; Suemura, M.; Saito, Y.; Sasazuki, T. 1987: HLA-linked nonresponsiveness to Cryptomeria japonica pollen antigen. I. Nonresponsiveness is mediated by antigen-specific suppressor T cell. Journal of Immunology 138(1): 109-115

Spadaro, M.; Giunti, P.; Lulli, P.; Frontali, M.; Jodice, C.; Cappellacci, S.; Morellini, M.; Persichetti, F.; Trabace, S.; Anastasi, R. 1992: HLA-linked spinocerebellar ataxia: a clinical and genetic study of large Italian kindreds. Acta Neurologica Scandinavica 85(4): 257-265

Mehra, N.K.; Kaul, R.; Taneja, V.; Chaudhuri, T.K.; Jhinghan, B.; Malaviya, A.N. 1988: HLA-linked susceptibility to rheumatoid arthritis in north India. Tissue Antigens 31(4): 220-223

Charpentier, F.; Bracq, C.; Bonin, P.; Berling, P.; Duedari, N. 1990: HLA-matched blood products and posttransfusion graft-versus-host disease. Transfusion 30(9): 850

Tosato, G.; Applebaum, F.R.; Deisseroth, A.B. 1978: HLA-matched platelet transfusion therapy of severe aplastic anemia. Blood 52(4): 846-854

Lundgren, G.; Groth, C.G.; Albrechtsen, D.; Brynger, H.; Flatmark, A.; Frödin, L.; Gäbel, H.; Husberg, B.; Klintmalm, G.; Maurer, W. 1986: HLA-matching and pretransplant blood transfusions in cadaveric renal transplantation--a changing picture with cyclosporin. Lancet 2(8498): 66-69

Lundgren, G.; Groth, C.G.; Albrechtsen, D.; Brynger, H.; Flatmark, A.; Frodin, L.; Gabel, H.; Husberg, B.; Klintmalm, G.; Maurer, W. 1986: HLA-matching in cyclosporine treated renal transplant recipients: a prospective Swedish-Norwegian multicenter study. Clinical Transplants 1986: 79-85

Tzeng, C.H.; Chen, P.M.; Chiu, C.F.; Chiou, T.J.; Hsien, R.K.; Chuang, M.W.; Chen, K.Y.; Yung, C.H.; Wang, S.Y.; Wang, S.R. 1987: HLA-mismatched allogeneic bone marrow transplantation. Zhonghua Yi Xue Za Zhi 39(3): 187-196

Beatty, P.G. 1992: HLA-mismatched bone marrow transplantation. Transplantation 54(5): 948

Galimberti, M.; Lucarelli, G.; Polchi, P.; Angelucci, E.; Baronciani, D.; Politi, P.; Donati, M.; Filocamo, M.; Giorgi, C.; Agostinelli, F. 1991: HLA-mismatched bone marrow transplantation in thalassemia. Bone Marrow Transplantation 7(Suppl 3): 98-100

Vilmer, E.; Sterkers, G.; Rahimy, C.; Elion, J.; Broyart, A.; Lescoeur, B.; Gerota, J.; Loche, M.; Tiercy, J.M.; Blot, P. 1991: HLA-mismatched cord blood transplantation in a patient with advanced leukemia. Bone Marrow Transplantation 7(Suppl 2): 125

Vilmer, E.; Sterkers, G.; Rahimy, C.; Denamur, E.; Elion, J.; Broyart, A.; Lescoeur, B.; Tiercy, J.M.; Gerota, J.; Blot, P. 1992: HLA-mismatched cord-blood transplantation in a patient with advanced leukemia. Transplantation 53(5): 1155-1157

Dyrszka, H.; Eberhardt, G.; Eckert, G. 1978: HLA-phenotype and hemochromatosis in Germany. Gastroenterology 75(3): 555-556

Dovgaliuk, I.F.; Moiseeva, L.M. 1985: HLA-phenotype in children with local forms of primary tuberculosis. Problemy Tuberkuleza 11: 28-31

Sharrock, C.E.; Sidhu, S.; Rust, N.; Davey, N.; Batchelor, J.R.; McMichael, A. 1987: HLA-reactive T cell clones: analysis of specificity. Transplantation Proceedings 19(1 Part 1): 874

Santoli, D.; Trinchieri, G.; Zmijewski, C.M.; Koprowski, H. 1976: HLA-related control of spontaneous and antibody-dependent cell-mediated cytotoxic activity in humans. Journal of Immunology 117(3): 765-770

Torpey, D.J.; Lindsley, M.D.; Rinaldo, C.R. 1989: HLA-restricted lysis of herpes simplex virus-infected monocytes and macrophages mediated by CD4+ and CD8+ T lymphocytes. Journal of Immunology 142(4): 1325-1332

Hahn, E. 1978: HLA-system and internal diseases. Der Internist 19(8): 491-500

Ludvigsson, J.; Säfwenberg, J.; Heding, L.G. 1977: HLA-types, C-peptide and insulin antibodies in juvenile diabetes. Diabetologia 13(1): 13-17

Ludvigsson, J.; Heding, L.; Säfwenberg, J. 1976: HLA-types, C-peptide and insulin antibodies in juvenile diabetics. Diabete and Metabolisme 2(3): 158

Mellergård, P.; Ljunggren, B.; Brandt, L.; Johnson, U.; Holtås, S. 1989: HLA-typing in a family with six intracranial aneurysms. British Journal of Neurosurgery 3(4): 479-485

Bengsch, N.; Köbberling, J.; Eckert, G.; Willms, B. 1978: HLA-typing in juvenile diabetics with and without positive family history and in families with one and two diabetic siblings. Diabetologia 15(6): 447-451

Canniff, J.P.; Batchelor, J.R.; Dodi, I.A.; Harvey, W. 1985: HLA-typing in oral submucous fibrosis. Tissue Antigens 26(2): 138-142

Royo, C.; Touraine, J.L.; Betuel, H. 1985: HLA-typing of fetal cells using interferon treatment in vitro. Progress in Clinical and Biological Research 193: 149-155

Larsen, B.; Pepper, B.; Barnard, J.M.; Farid, N.R. 1978: HLA/Bf haplotypes in a Newfoundland family. Tissue Antigens 12(1): 39-43

Blase, D.; Bercy, P.; de Bruyere, M. 1989: HLA: a review of actual knowledge and perspectives in periodontology. Journal de Parodontologie 8(1): 7-29

Barrett, A.W.; Williams, D.M.; Scott, J. 1992: HLADR+ Langerhans cell (LC) numbers in human lingual epithelium. Journal of Oral Pathology and Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 21(3): 143

Rossomando, E.F.; Hadjimichael, J.; Varnum-Finney, B.; Soll, D.R. 1987: HLAMP--a conjugate of hippuryllysine and AMP which contains a phosphoamide bond--stimulates chemotaxis in Dictyostelium discoideum. Differentiation; Research in Biological Diversity 35(2): 88-93

Felt, V. 1986: HLD-cholesterol and LDL-cholesterol in the blood in type i and Ii diabetes mellitus and the relation to atherogenesis. Vnitrni Lekarstvi 32(11): 1066-1072

Rytírová, H.; Skrivánek, O.; Bystron, L.; Pacáková, J. 1986: HLD-cholesterol and the risk of cerebrovascular accident. Ceskoslovenska Neurologie a Neurochirurgie 49(3): 167-173

Falkner, M.E. 1986: HLV transmission. New Zealand Medical Journal 99(812): 820

Tait, D.; McCready, V.R.; Ott, R.J. 1987: HM-PAO assessment of human tumour perfusion. European Journal of Cancer and Clinical Oncology 23(6): 789-793

Biersack, H.J.; Stefan, H.; Reichmann, K.; Linke, D.; Kurthen, M.; Kropp, J.; Penin, H. 1987: HM-PAO brain SPECT and epilepsy. Nuclear Medicine Communications 8(7): 513-518

Berlit, P.; Wetzel, E. 1992: HM-PAO cerebral blood flow scintigraphy in the manifestation stage of brain death. Der Nervenarzt 63(2): 101-104

Podreka, I. 1987: HM-PAO in clinical practice. Nuclear Medicine Communications 8(7): 559-572

Gonçalves, J.M.; Vaz, R.; Cerejo, A.; Cruz, C.; Pereira, J.; Mourão, A.; Amaral, I. 1992: HM-PAO spect in head trauma. Acta Neurochirurgica. Supplementum 55: 11-13

Oder, W.; Goldenberg, G.; Podreka, I.; Deecke, L. 1991: HM-PAO-SPECT in persistent vegetative state after head injury: prognostic indicator of the likelihood of recovery?. Intensive Care Medicine 17(3): 149-153

Cleator, G.M.; Lewis, A.G.; Klapper, P.E.; Sharma, H.L.; Smith, A.M. 1989: HM-PAO-imaging and herpes encephalitis. Archives of Virology 109(3-4): 263-268

Costa, D.C.; Ell, P.J.; Nowotnik, D.P. 1985: HM-PAO: a new technetium-99m labelled agent for brain SPECT. Journal of Nuclear Medicine and Allied Sciences 29(4): 337-338

Lumeng, J.; Kendro, B.; Higa, R. 1987: HMA testimony to Senate Judiciary Committee on Medical Malpractice Insurance, July 1987. Hawaii Medical Journal 46(10): 385-6 389

Glasgow, B.J.; McCall, L.C.; Foos, R.Y. 1990: HMB-45 antibody reactivity in pigmented lesions of the conjunctiva. American Journal of Ophthalmology 109(6): 696-700

Hancock, C.; Allen, B.C.; Herrera, G.A. 1991: HMB-45 detection in adenocarcinomas. Archives of Pathology and Laboratory Medicine 115(9): 886-890

McDonnell, J.M.; Sun, Y.Y.; Wagner, D. 1991: HMB-45 immunohistochemical staining of conjunctival melanocytic lesions. Ophthalmology 98(4): 453-458

Smoller, B.R.; Hsu, A.; Krueger, J. 1991: HMB-45 monoclonal antibody recognizes an inducible and reversible melanocyte cytoplasmic protein. Journal of Cutaneous Pathology 18(5): 315-322

Unger, P.D.; Hoffman, K.; Thung, S.N.; Pertsemlides, D.; Wolfe, D.; Kaneko, M. 1992: HMB-45 reactivity in adrenal pheochromocytomas. Archives of Pathology and Laboratory Medicine 116(2): 151-153

Smoller, B.R.; McNutt, N.S.; Hsu, A. 1989: HMB-45 recognizes stimulated melanocytes. Journal of Cutaneous Pathology 16(2): 49-53

Skelton, H.G.; Smith, K.J.; Barrett, T.L.; Lupton, G.P.; Graham, J.H. 1991: HMB-45 staining in benign and malignant melanocytic lesions. a reflection of cellular activation. American Journal of Dermatopathology 13(6): 543-550

Chetty, R.; Clark, S.P. 1992: HMB-45 staining in pigmented pheochromocytoma. Archives of Pathology and Laboratory Medicine 116(11): 1102-1103

Ahmed, I.; Piepkorn, M.; Goldgar, D.E.; Cannon-Albright, L.A.; Meyer, L.J.; Skolnick, M.H.; Zone, J.J. 1991: HMB-45 staining of dysplastic melanocytic nevi in melanoma risk groups. Journal of Cutaneous Pathology 18(4): 257-260

Smoller, B.R.; McNutt, N.S.; Hsu, A. 1989: HMB-45 staining of dysplastic nevi. Support for a spectrum of progression toward melanoma. American Journal of Surgical Pathology 13(8): 680-684

Friedman, H.D.; Tatum, A.H. 1991: HMB-45-positive malignant lymphoma. A case report with literature review of aberrant HMB-45 reactivity. Archives of Pathology and Laboratory Medicine 115(8): 826-830

Wick, M.R. 1991: HMB-45: a clue to the biology of malignant melanoma?. Journal of Cutaneous Pathology 18(5): 307-308

Schweckendiek, W.; Hillig, U.; Kruse, E.; Rodeck, G.; Wendt, G.G. 1976: HMC syndrome in identical twins. Human Genetics 33(3): 315-318

Stupnicki, R.; Kowalczyk-Przeewłoka, T.; Kula, E.; Kasongo, L.Y. 1987: HME--a novel derivative for direct iodination in steroid radioimmunoassays. Journal of Steroid Biochemistry 28(6): 663-667

Zuck, D.; Jeffreys, J. 1990: HMEs and body temperature. Anaesthesia 45(11): 991-992

Conn, I.G.; Crocker, J.; Emtage, L.A.; Wallace, D.M. 1988: HMFG-2 as a prognostic indicator in superficial bladder cancer. Journal of Clinical Pathology 41(11): 1191-1195

Moseley, R.P.; Oge, K.; Shafqat, S.; Moseley, C.M.; Sullivan, N.M.; Badley, R.A.; Burchell, J.; Taylor-Papadimitriou, J.; Coakham, H.B. 1989: HMFG1 antigen: a new marker for carcinomatous meningitis. International Journal of Cancer 44(3): 440-444

Sheflin, L.G.; Fucile, N.W.; Spaulding, S.W. 1991: HMG 14 and protamine enhance ligation of linear DNA to form linear multimers: phosphorylation of HMG 14 at Ser 20 specifically inhibits intermolecular DNA ligation. Biochemical and Biophysical Research Communications 174(2): 660-666

Hitchener, W.R.; Cenedella, R.J. 1987: HMG CoA reductase activity of lens epithelial cells: compared with true rates of sterol synthesis. Current Eye Research 6(8): 1045-1049

Maher, V.M.; Thompson, G.R. 1990: HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin. Quarterly Journal of Medicine 74(274): 165-175

Aronson, J.K.; Ng, L.L. 1990: HMG CoA reductase inhibitors in the treatment of hypercholesterolaemias. Quarterly Journal of Medicine 74(274): 111-115

Kostner, G.M.; Gavish, D.; Leopold, B.; Bolzano, K.; Weintraub, M.S.; Breslow, J.L. 1989: HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels. Circulation 80(5): 1313-1319

Walker, J.F. 1988: HMG CoA reductase inhibitors. Current clinical experience. Drugs 36(Suppl 3): 83-86

Ziegler, O.; Drouin, P.; Debry, G. 1989: HMG CoA reductase inhibitors: a new class of hypocholesterolemic agents. La Revue du Praticien 39(4): 313-315

Alberts, A.W. 1990: Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis. Cardiology 77(Suppl 4): 14-21

Mosevitskiĭ, M.I.; Novitskaia, V.A.; Iogannsen, M.G.; Zabezhinskiĭ, M.A. 1985: HMG protein levels in cell nuclei with different proliferative and transcription activities. Molekuliarnaia Biologiia 19(3): 722-729

Brawley, J.V.; Martinson, H.G. 1992: HMG proteins 14 and 17 become cross-linked to the globular domain of histone H3 near the nucleosome core particle dyad. Biochemistry 31(2): 364-370

Pani, B.; Plossi, P.; Russo, E. 1989: HMG proteins released from the chromatin following incubation of mammalian nuclei with ethidium bromide. Experimental Cell Research 180(2): 557-562

Meinders, A.E. 1988: HMG-CoA reductase inhibition: the start of a new age in the treatment of hypercholesterolaemia. Netherlands Journal of Medicine 32(5-6): 213-216

Smith, P.F.; Eydelloth, R.S.; Grossman, S.J.; Stubbs, R.J.; Schwartz, M.S.; Germershausen, J.I.; Vyas, K.P.; Kari, P.H.; MacDonald, J.S. 1991: HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine a interaction and mechanism studies. Journal of Pharmacology and Experimental Therapeutics 257(3): 1225-1235

Endo, A. 1991: HMG-CoA reductase inhibitors. Nihon Rinsho. Japanese Journal of Clinical Medicine 49(9): 2004-2009

Anonymous 1988: HMG-CoA reductase inhibitors for hypercholesterolemia. New England Journal of Medicine 319(18): 1222-1223

Grundy, S.M. 1988: HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. New England Journal of Medicine 319(1): 24-33

Geisel, J.; Oette, K.; Burrichter, H. 1990: HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences. Fortschritte der Medizin 108(4): 71

Williams, M.L.; Menon, G.K.; Hanley, K.P. 1992: HMG-CoA reductase inhibitors perturb fatty acid metabolism and induce peroxisomes in keratinocytes. Journal of Lipid Research 33(2): 193-208

Cressman, M.D.; Hoogwerf, B.J.; Moodie, D.S.; Olin, J.W.; Weinstein, C.E. 1988: HMG-CoA reductase inhibitors. a new approach to the management of hypercholesterolemia. Cleveland Clinic Journal of Medicine 55(1): 93-100

Kathawala, F.G. 1991: HMG-CoA reductase inhibitors: an exciting development in the treatment of hyperlipoproteinemia. Medicinal Research Reviews 11(2): 121-146

Saxenhofer, H.; Weidmann, P. 1990: HMG-CoA-reductase inhibitors: a new principle in the treatment of hypercholesterolemia. Therapeutische Umschau. Revue Therapeutique 47(6): 509-513

Shirakata, M.; Hüppi, K.; Usuda, S.; Okazaki, K.; Yoshida, K.; Sakano, H. 1991: HMG1-related DNA-binding protein isolated with V-(D)-J recombination signal probes. Molecular and Cellular Biology 11(9): 4528-4536

Micklem, K.J.; Dong, Y.; Willis, A.; Pulford, K.A.; Visser, L.; Dürkop, H.; Poppema, S.; Stein, H.; Mason, D.Y. 1991: HML-1 antigen on mucosa-associated T cells, activated cells, and hairy leukemic cells is a new integrin containing the beta 7 subunit. American Journal of Pathology 139(6): 1297-1301

Masuhara, M.; Wada, Y.; Tatsumi, N. 1979: HMM-decorated filaments in leukocyte nucleus. Tohoku Journal of Experimental Medicine 129(3): 219-223

Anonymous 1975: HMO Act is causing problems; many want amendments. Employee Benefit Plan Review 30(2): 12 14

Traska, M.R. 1987: HMO America's sale has financial twist to it. Hospitals 61(10): 47 49

Cohen, R. 1987: HMO Quality of Care Program. Quality Assurance and Utilization Review: Official Journal of the American College of Utilization Review Physicians 2(4): 111-125

Wagner, B. 1986: HMO advertising in Twin Cities gets even hotter. Hospitals 60(12): 60

Larkin, H. 1989: HMO conflict: market pressure vs. indigent care. Hospitals 63(14): 62 64

Johnsson, J. 1992: HMO contracting: how to minimize UR liability. Hospitals 66(20): 50; 52

McCormick, B. 1986: HMO cuts early births 22 percent. Hospitals 60(15): 57

Welch, W.P. 1988: HMO enrollment and Medicaid. Survival analysis with a Weibull function. Medical Care 26(1): 45-52

Siddharthan, K. 1990: HMO enrollment by Medicare beneficiaries in heterogeneous communities. Medical Care 28(10): 918-927

Tarlov, A.R. 1986: HMO enrollment growth and physicians: the third compartment. Health Affairs 5(1): 23-35

Traska, M.R. 1987: HMO execs shift focus, feel money pinch: survey. Hospitals 61(14): 50-51

Shahoda, T. 1985: Hospital group markets clinical trial research sites. Hospitals 59(22): 51-52

Anderson, W.H. 1988: HMO financial incentives and informed consent. JAMA 260(6): 791

Anonymous 1989: HMO financial reports. Wisconsin Medical Journal 88(9): 44-46

McLaughlin, C.G. 1987: HMO growth and hospital expenses and use: a simultaneous-equation approach. Health Services Research 22(2): 183-205

Zellner, B.B.; Wolfe, B.L. 1989: HMO growth and hospital expenses: a correction. Health Services Research 24(3): 409

Traska, M.R. 1985: HMO growth rapid but outstripped by PPAs. Hospitals 59(24): 51

Francis, W. 1986: HMO growth, costs, and customer service. Health Affairs 5(1): 173-182

Holthaus, D. 1988: HMO insolvency: who ends up paying the bills?. Hospitals 62(10): 66

Rymer, T.A. 1990: HMO liable for the negligence of a non-HMO consulting physician. Indiana Medicine: the Journal of the Indiana State Medical Association 83(2): 130-131

Hillman, A.L.; Pauly, M.V.; Kerman, K.; Martinek, C.R. 1991: HMO managers' views on financial incentives and quality. Health Affairs 10(4): 207-219

Robinson, J.C. 1991: HMO market penetration and hospital cost inflation in California. JAMA 266(19): 2719-2723

Lichtenstein, R.; Thomas, J.W.; Watkins, B.; Puto, C.; Lepkowski, J.; Adams-Watson, J.; Simone, B.; Vest, D. 1992: HMO marketing and selection bias: are TEFRA HMOs skimming?. Medical Care 30(4): 329-346

Austerlitz, J. 1987: HMO medicine: a personal experience. Rhode Island Medical Journal 70(2): 61-64

Francis, S.R. 1976: HMO or PSRO, so we want in or out?. Texas Dental Journal 94(8): 10-12

Larkin, H. 1990: HMO ownership pays off for systems that stick with it. Hospitals 64(3): 56-58

Bukata, W.R. 1989: HMO patients in the emergency department. Journal of Emergency Nursing 15(5): 374-376

Ellis, J.M.; Ernst, A.A.; Launius, J.; Karch, S.B. 1988: HMO patients with AMI: any difference in treatment?. Annals of Emergency Medicine 17(2): 188

Mays, W. 1978: HMO plan a health care alternative. Aorn Journal 28(1): 62-65

Scarpaci, J.L. 1987: HMO promotion and the privatization of health care in Chile. Journal of Health Politics Policy and Law 12(3): 551-567

Anonymous 1975: HMO regulations issued for Section 1310. Proposed dual choice regs leave unanswered questions. Employee Benefit Plan Review 29(9): 8-9

Traska, M.R. 1987: HMO review bidders stew over delayed RFP. Hospitals 61(6): 73-74

Traska, M.R. 1987: HMO review plan panned by prospective bidders. Hospitals 61(8): 56-57

Traska, M.R. 1988: HMO sales signal Maxicare break-up. Hospitals 62(12): 36-37

Ward, R.A. 1987: HMO satisfaction and understanding among recent Medicare enrollees. Journal of Health and Social Behavior 28(4): 401-412

Traska, M.R. 1986: HMO start-ups cost big money, experts say. Hospitals 60(12): 61-62

Firshein, J. 1986: HMO suit sparks concern over Medicare reimbursement. Hospitals 60(18): 74-75

Traska, M.R. 1988: HMO uses quality measures to pay its physicians. Hospitals 62(13): 34; 36

Tesch, H.; Jücker, M.; Falk, M.H.; Bornkamm, G.W.; Jones, D.B.; Diehl, V. 1988: Molecular analysis of Hodgkin's disease-derived cell lines. Hematological Oncology 6(3): 223-231

Vernon, S.W.; Hughes, J.I.; Heckel, V.M. 1990: HMO versus fee for service practice: a four-year retrospective analysis of colorectal cancer diagnosis and treatment. Is there a difference in quality of care?. Progress in Clinical and Biological Research 339: 341-350

Traska, M.R. 1986: HMO visits up; drop in inpatient days slows. Hospitals 60(14): 56

Rushmore, C.H.; Youngblood, S.A. 1979: Medically-related absenteeism: random or motivated behavior?. Journal of Occupational Medicine.: Official Publication of the Industrial Medical Association 21(4): 245-250

Carlisle, D.M.; Siu, A.L.; Keeler, E.B.; McGlynn, E.A.; Kahn, K.L.; Rubenstein, L.V.; Brook, R.H. 1992: HMO vs fee-for-service care of older persons with acute myocardial infarction. American Journal of Public Health 82(12): 1626-1630

Dorsey, J.L. 1978: HMO's and the cost of medical care. New England Journal of Medicine 298(24): 1360-1361

McLeod, W.J. 1975: HMO's and the employer. Journal of Occupational Medicine.: Official Publication of the Industrial Medical Association 17(10): 632-634

Anderson, W.H. 1987: HMO's incentives: a prescription for failure. Journal - Connecticut State Dental Association 61(1): 29-30

Judge, M. 1977: HMO's stimulate competition; bring hospitalization rates down. Forum 1(1): 2-5

Bagley, J.L. 1979: HMO's, friend or foe?. Dental Laboratory Review 54(10): 20-21

Hoffheimer, L.S. 1976: HMO's--worth the risk?. Group Practice 25(5): 28-29

Curtiss, F.R. 1986: HMO, CMP, or PPO?. American Journal of Hospital Pharmacy 43(2): 288 292

Skuza, B.H. 1976: Health planning and resources development: an opportunity for optometry. Journal of the American Optometric Association 47(2): 143-145

Fisher, D.W. 1986: HMO--the newest 'wave of the future'. Hospital Practice 21(3): 13; 17

Minzter, A. 1986: HMO-IPA proposal. New Jersey Medicine: the Journal of the Medical Society of new Jersey 83(11): 745-746

Traska, M.R. 1987: HMO/CMP review is up and running (finally). Hospitals 61(21): 55-56

Arm, F. 1991: HMO: a promising alternative health insurance. a model of integrated medicine. KRANKENPFLEGE. Soins Infirmiers 84(1): 29-31

Soh, G. 1987: HMO: doing better and feeling better? Some findings from a regional health survey. Singapore Medical Journal 28(2): 126-133

Hodges, A. 1976: HMO: new frontier for rehabilitation medicine perseonnel. American Corrective Therapy Journal 30(6): 171-173

Schondelmeyer, S.W. 1986: HMOS and PPOS: strategy for success through pharmacy networks. American Pharmacy 26(1): 44-47; 50-55

Greenberg, W. 1977: HMOS stimulate competition, FTC concludes. Hospital Progress 58(10): 10-11

Goldberg, L.S. 1987: HMOs and CMPs: federal regulations. Topics in Health Care Financing 13(3): 38-46

Grimaldi, P.L. 1985: HMOs and Medicare. Nursing Management 16(4): 16-20

Arnold, W.V.; Leonard, M.A. 1987: HMOs and PPOs: an operational guide. Topics in Health Care Financing 13(3): 19-31

Lee, K.E.; Lee, K.J. 1986: HMOs and PPOs: pointers and pitfalls. Connecticut Medicine 50(11): 753-757

Dalton, J.J. 1987: HMOs and PPOs: similarities and differences. Topics in Health Care Financing 13(3): 8-18

Dowd, B.E. 1986: HMOs and Twin Cities admission rates. Health Services Research 21(2 Part 1): 177-188

Shapiro, I.S. 1975: HMOs and health education. American Journal of Public Health 65(5): 469-473

Warden, G.; Tuller, E. 1979: HMOs and hospitals: what are the options?. Hospitals 53(16): 63-65

Rasaiah, B. 1988: HMOs and limited health care resources. Cmaj: Canadian Medical Association Journal 139(11): 1033-1034

Gold, M.R. 1991: HMOs and managed care. Health Affairs 10(4): 189-206

Moore, G.T. 1986: HMOs and medical education: fashioning a marriage. Health Affairs 5(1): 147-153

Losek, J.D.; Walsh-Kelly, C.M.; Altstadt, J.F. 1987: HMOs and pediatric emergency care. Pediatric Emergency Care 3(2): 79-81

Marshall, J.R. 1987: HMOs and psychiatry: could there be a silver lining?. International Journal of Law and Psychiatry 10(1): 35-43

Luft, H.S. 1988: HMOs and the quality of care. Inquiry: a Journal of Medical Care Organization Provision and Financing 25(1): 147-156

Haynes, B.E.; Bedard, L.A. 1989: HMOs and the use of 911. Annals of Emergency Medicine 18(4): 422

Lamont, J.H. 1990: HMOs are not the answer. Wisconsin Medical Journal 89(10): 564

Droste, T. 1987: HMOs bid for Florida state employee contracts. Hospitals 61(22): 74

Powills, S. 1986: HMOs can teach hospitals the marketing game. Hospitals 60(15): 52-53

Burda, D. 1986: HMOs carry antitrust risk. Hospitals 60(18): 38

Downs, C. 1979: HMOs change Michigan health care scene: but IPAs offer opportunities for private practice. Michigan Medicine 78(12): 239-240

Buchanan, J.L.; Lindsey, P.A.; Leibowitz, A.; Davies, A.R. 1992: HMOs for Medicaid: the road to financial independence is often poorly paved. Journal of Health Politics Policy and Law 17(1): 71-96

Scharf, A.M. 1987: HMOs in Pennsylvania--a primer. Pennsylvania Medicine 90(9): 34-36

Anonymous 1979: HMOs in Pennsylvania: how do they function?. Pennsylvania Nurse 34(4): 1 3

Rayner, G. 1988: HMOs in the U.S.A. and Britain: a new prospect for health care?. Social Science and Medicine 27(4): 305-320

Burda, D. 1986: HMOs may cause legal headaches for hospitals. Hospitals 60(3): 30

Traska, M.R. 1987: HMOs slam Senate aging committee's report. Hospitals 61(10): 46-47

Newald, J. 1986: HMOs start to capitate radiology services. Hospitals 60(19): 108; 111

Larkin, H. 1988: HMOs stay profitable by lowering hospital rates. Hospitals 62(21): 44

Arkans, H.D. 1991: HMOs today. New Jersey Medicine: the Journal of the Medical Society of new Jersey 88(6): 395-396

Larkin, H. 1988: HMOs turn to hospitals for skilled nursing. Hospitals 62(20): 44; 46

Traska, M.R. 1986: HMOs' grasp on drug benefits is getting stronger. Hospitals 60(8): 68

Adams, T.L. 1989: HMOs, MDs, and the term 'hold harmless'. Wisconsin Medical Journal 88(6): 4

McNeil, R.; Schlenker, R.E. 1975: HMOs, competition, and government. Milbank Memorial Fund Quarterly. Health and Society 53(2): 195-224

Moran, D.W.; Savela, T.E. 1986: HMOs, finance, and the hereafter. Health Affairs 5(1): 51-65

Bernstein, A.R. 1979: HMOs, hospitals, and the law. Hospitals 53(23): 35; 38 42

Seubold, F.H. 1975: HMOs--the view from the program. Public Health Reports 90(2): 99-103

Anderegg, A.F. 1979: HMOs--their limitations and role. Minnesota Medicine 62(11): 797-798

Butler, R.N. 1992: HMOs: 'medicine, Soviet style'?. Geriatrics 47(12): 11

Richards, T. 1986: HMOs: America today, Britain tomorrow? A doctor's perspective. British Medical Journal 292(6518): 460-463

Richards, T. 1986: HMOs: America today, Britain tomorrow? Even the rich can't afford it. British Medical Journal 292(6515): 257-259

Richards, T. 1986: HMOs: America today, Britain tomorrow? Exit the white coat, enter the pinstriped suit. British Medical Journal 292(6519): 539-542

Richards, T. 1986: HMOs: America today, Britain tomorrow? Nuts, bolts, and the customers. British Medical Journal 292(6517): 392-394

Falkson, J.L. 1979: HMOs: a look back, a look ahead. Hospitals 53(16): 86; 90 92 Passim

Traska, M.R. 1986: HMOs: a shake-up (and shakeout) on the horizon?. Hospitals 60(3): 40-45

Aries, N.; Fahs, M.C. 1988: HMOs: an answer to fee-for-service?. Mount Sinai Journal of Medicine new York 55(2): 117-125

Foy, D.F. 1979: HMOs: better than fee-for-service system?. Journal of the Indiana State Medical Association 72(4): 230-231

Krigstein, D.J.; Brusadin, R.A.; Crook, D.M.; Naber, P.; Neels, J.; Penna, P.M. 1985: HMOs: challenges & opportunities. American Pharmacy 25(10): 31-39

Droste, T. 1988: HMOs: employers shed casual attitudes, contracts. Hospitals 62(12): 60; 62

Raman, S. 1988: N of 1 randomized controlled trials. Cmaj: Canadian Medical Association Journal 139(6): 478-479

Willis, D.B. 1987: HMOs: financial feasibility, planning, and control. Topics in Health Care Financing 13(3): 32-37

Smith, D.A. 1979: HMOs: hope on the horizon?. Pennsylvania Medicine 82(12): 6

Backus, V.P. 1987: HMOs: not always the best medicine. Hospital and Community Psychiatry 38(3): 229

Considine, J.M.; Oakes, L.S. 1991: HMOs: survival of the fittest. New Jersey Medicine: the Journal of the Medical Society of new Jersey 88(2): 111-114

Kushner, J. 1989: HMOs: the failed promise. Surgical Neurology 31(2): 120-121

Conner, S.L. 1979: The NHi chess game. Journal of the Medical Association of the State of Alabama 49(1): 2,4

Baker, W.H. 1988: HMOs: the view from the right. American Surgeon 54(6): 321-323

Columbano, A.; Dessì, S.; Ledda-Columbano, G.M.; Chiodino, C.; Coni, P.; Pani, P.; Rao, K.N. 1987: HMP-shunt and cholesterol metabolism in experimental models involving normal and preneoplastic liver growth. Toxicologic Pathology 15(1): 43-50

Le Scao, Y.; Baulieu, J.L.; Robier, A.; Girard, M.; Pourcelot, L.; Beutter, P. 1991: HMPAO radionuclide of temporal cortex in the study of deafness. Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 108(8): 451-454

Conrad, G.R.; Dean, B.L.; Baumann, R.J.; Seabold, J.E. 1991: HMPAO scintigraphy, MRI, and CT of a vascular fibrous dysplasia of the craniofacial bones. Clinical Nuclear Medicine 16(10): 743-746

Broich, K.; Horwich, D.; Alavi, A. 1991: HMPAO-SPECT and MRi in acute disseminated encephalomyelitis. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 32(10): 1897-1900

Grünwald, F.; Zierz, S.; Broich, K.; Schumacher, S.; Bockisch, A.; Biersack, H.J. 1990: HMPAO-SPECT imaging resembling Alzheimer-type dementia in mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS). Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 31(10): 1740-1742

Grünwald, F.; Durwen, H.; Bülau, P.; Bockisch, A.; Elger, C.E.; Rohde, A.; Reichmann, K.; Ammari, B.; Hotze, A.; Penin, H. 1988: HMPAO-SPECT in cerebral seizures. Nuklearmedizin. Nuclear Medicine 27(6): 248-251

McLean, B. 1986: HMRi and care appraisal. Australian Clinical Review 6(21): 107-109

McNab, J. 1977: HMRi has come of age. Dimensions in Health Service 54(4): 8-9

Lunn, D.V. 1987: HMS Illustrious gearbox explosion and fire--3 April 1986. Journal of the Royal Naval Medical Service 73(2): 77-79

Konings, A.W. 1979: Dose-rate effects in biomembranes. Journal of Radiation Research 20(4): 259-263

Murray, R. 1975: HMS etcetera. Occupational Health; a Journal for Occupational Health Nurses 27(4): 138-139

Trizio, M.; Pozio, G.; Coviello, V.; Serlenga, L. 1986: HMSN type Ii with autosomal recessive transmission. Description of 2 cases with early onset. Acta Neurologica 8(3): 234-239

Stolee, T.A. 1992: HMSS tackles the tough questions. Minnesota Medicine 75(2): 41-42

Neely, M.D.; Erickson, H.P.; Boekelheide, K. 1990: HMW-2, the Sertoli cell cytoplasmic dynein from rat testis, is a dimer composed of nearly identical subunits. Journal of Biological Chemistry 265(15): 8691-8698

Sandman, K.; Krzycki, J.A.; Dobrinski, B.; Lurz, R.; Reeve, J.N. 1990: HMf, a DNA-binding protein isolated from the hyperthermophilic archaeon Methanothermus fervidus, is most closely related to histones. Proceedings of the National Academy of Sciences of the United States of America 87(15): 5788-5791

Tabassum, R.; Sandman, K.M.; Reeve, J.N. 1992: HMt, a histone-related protein from Methanobacterium thermoautotrophicum delta H. Journal of Bacteriology 174(24): 7890-7895

Brooksbank, D.F. 1987: HN(84)25 LASSL(84)5 (adolescent suicide). British Journal of Hospital Medicine 38(6): 578

Cosentino, F.; Schirger, A.; Katusić, Z.S. 1992: HN-10200 causes endothelium-independent relaxations in isolated canine arteries. Cardiovascular Drugs and Therapy 6(2): 159-165

Kumari, H.L.; Shuler, C.; Mannix, D.G.; Milo, G.E. 1990: HNF transfection with chondrosarcoma DNA results in the development of a sarcoma cell surface-associated epitope. Experimental and Molecular Pathology 53(2): 167-179

Mendel, D.B.; Hansen, L.P.; Graves, M.K.; Conley, P.B.; Crabtree, G.R. 1991: HNF-1 alpha and HNF-1 beta (vHNF-1) share dimerization and homeo domains, but not activation domains, and form heterodimers in vitro. Genes and Development 5(6): 1042-1056

Baumhueter, S.; Mendel, D.B.; Conley, P.B.; Kuo, C.J.; Turk, C.; Graves, M.K.; Edwards, C.A.; Courtois, G.; Crabtree, G.R. 1990: HNF-1 shares three sequence motifs with the POU domain proteins and is identical to LF-B1 and APF. Genes and Development 4(3): 372-379

Lai, E.; Prezioso, V.R.; Smith, E.; Litvin, O.; Costa, R.H.; Darnell, J.E. 1990: HNF-3A, a hepatocyte-enriched transcription factor of novel structure is regulated transcriptionally. Genes and Development 4(8): 1427-1436

Manara, G.C.; Ferrari, C.; De Panfilis, G. 1988: HNK-1 antigen is not specific for natural killer cells. Journal of Investigative Dermatology 91(4): 374-375

Nordlander, R.H. 1989: HNK-1 marks earliest axonal outgrowth in Xenopus. Brain Research. Developmental Brain Research 50(1): 147-153

Piras, M.A.; Lovigu, C.; Sanna, M.G.; Babudieri, S.; Caiazza, R.; Salis, M.T.; Panichi, G. 1990: HNK-1 peripheral blood lymphocytes in HIV infected patients. Bollettino Dell'istituto Sieroterapico Milanese 69(1): 343-347

Fregona, I.; Guttmann, R.D.; Jean, R. 1985: HNK-1+ (Leu-7) and other lymphocyte subsets in long-term survivors with renal allotransplants. Transplantation 39(1): 25-29

Komiyama, K.; Hirsch, H.Z.; Moro, I.; Umemura, S.; Mestecky, J. 1988: HNK-1+ (Leu-7) cells and natural killer cell activity in inflamed human gingival tissue. Journal of Oral Pathology 17(3): 118-123

Ando, I.; Tamaki, K. 1985: HNK-i antibody reacts with peripheral nerves and sweat glands in the skin. British Journal of Dermatology 113(2): 175-178

Ohashi, H.; Hashizume, S.; Murakami, H.; Aihara, K.; Shinohara, K.; Omura, H. 1986: HO-323, a human B-lymphoblastoid cell line useful for making human-human hybridomas. Cell Biology International Reports 10(2): 77-83

Liang, R.; Todd, D.; Chan, T.K. 1988: HOAP-Bleo as salvage therapy for diffuse aggressive non-Hodgkin's lymphoma. Cancer ChemoTherapy and Pharmacology 22(2): 169-171

Shan, Y.D. 1985: HOAP/HOAGP in the treatment of acute non-lymphocytic leukemia: an analysis of 68 cases. Zhonghua Yi Xue Za Zhi 65(10): 590-592

Machii, K. 1977: HOCM (IHSS, ASH)--hypertrophic obstructive cardiomyopathy (idiopathic hypertrophic subaortic stenosis and asymmetric septal hypertrophy). Nihon Rinsho. Japanese Journal of Clinical Medicine 35(Suppl 1): 744-745

Lang, Z.H.; Murlas, C.G. 1991: HOCl exposure of a human airway epithelial cell line decreases its plasma membrane neutral endopeptidase. Lung 169(6): 311-323

Pittman, J.L. 1976: HOD proposal best!. Journal of the Michigan Dental Association 58(3): 171

Bao, G.; Qadri, F.; Stauss, B.; Stauss, H.; Gohlke, P.; Unger, T. 1991: HOE 140, a new highly potent and long-acting bradykinin antagonist in conscious rats. European Journal of Pharmacology 200(1): 179-182

Von Hagen, V.; Morens, A.; Krief, B. 1991: HOME: Highly Optimized Microscopic Environment (a new workstation for microscopic analysis in pathology). Analytical Cellular Pathology: the Journal of the European Society for Analytical Cellular Pathology 3(4): 249-256

Stockwell, P.A. 1988: HOMED: a homologous sequence editor. Trends in Biochemical Sciences 13(8): 322-324

Chalvardjian, A.; Lee, S. 1986: HOPS: a tetrachrome stain useful in dermatopathology. American Journal of Dermatopathology 8(2): 178-179

Cillo, C.; Barba, P.; Freschi, G.; Bucciarelli, G.; Magli, M.C.; Boncinelli, E. 1992: HOX gene expression in normal and neoplastic human kidney. International Journal of Cancer 51(6): 892-897

Dollé, P.; Izpisúa-Belmonte, J.C.; Brown, J.M.; Tickle, C.; Duboule, D. 1991: HOX-4 genes and the morphogenesis of mammalian genitalia. Genes and Development 5(10): 1767

Kennedy, M.A.; Gonzalez-Sarmiento, R.; Kees, U.R.; Lampert, F.; Dear, N.; Boehm, T.; Rabbitts, T.H. 1991: HOX11, a homeobox-containing T-cell oncogene on human chromosome 10q24. Proceedings of the National Academy of Sciences of the United States of America 88(20): 8900-8904

Zappavigna, V.; Renucci, A.; Izpisúa-Belmonte, J.C.; Urier, G.; Peschle, C.; Duboule, D. 1991: HOX4 genes encode transcription factors with potential auto- and cross-regulatory capacities. EMBO Journal 10(13): 4177-4187

Hafkemeyer, P.; Neftel, K.; Hobi, R.; Pfaltz, A.; Lutz, H.; Lüthi, K.; Focher, F.; Spadari, S.; Hübscher, U. 1991: HP 0.35, a cephalosporin degradation product is a specific inhibitor of lentiviral RNAses H. Nucleic Acids Research 19(15): 4059-4065

Coryell, W.; Noyes, R. 1988: HPA axis disturbance and treatment outcome in panic disorder. Biological Psychiatry 24(7): 762-766

Coryell, W.H.; Black, D.W.; Kelly, M.W.; Noyes, R. 1989: HPA axis disturbance in obsessive-compulsive disorder. Psychiatry Research 30(3): 243-251

Gurevich, D.; Siegel, B.; Dumlao, M.; Perl, E.; Chaitin, P.; Bagne, C.; Oxenkrug, G. 1990: HPA axis responsivity to dexamethasone and cognitive impairment in dementia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 14(3): 297-308

Kaplan, C.; Morel-Kopp, M.C.; Kroll, H.; Kiefel, V.; Schlegel, N.; Chesnel, N.; Mueller-Eckhardt, C. 1991: HPA-5b (Br(a)) neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 cases. British Journal of Haematology 78(3): 425-429

Coryell, W.; Zimmerman, M. 1987: HPA-axis abnormalities in psychiatrically well controls. Psychiatry Research 20(4): 265-273

Maes, M.; D'Hondt, P.; Suy, E.; Minner, B.; Vandervorst, C.; Raus, J. 1991: HPA-axis hormones and prolactin responses to dextro-fenfluramine in depressed patients and healthy controls. Progress in Neuro-Psychopharmacology and Biological Psychiatry 15(6): 781-790

Träskman-Bendz, L.; Ekman, R.; Regnéll, G.; Ohman, R. 1992: HPA-related CSF neuropeptides in suicide attempters. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 2(2): 99-106

Budváriné-Bárány, Z.; Radeczky, G.; Szász, G.; Shalaby, A. 1991: HPC purity tests for caffeine, theophylline and theobromine. Acta Pharmaceutica Hungarica 61(1): 1-7

Lubaroff, D.M. 1978: HPC-36: an epithelial tissue culture line derived from human prostate adenocarcinoma. National Cancer Institute Monograph 49: 35-39

Kyank, H.R. 1985: HPL as indicator of intrauterine malnutrition. Journal of Perinatal Medicine 13(2): 100-101

Schneider, L.; Rigaud, M.; Tabaste, J.L.; Chebroux, P.; Lacour, B.; Baudet, J. 1978: HPL measurements: relationships with maternal weight gain in twin pregnancy. Progress in Clinical and Biological Research 24 Pt C: 123-128

Heller, S.; Weber, H.; Kunz, S.; Glomm, H. 1975: HPL, HCG, estriol and blood coagulation and fibrinolysis parameters in EPH gestosis. Archiv für Gynakologie 219(1-4): 426

Gosseye, S.; van der Veen, F. 1992: HPL-positive infiltrating trophoblastic cells in normal and abnormal pregnancy. European Journal of Obstetrics Gynecology and Reproductive Biology 44(2): 85-90

Svanosio, M.; Calleri, W.; Ottone, P.; Massobrio, M. 1976: HPL/HASP correlations in some types of placental pathology. Annali di Ostetricia Ginecologia Medicina Perinatale 97(2): 116-121

Paintz, M.; Richter, M.; Hauptmann, J. 1987: HPLC Determination of the synthetic thrombin inhibitor N alpha-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide in biological material. Die Pharmazie 42(5): 346

Gasparro, F.P.; Bagel, J.; Edelson, R.L. 1985: HPLC analysis of 4',5'-monoadduct formation in calf thymus DNA and synthetic polynucleotides treated with UVA and 8-methoxypsoralen. Photochemistry and Photobiology 42(1): 95-98

Rudy, J.L.; Argyle, J.C.; Winick, N.; Van Dreal, P. 1988: HPLC analysis of 6-mercaptopurine and metabolites in extracellular body fluids. Annals of Clinical Biochemistry 25: 504-509

Kubacki, S.J.; Havery, D.C.; Fazio, T. 1989: HPLC analysis of N-nitrosamino acids and N-nitrosodipeptides N-terminal in proline. Zeitschrift für die Gesamte Hygiene und ihre Grenzgebiete 35(2): 98-100

Ficarra, P.; Ficarra, R.; Tommasini, A.; De Pasquale Costa, R.; Guarniera Fenech, C.; Ragusa, S. 1986: HPLC analysis of a drug in traditional medicine: Harpagophytum procumbens DC. i. Bollettino Chimico Farmaceutico 125(7): 250-253

Spagnolo, F.; Hatcher, M.T.; Faulseit, B.K. 1987: HPLC analysis of commercial alkyl and aryl quaternary ammonium compounds used in organoclay type rheological additives. Journal of Chromatographic Science 25(9): 399-401

Goh, E.H.; Colles, S.M.; Otte, K.D. 1989: HPLC analysis of desmosterol, 7-dehydrocholesterol, and cholesterol. Lipids 24(7): 652-655

Camaggi, C.M.; Comparsi, R.; Strocchi, E.; Testoni, F.; Pannuti, F. 1988: HPLC analysis of doxorubicin, epirubicin and fluorescent metabolites in biological fluids. Cancer ChemoTherapy and Pharmacology 21(3): 216-220

Shahabi, N.A.; Hyder, S.M.; Wiehle, R.D.; Wittliff, J.L. 1986: HPLC analysis of estrogen receptor by a multidimensional approach. Journal of Steroid Biochemistry 24(6): 1151-1157

Palmero, S.; de Marchis, M.; Prati, M.; Fugassa, E. 1992: HPLC analysis of free amino acids and amino acids of total proteins in cultured cells: an application to the study of rat Sertoli cell protein metabolism. Analytical Biochemistry 202(1): 152-158

Komodo, Y.; Nakamura, H.; Uchida, M. 1988: HPLC analysis of ginkgolides by using a differential refractometer. Iyo Kizai Kenkyujo Hokoku. Reports of the Institute for Medical and Dental Engineering Tokyo Medical and Dental University 22: 83-85